0001564590-20-039314.txt : 20200811 0001564590-20-039314.hdr.sgml : 20200811 20200811161346 ACCESSION NUMBER: 0001564590-20-039314 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200811 DATE AS OF CHANGE: 20200811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Altimmune, Inc. CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 201092571 BUSINESS ADDRESS: STREET 1: 910 CLOPPER ROAD STREET 2: SUITE 201S CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2406541450 MAIL ADDRESS: STREET 1: 910 CLOPPER ROAD STREET 2: SUITE 201S CITY: GAITHERSBURG STATE: MD ZIP: 20878 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATHENE, INC DATE OF NAME CHANGE: 20071016 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 10-Q 1 alt-10q_20200630.htm 10-Q alt-10q_20200630.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

Commission file number 001-32587

 

ALTIMMUNE, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

 

20-2726770

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

910 Clopper Road Suite 201S, Gaithersburg, Maryland

 

20878

(Address of Principal Executive Offices)

 

(Zip Code)

 

(240) 654-1450

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.0001 per share

ALT

The NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes      No  

As of August 7, 2020 there were 32,904,333 shares of the registrant’s common stock, par value $0.0001 per share, outstanding.

 

 

 


 

 

 

ALTIMMUNE, INC.

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

PART I. FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements

 

1

 

 

 

 

 

Consolidated Balance Sheets as of June 30, 2020 (unaudited) and December 31, 2019

 

1

 

 

 

 

 

Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2020 and 2019 (unaudited)

 

2

 

 

 

 

 

Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2020 and 2019 (unaudited)

 

3

 

 

 

 

 

Consolidated Statements of Cash Flows for the six months ended June 30, 2020 and 2019 (unaudited)

 

4

 

 

 

 

 

Notes to Consolidated Financial Statements (unaudited)

 

5

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

14

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

18

 

 

 

 

Item 4.

Controls and Procedures

 

18

 

 

 

 

 

 

 

PART II. OTHER INFORMATION

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

19

 

 

 

 

Item 1A.

Risk Factors

 

19

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

20

 

 

 

 

Item 3.

Defaults Upon Senior Securities

 

20

 

 

 

 

Item 4.

Mine Safety Disclosures

 

20

 

 

 

 

Item 5.

Other Information

 

20

 

 

 

 

Item 6.

Exhibits

 

21

 

 

 

 

 

Signatures

 

22

 

 

 

 

 

 

 


 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

ALTIMMUNE, INC.

CONSOLIDATED BALANCE SHEETS

 

 

 

June 30, 2020

 

 

December 31, 2019

 

 

 

(unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

64,741,921

 

 

$

8,962,686

 

Restricted cash

 

 

34,174

 

 

 

34,174

 

Total cash, cash equivalents and restricted cash

 

 

64,776,095

 

 

 

8,996,860

 

Short-term investments

 

 

15,484,402

 

 

 

28,277,386

 

Accounts receivable

 

 

1,182,099

 

 

 

1,021,179

 

Tax refund receivable

 

 

5,506,946

 

 

 

629,096

 

Prepaid expenses and other current assets

 

 

1,020,876

 

 

 

470,228

 

Total current assets

 

 

87,970,418

 

 

 

39,394,749

 

Property and equipment, net

 

 

1,024,640

 

 

 

1,104,208

 

Right of use asset

 

 

662,074

 

 

 

698,321

 

Intangible assets, net

 

 

12,785,655

 

 

 

12,732,195

 

Other assets

 

 

100,980

 

 

 

128,547

 

Total assets

 

$

102,543,767

 

 

$

54,058,020

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

195,217

 

 

$

18,232

 

Accrued expenses and other current liabilities

 

 

4,089,749

 

 

 

3,904,767

 

Notes payable

 

 

632,000

 

 

 

 

Total current liabilities

 

 

4,916,966

 

 

 

3,922,999

 

Contingent consideration

 

 

16,390,000

 

 

 

2,750,000

 

Other long-term liabilities

 

 

1,715,024

 

 

 

1,864,875

 

Total liabilities

 

 

23,021,990

 

 

 

8,537,874

 

Commitments and contingencies (Note 14)

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock, $0.0001 par value; 200,000,000 shares authorized;

   26,553,957 and 15,312,381 shares issued; 26,553,886 and 15,312,167

   shares outstanding at June 30, 2020 and December 31, 2019, respectively

 

 

2,635

 

 

 

1,508

 

Additional paid-in capital

 

 

242,579,532

 

 

 

187,914,916

 

Accumulated deficit

 

 

(158,028,687

)

 

 

(137,376,122

)

Accumulated other comprehensive loss, net

 

 

(5,031,703

)

 

 

(5,020,156

)

Total stockholders’ equity

 

 

79,521,777

 

 

 

45,520,146

 

Total liabilities and stockholders’ equity

 

$

102,543,767

 

 

$

54,058,020

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

 

 

 

1


 

 

ALTIMMUNE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(unaudited)

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

721,636

 

 

$

1,626,029

 

 

$

2,934,330

 

 

$

4,581,622

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

16,594,250

 

 

 

2,945,096

 

 

 

23,781,781

 

 

 

6,162,768

 

General and administrative

 

 

2,545,356

 

 

 

2,231,817

 

 

 

4,877,273

 

 

 

4,298,299

 

Total operating expenses

 

 

19,139,606

 

 

 

5,176,913

 

 

 

28,659,054

 

 

 

10,461,067

 

Loss from operations

 

 

(18,417,970

)

 

 

(3,550,884

)

 

 

(25,724,724

)

 

 

(5,879,445

)

Other (expense) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in fair value of warrant liability

 

 

 

 

 

(46,000

)

 

 

 

 

 

(46,000

)

Interest expense

 

 

(3,308

)

 

 

(748

)

 

 

(5,193

)

 

 

(1,488

)

Interest income

 

 

81,458

 

 

 

239,964

 

 

 

233,027

 

 

 

425,211

 

Other (expense) income, net

 

 

(5,878

)

 

 

(29,220

)

 

 

19,664

 

 

 

17,528

 

Total other (expense) income, net

 

 

72,272

 

 

 

163,996

 

 

 

247,498

 

 

 

395,251

 

Net loss before income tax benefit

 

 

(18,345,698

)

 

 

(3,386,888

)

 

 

(25,477,226

)

 

 

(5,484,194

)

Income tax benefit

 

 

1,578,782

 

 

 

 

 

 

4,824,661

 

 

 

 

Net loss

 

 

(16,766,916

)

 

 

(3,386,888

)

 

 

(20,652,565

)

 

 

(5,484,194

)

Other comprehensive loss – unrealized gain (loss) on investments

 

 

20,888

 

 

 

 

 

 

(11,547

)

 

 

 

Comprehensive loss

 

$

(16,746,028

)

 

$

(3,386,888

)

 

$

(20,664,112

)

 

$

(5,484,194

)

Net loss

 

$

(16,766,916

)

 

$

(3,386,888

)

 

$

(20,652,565

)

 

$

(5,484,194

)

Deemed dividends

 

 

 

 

 

 

 

 

 

 

 

(452,925

)

Net loss attributed to common stockholders

 

$

(16,766,916

)

 

$

(3,386,888

)

 

$

(20,652,565

)

 

$

(5,937,119

)

Net loss per share attributed to common stockholders, basic and diluted

 

$

(0.94

)

 

$

(0.26

)

 

$

(1.25

)

 

$

(0.52

)

Weighted-average common shares outstanding, basic and diluted

 

 

17,886,853

 

 

 

13,127,773

 

 

 

16,498,719

 

 

 

11,318,819

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

2


 

 

ALTIMMUNE, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(unaudited)

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

Equity

 

Balance at December 31, 2019

 

 

15,312,167

 

 

$

1,508

 

 

$

187,914,916

 

 

$

(137,376,122

)

 

$

(5,020,156

)

 

$

45,520,146

 

Stock-based compensation

 

 

 

 

 

 

 

 

214,921

 

 

 

 

 

 

 

 

 

214,921

 

Vesting of restricted stock awards including withholding, net

 

 

(5,974

)

 

 

1

 

 

 

(17,080

)

 

 

 

 

 

 

 

 

(17,079

)

Issuance of common stock from Employee Stock Purchase Plan

 

 

38,809

 

 

 

3

 

 

 

56,736

 

 

 

 

 

 

 

 

 

56,739

 

Issuance of common stock upon exercise of warrants

 

 

14,500

 

 

 

2

 

 

 

39,972

 

 

 

 

 

 

 

 

 

39,974

 

Unrealized loss on short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(32,435

)

 

 

(32,435

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,885,649

)

 

 

 

 

 

(3,885,649

)

Balance at March 31, 2020

 

 

15,359,502

 

 

 

1,514

 

 

 

188,209,465

 

 

 

(141,261,771

)

 

 

(5,052,591

)

 

 

41,896,617

 

Stock-based compensation

 

 

 

 

 

 

 

 

330,510

 

 

 

 

 

 

 

 

 

330,510

 

Exercise of stock options

 

 

13,935

 

 

 

1

 

 

 

36,174

 

 

 

 

 

 

 

 

 

36,175

 

Vesting of restricted stock awards including withholding, net

 

 

(5,974

)

 

 

1

 

 

 

(46,390

)

 

 

 

 

 

 

 

 

(46,389

)

Issuance of common stock in at the market offering, net of offering costs

 

 

2,965,144

 

 

 

297

 

 

 

22,780,432

 

 

 

 

 

 

 

 

 

22,780,729

 

Issuance of common stock upon exercise of warrants

 

 

8,221,279

 

 

 

822

 

 

 

31,269,341

 

 

 

 

 

 

 

 

 

31,270,163

 

Unrealized gain on short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20,888

 

 

 

20,888

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(16,766,916

)

 

 

 

 

 

(16,766,916

)

Balance at June 30, 2020

 

 

26,553,886

 

 

$

2,635

 

 

$

242,579,532

 

 

$

(158,028,687

)

 

$

(5,031,703

)

 

$

79,521,777

 

 

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

Equity

 

Balance at December 31, 2018

 

 

9,078,239

 

 

$

876

 

 

$

170,207,844

 

 

$

(116,855,991

)

 

$

(5,040,163

)

 

$

48,312,566

 

Stock-based compensation

 

 

 

 

 

 

 

 

407,714

 

 

 

 

 

 

 

 

 

407,714

 

Vesting of restricted stock awards

 

 

71

 

 

 

 

 

 

28

 

 

 

 

 

 

 

 

 

28

 

Issuance of common stock in registered direct offering, net of offering costs

 

 

4,361,370

 

 

 

436

 

 

 

12,668,348

 

 

 

 

 

 

 

 

 

12,668,784

 

Issuance of common stock upon exercise of warrants

 

 

11,000

 

 

 

1

 

 

 

30,323

 

 

 

 

 

 

 

 

 

30,324

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(2,097,306

)

 

 

 

 

 

(2,097,306

)

Balance at March 31, 2019

 

 

13,450,680

 

 

 

1,313

 

 

 

183,314,257

 

 

 

(118,953,297

)

 

 

(5,040,163

)

 

 

59,322,110

 

Stock-based compensation and vesting of restricted stock

 

 

71

 

 

 

 

 

 

289,800

 

 

 

 

 

 

 

 

 

289,800

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,386,888

)

 

 

 

 

 

(3,386,888

)

Balance at June 30, 2019

 

 

13,450,751

 

 

$

1,313

 

 

$

183,604,057

 

 

$

(122,340,185

)

 

$

(5,040,163

)

 

$

56,225,022

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

 

3


 

 

ALTIMMUNE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net loss

 

$

(20,652,565

)

 

$

(5,484,194

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Change in fair value of contingent consideration

 

 

13,640,000

 

 

 

 

Stock-based compensation expense

 

 

545,431

 

 

 

697,486

 

Depreciation

 

 

120,169

 

 

 

121,899

 

Amortization

 

 

25,876

 

 

 

107,580

 

Unrealized losses (gains) on foreign currency exchange

 

 

(18,851

)

 

 

(24,943

)

Changes in fair value of warrant liability

 

 

 

 

 

46,000

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(160,920

)

 

 

832,098

 

Prepaid expenses and other current assets

 

 

(343,337

)

 

 

(113,200

)

Accounts payable

 

 

176,985

 

 

 

(102,763

)

Accrued expenses and other liabilities

 

 

26,761

 

 

 

(1,181,457

)

Tax refund receivable

 

 

(4,877,851

)

 

 

(71,586

)

Net cash used in operating activities

 

 

(11,518,302

)

 

 

(5,173,080

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Proceeds from sales and maturities of short-term investments

 

 

24,900,000

 

 

 

 

Purchases of short-term investments

 

 

(12,118,563

)

 

 

 

Purchase of property and equipment

 

 

(40,601

)

 

 

(1,226

)

Cash paid for internally developed patents

 

 

(79,336

)

 

 

(15,874

)

Net cash provided by (used in) investing activities

 

 

12,661,500

 

 

 

(17,100

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Payments of deferred offering costs

 

 

(179,743

)

 

 

 

Proceeds from exercises of warrants

 

 

31,310,137

 

 

 

30,324

 

Proceeds from issuance of common stock in at the market offering, net of offering costs

 

 

22,780,729

 

 

 

 

Proceeds from issuance of common units, net of issuance costs

 

 

 

 

 

12,668,784

 

Proceeds from issuance of notes payable

 

 

632,000

 

 

 

 

Proceeds from issuance of common stock from Employee Stock Purchase Plan

 

 

56,739

 

 

 

 

Proceeds from exercises of stock options

 

 

36,175

 

 

 

 

Payments of notes payable

 

 

 

 

 

(156,145

)

Net cash provided by financing activities

 

 

54,636,037

 

 

 

12,542,963

 

Net increase in cash and cash equivalents and restricted cash

 

 

55,779,235

 

 

 

7,352,783

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

8,996,860

 

 

 

34,353,129

 

Cash, cash equivalents and restricted cash at end of period

 

$

64,776,095

 

 

$

41,705,912

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

4


 

ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Nature of Business and Basis of Presentation

Nature of Business

Altimmune, Inc., headquartered in Gaithersburg, Maryland, together with its subsidiaries (collectively, the “Company” or “Altimmune”) is a clinical stage biopharmaceutical company incorporated under the laws of the State of Delaware.

The Company is focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. The Company’s diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital, and has financed its operations through the issuance of common and preferred stock, long-term debt, and proceeds from research grants and government contracts. The Company has not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales.

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States (“U.S. GAAP”) for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2019 included in the annual report on Form 10-K which was filed with the SEC on March 27, 2020. In the opinion of management, the Company has prepared the accompanying unaudited consolidated financial statements on the same basis as the audited consolidated financial statements, and these consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year 2020 or any future years or periods.

The unaudited consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.

2. Summary of Significant Accounting Policies

During the six months ended June 30, 2020, there have been no significant changes to the Company’s summary of significant accounting policies contained in the Company’s Annual report on Form 10-K for the year ended December 31, 2019 as filed with the SEC, except for the recently adopted accounting standard for investments.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s consolidated financial statements as of and for the three and six months ended June 30, 2020. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.

Recently Issued Accounting Pronouncements - Adopted

In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820) – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU No. 20218-13”). ASU No. 2018-13 was issued to modify and enhance the disclosure requirements for fair value measurements and eliminates certain disclosure requirements, such as the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy. This ASU adds new disclosure requirements for Level 3 measurements and is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2020 which resulted in expanded disclosures in Note 15 regarding the Company’s recurring Level 3 fair value measurements.    

3. Contingent Consideration

5


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

The Company entered into a definitive agreement to acquire all of the equity interests of Spitfire Pharma, Inc. (“Spitfire”) on July 8, 2019. Spitfire was a privately held, preclinical pharmaceutical company developing a novel dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis.  

The transaction closed on July 12, 2019. The Company issued 1,887,250 unregistered shares of its common stock (the “shares”) as upfront consideration to certain former securityholders of Spitfire (collectively, the “Spitfire Equityholders”), representing an amount equal to $5.0 million less working capital and transaction expense adjustment amounts as defined in the agreement.

The Merger Agreement also includes future contingent payments up to $88.0 million in cash and shares of the Company’s common stock as follows (each, a “Milestone Event”):

 

a one-time payment of $5.0 million (the “IND Milestone Consideration Amount”) within sixty days of the submission of an Investigational New Drug Application (“IND”) to the United States Food and Drug Administration (the “FDA”) or other applicable governmental authority in a foreign jurisdiction, which IND has not been rejected or placed on clinical hold by the FDA or such applicable foreign governmental authority within time specified in the Merger Agreement;

 

a one-time payment of $3.0 million (the “Phase 2 Milestone Consideration Amount” and together with the IND Milestone Consideration Amount, the “Regulatory Milestones”) within sixty days of the initiation of a Phase 2 clinical trial of a product candidate anywhere in the world; and

 

payments of up to $80.0 million upon the achievement of specified worldwide net sales (the “Sales Milestones”) of all products developed using the technology acquired in the License Agreement within ten years following the approval of a new drug application filed with the FDA.

The Regulatory Milestones will be payable in shares of the Company’s Common Stock, with the number of shares of the Company’s Common Stock to be issued in connection with each milestone amount, if any, are dependent on the share price at the time of achievement. The number of any shares issued in consideration for the IND Milestone Consideration Amount will be determined based on lower of (A) the average of the closing prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days prior to the IND Reference Date or (B) $2.95. The value of any shares issued in consideration for the Phase 2 Milestone Consideration Amount shall be determined based the lower of (A) on the average of the closing trading prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days immediately preceding the date of the occurrence of the Phase 2 Milestone Event or (B) $3.54.

The acquisition of Spitfire was accounted for as an asset acquisition instead of a business combination because substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets, and therefore, the asset was not considered a business. The Company expensed the acquired intellectual property as of the acquisition date as in-process research and development with no alternative future uses. The Company recorded an in-process research and development expense for the up-front consideration during the third quarter of 2019. Transaction costs of $0.6 million were recorded within research and development expense on the Company’s consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2019.

The future contingent payments related to the Regulatory Milestones are stock-based payments accounted for under FASB Accounting Standards Codification Topic 480, Distinguishing Liabilities From Equity. Such stock-based payments are subject to a lock-up whereby 50% of the shares are released at 3 months and 50% are released at 6 months. As of the acquisition date, the Company estimated future contingent consideration of $2.8 million based upon a Monte Carlo simulation that was risk adjusted based on the probability of achieving the milestones and a discount for lack of marketability, which was expensed to in-process research and development expenses during the third quarter of 2019. The Company remeasured the fair value of the contingent consideration as of June 30, 2020, and increased the liability from March 31, 2020 to $16.4 million primarily due to an increase in the share price during the six months ended June 30, 2020 and an increase in the probability of milestone achievement. The increased change in the liability of $11.9 million and $13.6 million was expensed to research and development expense during the three and six months ended June 30, 2020, respectively.

The future contingent payments related to the Sales Milestones are predominately cash-based payments accounted for under FASB Accounting Standards Codification Topic 450, Contingencies. Accordingly, the Company will recognize the Sales Milestones when the contingency is resolved and the amount is paid or payable.

4. Net Loss Per Share

Because the Company has reported a net loss attributable to common stockholders for all periods presented, basic and diluted net loss per share attributable to common stockholders are the same for all periods presented. For periods presented, all unvested restricted stock, common stock warrants, and stock options have been excluded from the computation of diluted weighted-average shares outstanding because such securities would have an antidilutive impact.

 

6


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:

 

 

 

For the Three and Six Months Ended

 

 

For the Three and Six Months Ended

 

 

 

June 30, 2020

 

 

June 30, 2019

 

Common stock warrants

 

 

2,150,285

 

 

 

10,386,256

 

Common stock options

 

 

1,527,978

 

 

 

873,066

 

Restricted stock

 

 

304,686

 

 

 

323,262

 

 

5. Intangible Assets

The Company’s intangible assets consisted of the following:

 

 

 

June 30, 2020

 

 

 

Estimated

Useful

Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

825,659

 

 

$

(466,866

)

 

$

358,793

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(277,105

)

 

 

7,895

 

Total intangible assets subject to amortization

 

 

 

 

1,110,659

 

 

 

(743,971

)

 

 

366,688

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,529,626

 

 

$

(743,971

)

 

$

12,785,655

 

 

 

 

December 31, 2019

 

 

 

Estimated

Useful

Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

746,323

 

 

$

(448,874

)

 

$

297,449

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(269,221

)

 

 

15,779

 

Total intangible assets subject to amortization

 

 

 

 

1,031,323

 

 

 

(718,095

)

 

 

313,228

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,450,290

 

 

$

(718,095

)

 

$

12,732,195

 

Amortization expense of intangible assets was $12,025 and $14,836 for the three months ended June 30, 2020 and 2019, and $25,876 and $107,580 for the six months ended June 30, 2020 and 2019, respectively. Amortization expense was classified as research and development expenses in the accompanying unaudited consolidated statements of operations and comprehensive loss.

As of June 30, 2020, future estimated amortization expense are as follows:

 

Years ending December 31,

 

 

 

 

The remainder of 2020

 

$

20,596

 

2021

 

 

27,687

 

2022

 

 

27,687

 

2023

 

 

27,687

 

2024

 

 

23,781

 

2025 and thereafter

 

 

239,250

 

Total

 

$

366,688

 

 

7


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

6. Accrued Expenses

Accrued expenses and other current liabilities consist of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Accrued professional services

 

$

472,329

 

 

$

429,467

 

Accrued payroll and employee benefits

 

 

956,584

 

 

 

1,183,130

 

Accrued interest

 

 

10,240

 

 

 

5,047

 

Accrued research and development

 

 

2,343,629

 

 

 

1,966,111

 

Lease obligation, current portion (see Note 12)

 

 

273,276

 

 

 

259,449

 

Deferred revenue

 

 

33,691

 

 

 

61,563

 

Total accrued expenses

 

$

4,089,749

 

 

$

3,904,767

 

 

7. Notes Payable

Paycheck Protection Program

On April 7, 2020, the Company applied for a loan from ServisFirst Bank, as lender, pursuant to the Paycheck Protection Program of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) as administered by the U.S. Small Business Administration (the "SBA"). On April 13, 2020, the Loan was approved and the Company received the proceeds from a loan in the amount of $632,000 (the “PPP Loan”).

The PPP Loan, which took the form of a promissory note (the “Promissory Note”), was set to mature on April 7, 2022 and bore interest at a rate of 1% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (discussed below), was to commence on November 7, 2020. The Company did not provide any collateral or guarantees for the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan. The Promissory Note provided for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company could prepay the principal of the PPP Loan at any time without incurring any prepayment charges.

All or a portion of the Loan may be forgiven by the SBA and lender upon application by the Company upon documentation of expenditures in accordance with the SBA requirements. Subsequent to the quarter ended June 30, 2020, the Company received approximately $136.2 million in net proceeds from warrant exercises, ATM usage, and the public offering of its common stock and decided to voluntarily extinguish the Promissory Note on July 21, 2020 by paying the outstanding principal and accrued interest in cash.

8. Other Long-Term Liabilities

The Company’s other long-term liabilities are summarized as follows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Lease obligation, long-term portion (see Note 12)

 

$

1,344,779

 

 

$

1,484,679

 

Common stock warrant liability (see Note 10)

 

 

10,000

 

 

 

10,000

 

Economic conditional grants

 

 

250,000

 

 

 

250,000

 

Other

 

 

110,245

 

 

 

120,196

 

Total other long-term liabilities

 

$

1,715,024

 

 

$

1,864,875

 

 

9. At-the-Market Offering

On March 27, 2020, the Company entered into an Equity Distribution Agreement (the “Agreement”) with JMP Securities LLC, serving as placement agent (the “Placement Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50.0 million (the “Shares”) through the Placement Agent (the “Offering”).

Any Shares offered and sold in the Offering will be issued pursuant to the Company’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on April 4, 2019, which was declared effective on April 12, 2019, the prospectus supplement relating to the Offering filed with the SEC on March 27, 2020 and any applicable additional prospectus supplements related to the Offering that

8


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

form a part of the Registration Statement. The aggregate market value of Shares eligible for sale in the Offering and under the Equity Distribution Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. The Company offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020.

On June 1, 2020, the Company filed an amendment to the Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million.

As of June 30, 2020, the Company has sold 2,965,144 shares of Common Stock under the Agreement resulting in $22.8 million in net proceeds, leaving $26.3 million available to be sold under the amended Agreement. As of June 30, 2020, the Company recorded approximately $0.3 million of offering costs which offset the proceeds received from the shares sold through June 30, 2020 and recognized approximately $0.2 million of deferred offering costs which will offset future proceeds received under the Agreement.

Subsequent to the quarter ended June 30, 2020, the Company sold 234,856 shares of Common Stock under the Equity Distribution Agreement, that resulted in $2.5 million in net proceeds, leaving $23.7 million available to be sold under the amended Agreement.

10. Warrants

A summary of warrant activity during the six months ended June 30, 2020 is as follows:

 

 

 

 

 

 

 

 

 

Warrants outstanding, December 31, 2019

 

 

10,384,706

 

 

Warrants issued due to anti-dilution features triggered from Registered Direct Offering

 

 

1,358

 

 

Exercises

 

 

(8,235,779

)

 

Warrants outstanding, June 30, 2020

 

 

2,150,285

 

 

 

During the six months ended June 30, 2020, the Company received net proceeds of $31.3 million from warrant exercises.

 

For warrants classified as a liability, the following is a summary of the periodic changes in their fair value during the six months ended June 30, 2020:

 

Balance, December 31, 2019

 

$

10,000

 

Changes in fair value

 

 

 

Balance, June 30, 2020

 

$

10,000

 

 

Subsequent to the quarter ended June 30, 2020, there were additionally 1,983,110 warrants exercised resulting in net proceeds of $9.6 million and 1,630,436 pre-funded warrants issued in connection with a Public Offering (see Note 16).

11. Stock-Based Compensation

Stock Options

The Company’s stock option awards generally vest over four years and typically have a contractual life of ten years. At June 30, 2020, there was $1.9 million of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 3.06 years. During the six months ended June 30, 2020, the Company granted 520,500 stock options with a weighted average exercise price of $2.31 and per share weighted average grant date fair value of $1.83.

Information related to stock options outstanding at June 30, 2020 is as follows:

 

 

Number

of Stock

Options

 

 

Weighted-

average

Exercise

Price

 

 

Weighted-

average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding

 

 

1,477,153

 

 

$

3.65

 

 

 

5.96

 

 

$

12,804,940

 

Exercisable

 

 

416,022

 

 

$

5.97

 

 

 

5.69

 

 

$

3,097,502

 

Unvested

 

 

1,061,131

 

 

$

2.74

 

 

 

6.07

 

 

$

9,707,438

 

9


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

Restricted Stock

At June 30, 2020, the Company had unvested restricted stock of 195,161 shares with total unrecognized compensation expense of $0.7 million, which the Company expects to recognize over a weighted average period of approximately 2.42 years. During the six months ended June 30, 2020, the Company released 40,505 shares of common stock from restriction as a result of the vesting of restricted stock.

Restricted Stock Units

During the three months ended June 30, 2020, the Company granted 109,525 shares of restricted stock units which vest during the third quarter of 2020. At June 30, 2020, the Company had unvested restricted stock units of 109,525 shares with total unrecognized compensation expense of $0.9 million, which the Company expects to recognize over a weighted average period of approximately 0.25 years.

2019 Employee Stock Purchase Plan

Under the Employee Stock Purchase Plan (“ESPP”), employees purchased 38,809 shares for $56,739 during the six months ended June 30, 2020. During the three and six months ended June 30, 2020, the Company recognized compensation expense of $20,372 and $35,084, respectively.

Stock-based Compensation Expense

Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2020 and 2019 as follows:

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Research and development

 

$

77,939

 

 

$

92,060

 

 

$

106,939

 

 

$

168,684

 

General and administrative

 

 

252,571

 

 

 

197,712

 

 

 

438,492

 

 

 

528,802

 

Total

 

$

330,510

 

 

$

289,772

 

 

$

545,431

 

 

$

697,486

 

 

12. Operating Leases

The Company rents office and laboratory space in the United States. The Company also leases office equipment under a non-cancellable equipment lease through December 2022. Rent expense during the three and six months ended June 30, 2020 under all of the Company’s operating leases was $86,295 and $173,894, respectively. Rent expense during the three and six months ended June 30, 2019 was $83,903 and $174,079, respectively. Rent expense includes short-term leases and variable lease costs that are not included in the lease obligation.

Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.

The office space lease provides for increases in future minimum annual rental payments as defined in the lease agreements. The Company has determined the lease renewal option is not reasonably certain.

The cash paid for operating lease liabilities for the three and six months ended June 30, 2020 was $64,193 and $126,073, respectively.

Supplemental other information related to the operating leases balance sheet information is as follows:

 

 

June 30, 2020

 

Operating lease obligations

 

$

1,618,055

 

Operating lease right-of-use assets

 

$

662,074

 

Weighted-average remaining lease term

 

 

4.83

 

Weighted-average discount rate

 

 

8.0

%

Maturities of lease liabilities is as follows:

 

10


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

Year ending December 31,

 

 

 

 

The remainder of 2020

 

$

194,596

 

2021

 

 

393,542

 

2022

 

 

400,198

 

2023

 

 

407,054

 

2024

 

 

414,116

 

2025 and thereafter

 

 

138,831

 

Total lease payments

 

 

1,948,337

 

Less imputed interest

 

 

(330,282

)

Total

 

$

1,618,055

 

 

13. Income Taxes

 

In response to global pandemic associated with COVID-19, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) on March 27, 2020. The CARES Act provided both stimulus measures and a number of tax provisions, including: temporary changes regarding the utilization and carry back of net operating losses, temporary changes to the prior and future limitations on interest deductions, technical corrections from prior tax legislation for tax depreciation of qualified improvement property, and certain refundable employee retention credits. The CARES Act enables the Company to file a refund claim to reflect a refund of its 2016 tax liability by carrying back its 2018, 2019 and 2020 losses to fully offset this liability. The refund claim attributable to the 2018 and 2019 tax years has been recorded as a discrete item in the income tax benefit for the three months ended March 31, 2020 of $2.9 million. In addition, the Company is currently estimating it will be able to carry back a portion of its current and forecasted 2020 net operating losses as of the end of the year and has included an estimate in its annual effective tax rate calculation as of June 30, 2020, which resulted in an additional income tax benefit of $1.0 million recorded during the six months ended June 30, 2020.

 

On June 12, 2020, the Comptroller of Maryland issued a report announcing that the state decoupled from the CARES Act loss carryback provisions for the 2020 year only, but indicated uncertainty as to whether the General Assembly would pass a measure to decouple from all years in the CARES Act and not process amended filings in the interim. As a result, an additional discrete item in the income tax benefit of $1.0 million was recognized for the three months ended June 30, 2020 related to the release of valuation allowance related to losses that could potentially be carried back to the 2016 tax year under current law.

Accordingly, the Company has recognized a total tax benefit of $4.8 million for the six months ended June 30, 2020.

14. Commitments and Contingencies

 

Spitfire Acquisition

As disclosed in Note 3, the Company is obligated to make payments of up to $80.0 million upon the achievement of specified worldwide net sales of all products developed using the technology acquired from Spitfire Pharma Inc. within ten years following the approval of a new drug application filed with the FDA.

PER.C6 License Agreement Expansion

On April 2, 2020, the Company entered into Amendment No. 3 to the Second Restated License Agreement (the “Amendment”), by and between the Company and Janssen Vaccines & Prevention B.V. (formerly known as Crucell Holland B.V.) (as amended by Amendment No. 1 to Second Restated License Agreement and Amendment No. 2 to Second Restated License Agreement, together with the Amendment, the “License Agreement”). Pursuant to the Amendment, the field of licenses granted to the Company for the use of the PER.C6 cell line under the License Agreement is expanded to cover COVID-19 caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in addition to the existing licenses related to Bacillus anthracis and influenza virus. All capitalized terms not defined herein shall have the meanings assigned to them in the Amendment or the License Agreement, as applicable.

Pursuant to the Amendment, the Company agreed to pay certain additional development-based milestone payments through approval of licensed products by the FDA for the treatment or prevention of COVID-19, up to an aggregate amount of $1.2 million. The Company also agreed to pay royalty payments as a percentage of net sales of products to a royalty stacking reduction and minimum annual royalty payments, until the expiration of the term of the License Agreement, as amended. As of June 30, 2020, payments made under the License Agreement were de minimis.

Litigation

11


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (“Plaintiff”) against the Company in U.S. District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as “Defendants”). In March 2020 the Defendants’ filed a motion to dismiss the complaint. The Court denied the motion without prejudice and allowed Plaintiff an opportunity to file an amended complaint. Plaintiff’s second amended complaint was filed on April 17, 2020, and Defendants filed a motion to dismiss that complaint on May 1, 2020. Plaintiff, who is representing himself, alleges five causes of action as follows: (1) Defendants’ alleged retention of Plaintiff’s lab notebooks; (2) alleged plagiarism based on publishing an article without naming Plaintiff as an author; (3) use of the Adhigh System, which Plaintiff alleges he developed; (4) allegations that Defendants manipulated the Company’s stock and caused a decrease in value; and (5) allegations that the Defendants “wast[ed] government grant money and poison[ed] science by leaving data to rot.” A hearing on Defendants’ motion to dismiss was held on May 20, 2020, and the motion is currently pending. The Company believes the allegations in the complaint are without merit and intends to vigorously defend the litigation. However, the outcome of this legal proceeding is uncertain at this time and the Company cannot reasonably estimate a range of loss, if any. Accordingly, the Company has not accrued any liability associated with this action. The Company is a party in various other contractual disputes, litigation, and potential claims arising in the ordinary course of business none of which are currently reasonably possible or probable of material loss.

15. Fair Value Measurement

The Company’s assets and liabilities measured at fair value on a recurring basis at June 30, 2020 consisted of the following:

 

 

Fair Value Measurement at June 30, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Recurring fair value measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

38,011,208

 

 

$

38,011,208

 

 

$

 

 

$

 

Short-term investments

 

 

15,484,402

 

 

 

 

 

 

15,484,402

 

 

 

 

Contingent consideration

 

 

16,390,000

 

 

 

 

 

 

 

 

 

16,390,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

The Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2019 consisted of the following:

 

 

Fair Value Measurement at December 31, 2019

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Recurring fair value measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

8,034,640

 

 

$

8,034,640

 

 

$

 

 

$

 

Short-term investments

 

 

28,277,386

 

 

 

 

 

 

28,277,386

 

 

 

 

Contingent consideration

 

 

2,750,000

 

 

 

 

 

 

 

 

 

2,750,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Assets recorded at fair value on a nonrecurring basis, such as property and equipment and intangible assets are recognized at fair value when they are impaired.

Cash equivalents and short-term investments have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value. Short-term investments had quoted prices at June 30, 2020 as shown below:

 

 

June 30, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificate of deposit

 

$

5,000,000

 

 

$

 

 

$

5,000,000

 

Financial and corporate debt securities

 

 

10,475,942

 

 

 

8,460

 

 

 

10,484,402

 

Total

 

$

15,475,942

 

 

$

8,460

 

 

$

15,484,402

 

 

The fair value of contingent payments classified as a liability was based on the regulatory milestones described in Note 3 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs. The following table is a reconciliation of the beginning and ending balance of contingent consideration liability:

12


ALTIMMUNE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

Balance at December 31, 2019

$

2,750,000

 

Change in fair value

 

13,640,000

 

Balance at June 30, 2020

$

16,390,000

 

The assumptions used to estimate the fair value of contingent payments that are classified as a liability at June 30, 2020 include the following significant unobservable inputs:

Unobservable input

 

Value or Range

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

112.9%

 

 

112.9%

 

Risk-free interest rate

 

0.16%

 

 

0.16%

 

Cost of capital

 

30.0%

 

 

30.0%

 

Discount for lack of marketability

 

14%-22%

 

 

18.0%

 

Probability of payment

 

52%-83%

 

 

76%

 

Projected year of payment

 

2020-2022

 

 

2020

 

The Company’s warrant liability is valued using the Monte Carlo simulation valuation model. If applicable, the Company will recognize transfers into and out of levels within the fair value hierarchy at the end of the reporting period in which the actual event or change in circumstance occurs.

There were no transfers into and out of any of the levels of the fair value hierarchy as of June 30, 2020 and December 31, 2019.

16. Subsequent Events

Public Offering

On July 16, 2020, the Company offered and sold (i) 3,369,564 shares of common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants of the Company to purchase 1,630,436 shares of common stock at an exercise price equal to $0.0001 per share (the “Pre-Funded Warrants”), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of the Company’s common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock then issued and outstanding, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

    

 

 

13


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes appearing elsewhere in this quarterly report on Form 10-Q and our consolidated financial statements and related notes for the year ended December 31, 2019 included in our annual report on Form 10-K, which was filed with the Securities and Exchange Commission on March 27, 2020.

This quarterly report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. The words “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “may,” “will,” “should,” “could,” “target,” “strategy,” “intend,” “project,” “guidance,” “likely,” “usually,” “potential,” or the negative of these words or variations of such words, similar expressions, or comparable terminology are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. There are a number of important risks and uncertainties that could cause our actual results to differ materially from those indicated by forward-looking statements. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in this quarterly report on Form 10-Q, particularly in the section entitled “Risk Factors” in Part II, Item 1A, that could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements, other than as required by law. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we, in the future, may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Overview

Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell).

Impact of COVID-19

We are closely monitoring how the spread of COVID-19 is affecting our employees, business, preclinical studies and clinical trials. In response to the COVID-19 pandemic, we have closed our executive offices with certain employees continuing their work outside of our offices and travel for all employees has been restricted. Essential laboratory staff continue to work onsite with enhanced safety measures. We are continuing our regular interactions with the FDA and other regulatory agencies and based on current information, we do not anticipate COVID-19 to materially affect our regulatory timelines for NasoShield, T-COVID, AdCOVID and ALT-801. We expect the pandemic to have some near-term impact on the initiation of our HepTcell Phase 2 trial and, accordingly, we will delay the initiation of this trial. We expect we will be able to provide an update on timing for initiating the study in the second half of 2020.

Although operations have not been materially affected by the COVID-19 pandemic as of and for the three and six months ended June 30, 2020, at this time, however, there is significant uncertainty relating to the trajectory of the pandemic and the impact of related responses, and disruptions caused by the COVID-19 pandemic may result in difficulties or delays in initiating, enrolling, conducting or completing our planned and ongoing trials and the incurrence of unforeseen costs as a result of disruptions in clinical supply or preclinical study or clinical trial delays. The impact of COVID-19 on our future results will largely depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions, the ultimate impact on financial markets and the global economy, and the effectiveness of actions taken in the United States and other countries to contain and treat the disease. See “Risk Factors— Our business, results of operations and financial condition may be adversely affected by the widespread outbreak of an illness or any other communicable disease, or any other public health crisis, including the ongoing coronavirus disease (COVID-19) pandemic.” in Part II, Item 1A of this Quarterly Report on Form 10-Q.

 

Critical Accounting Policies and Significant Judgment and Estimates

Management’s Discussion and Analysis of Financial Condition and Results of Operations is based upon our unaudited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S. and the rules and regulations of the SEC for interim financial reporting. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and the related disclosure of contingent assets and liabilities. We base our estimates and judgments on historical experience, knowledge of current conditions, and expectations of what could occur in the future given available information.

14


 

There have been no changes in our critical accounting policies and significant judgment and estimates as disclosed in our annual report on Form 10-K for the year ended December 31, 2019 except for recently adopted accounting standards (See Note 2 to the consolidated financial statements appearing in Item 1 of this report). For more information regarding our critical accounting policies, we encourage you to read the discussion contained in Item 7 under the heading “Critical Accounting Policies and Significant Judgments and Estimates” and Note 2 “Summary of Significant Accounting Policies” included in the notes to the consolidated financial statements contained in our annual report on Form 10-K for the year ended December 31, 2019.

Results of Operations

Comparison of the three months ended June 30, 2020 and 2019:

 

 

 

For the Three Months Ended

June 30,

 

 

2020

 

 

2019

 

 

Increase (Decrease)

Revenue

 

$

721,636

 

 

$

1,626,029

 

 

$

(904,393

)

 

 

(56

)

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

16,594,250

 

 

 

2,945,096

 

 

 

13,649,154

 

 

 

463

 

 

General and administrative

 

 

2,545,356

 

 

 

2,231,817

 

 

 

313,539

 

 

 

14

 

 

Total operating expenses

 

 

19,139,606

 

 

 

5,176,913

 

 

 

13,962,693

 

 

 

270

 

 

Loss from operations

 

 

(18,417,970

)

 

 

(3,550,884

)

 

 

(14,867,086

)

 

 

(419

)

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in fair value of warrant liability

 

 

 

 

 

(46,000

)

 

 

46,000

 

 

 

100

 

 

Interest expense

 

 

(3,308

)

 

 

(748

)

 

 

(2,560

)

 

 

(342

)

 

Interest income

 

 

81,458

 

 

 

239,964

 

 

 

(158,506

)

 

 

(66

)

 

Other (expenses), net

 

 

(5,878

)

 

 

(29,220

)

 

 

23,342

 

 

 

80

 

 

Total other (expense) income, net

 

 

72,272

 

 

 

163,996

 

 

 

(91,724

)

 

 

(56

)

 

Net loss before income tax benefit

 

 

(18,345,698

)

 

 

(3,386,888

)

 

 

(14,958,810

)

 

 

(442

)

 

Income tax benefit

 

 

1,578,782

 

 

 

 

 

 

1,578,782

 

 

 

100

 

 

Net loss

 

$

(16,766,916

)

 

$

(3,386,888

)

 

$

(13,380,028

)

 

 

(395

)

%

Comparison of the six months ended June 30, 2020 and 2019:

 

 

 

For the Six Months Ended

June 30,

 

 

2020

 

 

2019

 

 

Increase (Decrease)

Revenue

 

$

2,934,330

 

 

$

4,581,622

 

 

$

(1,647,292

)

 

 

(36

)

%

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

23,781,781

 

 

 

6,162,768

 

 

 

17,619,013

 

 

 

286

 

 

General and administrative

 

 

4,877,273

 

 

 

4,298,299

 

 

 

578,974

 

 

 

13

 

 

Total operating expenses

 

 

28,659,054

 

 

 

10,461,067

 

 

 

18,197,987

 

 

 

174

 

 

Loss from operations

 

 

(25,724,724

)

 

 

(5,879,445

)

 

 

(19,845,279

)

 

 

(338

)

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in fair value of warrant liability

 

 

 

 

 

(46,000

)

 

 

46,000

 

 

 

100

 

 

Interest expense

 

 

(5,193

)

 

 

(1,488

)

 

 

(3,705

)

 

 

(249

)

 

Interest income

 

 

233,027

 

 

 

425,211

 

 

 

(192,184

)

 

 

(45

)

 

Other (expenses) income, net

 

 

19,664

 

 

 

17,528

 

 

 

2,136

 

 

 

12

 

 

Total other income, net

 

 

247,498

 

 

 

395,251

 

 

 

(147,753

)

 

 

(37

)

 

Net loss before income tax benefit

 

 

(25,477,226

)

 

 

(5,484,194

)

 

 

(19,993,032

)

 

 

(365

)

 

Income tax benefit

 

 

4,824,661

 

 

 

 

 

 

4,824,661

 

 

 

100

 

 

Net loss

 

$

(20,652,565

)

 

$

(5,484,194

)

 

$

(15,168,371

)

 

 

(277

)

%

Revenue

Revenue consists primarily of research grants from Biomedical Advanced Research and Development Authority, or BARDA, and in 2019, the National Institute of Allergy and Infectious Diseases, or NIAID, in the United States for our anthrax vaccine product candidates. These grants consist of cost reimbursement contracts, with a fixed fee based on either costs or milestones.

Revenue decreased by $0.9 million, or 56%, for the three months ended June 30, 2020 as compared to the same period in 2019. The decrease was primarily the result of:

 

a decrease of $1.1 million in BARDA revenue due to timing of clinical trials and development activities on the NasoShield program; and

 

an increase of $0.2 million in other revenue related to the sale of flu virus vials.

15


 

Revenue decreased by $1.6 million, or 36%, for the six months ended June 30, 2020 as compared to the same period in 2019. The decrease was primarily the result of:

 

a decrease of $2.3 million in BARDA revenue due to timing of clinical trials and development activities on the NasoShield program;

 

a decrease of $0.2 million in NIAID revenue due to the completion of the SparVax-L contract in 2019;

 

an increase of $0.6 million in BARDA revenue attributable to a final payment under the Company’s previous NasoShield contract representing a reconciliation of the actual indirect rates compared to billed indirect rates; and

 

an increase of $0.3 million in other revenue primarily related to the sale of flu virus vials.

 

In June 2020, we were awarded $4.7 million from the U.S. Army Medical Research & Development Command (“USAMRDC”) to fund our Phase 1/2 clinical trial of T-COVID. The competitive award was granted by USAMRDC in collaboration with the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)(3) biomedical technology consortium working in partnership with the Department of Defense (“DoD”). Under the contract, MTEC pays us a firm fixed fee based on achieving certain milestones for conduct and completion of a Phase 1/2 study and research and development work on the replication-deficient adenovirus 5 (“RD-Ad5”) vector vaccine platform. As of June 30, 2020, we have not received any cash under the contract nor have we recognized any amounts of grant revenue within the statement of operations.

Research and development expenses

Research and development operating expense increased by $13.6 million, or 463%, for the three months ended June 30, 2020 as compared to the same period in 2019. The increase was primarily the result of:

 

an increase of $11.9 million due to an increase in the contingent consideration liability related to the acquisition of ALT-801;

 

an increase of $2.0 million due to development activities for ALT-801 which was acquired in July 2019;

 

an increase of $1.1 million due to development activities for the COVID-19 programs;

 

a decrease of $0.8 million due to timing of a clinical trial and development activities for NasoShield; and

 

a decrease of $0.6 million in pre-clinical projects and non-project specific research and development costs including employee compensation and facility costs.

Research and development operating expense increased by $17.6 million, or 286%, for the six months ended June 30, 2020 as compared to the same period in 2019. The increase was primarily the result of:

 

an increase of $13.6 million due to an increase in the contingent consideration liability related to the acquisition of ALT-801;

 

an increase of $4.4 million due to development activities for ALT-801 which was acquired in July 2019;

 

an increase of $1.1 million due to development activities for the COVID-19 programs;

 

an increase of $0.2 million in pre-clinical projects and non-project specific research and development costs including employee compensation and facility costs; and

 

a decrease of $1.7 million due to timing of a clinical trial and development activities for NasoShield.

General and administrative expenses

General and administrative expense increased by $0.3 million, or 14%, for the three months ended June 30, 2020 and by $0.6 million, or 13%, for the six months ended June 30, 2020, as compared to the same periods in 2019 due primarily to an increase in legal, professional and labor costs.

Total other (expense) income, net

Total other (expense) income, net decreased by $0.1 million and $0.1 million during the three and six months ended June 30, 2020, respectively, as compared to the same period in 2019. The decreases are primarily due to changes in interest income.

Income tax benefit

Income tax benefit increased by $1.6 million and $4.8 million during the three and six months ended June 30, 2020, as compared to the same period in 2019. The increase is due to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) signed into law on March 27, 2020 which made temporary changes regarding the utilization and carry back of net operating losses. As of June 30, 2020, the Company intends to file a refund claim for a discrete item of $2.9 million with the Internal Revenue Service reflecting a partial refund of its 2016 tax liability by carrying back its 2019 and 2018 losses not previously claimed, and estimates $2.9 million related to net operating losses arising during the six months ended June 30, 2020 will be claimed.

On June 12, 2020, the Comptroller of Maryland issued a report announcing that the state decoupled from the CARES Act loss carryback provisions for the 2020 year only, but indicated uncertainty as to whether the General Assembly would pass a measure to decouple from all years in the CARES Act and not process amended filings in the interim. As a result, an additional discrete item in the income tax benefit of $1.0 million was recognized for the three months ended June 30, 2020 related to the release of valuation allowance related to losses that could potentially be carried back to the 2016 tax year under current law.

16


 

Liquidity and Capital Resources

Overview

Our primary sources of cash during the six months ended June 30, 2020 were from equity activity, maturities of short-term investments and cash receipts of revenue from our BARDA contract. Our cash, cash equivalents, and short-term investments were $80.3 million at June 30, 2020. We believe, based on the operating cash requirements and capital expenditures expected for 2020, our cash on hand at June 30, 2020, short-term investments, revenue from our government sponsored contracts and tax refunds, are sufficient to fund operations for at least a twelve-month period from the issuance date of our June 30, 2020 financial statements.

We have not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales. Our sources of revenue have consisted of revenues under our contract with BARDA for the development of NasoShield and to a lesser degree from other licensing arrangements. We have incurred significant losses since we commenced operations. As of June 30, 2020, we had accumulated losses of $158.0 million since our inception. In addition, we have not generated positive cash flows from operations. We have had to rely on a variety of financing sources, including the issuance of debt and equity securities. As capital resources are consumed to fund our research and development activities, we may not have sufficient capital to fund our plan of operations. In order to address our capital needs, including our planned clinical trials, we have initiated the ATM Offering and the Public Offering and must continue to actively pursue additional equity or debt financing, government funding, and monetization of our existing programs through partnership arrangements or sales to third parties.

In July 2016, we signed a five-year contract with BARDA. The contract, as amended, has a total value of up to $133.7 million and is used to fund clinical development of NasoShield. Under the contract, BARDA pays us a fixed fee and reimburses certain costs for the research and development of an Ad5-vectored, protective antigen-based intranasal anthrax vaccine through cGMP manufacture and conduct of a Phase 1 clinical trial dose ranging assessment of safety and immunogenicity. The contract consists of an initial base performance period providing approximately $27.8 million in funding for the period July 2016 through December 2020. BARDA has seven options to extend the contract to fund certain continued development and manufacturing activities for the anthrax vaccine, including Phase 2 clinical trials. Each option, if exercised by BARDA, would provide additional funding ranging from approximately $1.1 million to $34.4 million for a three-year period beginning January 2021. Through June 30, 2020, we have received an aggregate of approximately $23.8 million under the current BARDA contract.

Cash Flows

The following table provides information regarding our cash flows for the six months ended June 30, 2020 and 2019:

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

Net cash provided by (used in):

 

 

 

 

 

 

 

 

Operating activities

 

$

(11,518,302

)

 

$

(5,173,080

)

Investing activities

 

 

12,661,500

 

 

 

(17,100

)

Financing activities

 

 

54,636,037

 

 

 

12,542,963

 

Net increase in cash and cash equivalents and restricted cash

 

$

55,779,235

 

 

$

7,352,783

 

Operating Activities

Net cash used in operating activities was $11.5 million for the six months ended June 30, 2020 compared to $5.2 million during the six months ended June 30, 2019. Our sources of cash provided by operations during the six months ended June 30, 2020 were primarily cash receipts of revenue generated by our BARDA contract. The primary uses of cash from our operating activities include payments for labor and labor-related costs, professional fees, research and development costs associated with our clinical trials, and other general corporate expenditures. The increase in cash used in operations of $6.3 million year over year is due to an increase in net loss as adjusted for non-cash items of $1.8 million and changes in working capital accounts of $4.5 million, primarily due to recording of the income tax benefit receivable.

Investing Activities

Net cash provided by investing activities was $12.7 million for the six months ended June 30, 2020 compared to net cash used in investing activities of $17,100 during the six months ended June 30, 2019. The net cash provided by investing activities during 2020 was primarily due to maturities of short-term investments. The net cash used in investing activities in 2019 was primarily due to purchases of equipment and capitalized patent costs.

Financing Activities

Net cash provided by financing activities during the six months ended June 30, 2020 was $54.6 million compared to $12.5 million for the six months ended June 30, 2019. The net cash provided by financing activities during the six months ended June 30, 2020 was primarily the result of $31.3 million in proceeds from the exercise of warrants and $22.8 million in proceeds from the issuance of common stock from our at-the-market offering program. The net cash provided by financing activities during the six months ended June 30, 2019 was primarily the result of $12.7 million in proceeds from a registered direct offering of units that consisted of common stock and warrants.

Financing

Public Offering

17


 

On July 16, 2020, we offered and sold (i) 3,369,564 shares of our common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants to purchase 1,630,436 shares of our common stock at an exercise price equal to $0.0001 per share (the “Pre-Funded Warrants”), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of our common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of our common stock then issued and outstanding, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to us. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

At-the-Market Offering

On March 27, 2020, we entered into an Equity Distribution Agreement (the “Agreement”) with JMP Securities LLC, serving as placement agent (the “Placement Agent”) with respect to an at-the-market offering program under which we may offer and sell, from time to time at our sole discretion, shares of our common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50.0 million (the “Shares”) through the Placement Agent (the “Offering”). We offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020. On June 1, 2020, we filed an amendment to the Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million. As of June 30, 2020, we sold 2,965,144 shares of Common Stock under the Agreement resulting in $22.8 million in net proceeds, leaving $26.3 million available to be sold under the amended Agreement.

Current Resources

We have financed our operations to date principally through our equity offerings and proceeds from issuances of our preferred stock, common stock, and warrants. At June 30, 2020, we had $64.8 million of cash, cash equivalents and restricted cash and $15.5 million of short-term investments. Accordingly, management believes that the Company has sufficient capital to fund its plan of operations for at least a twelve-month period from the issuance date of our June 30, 2020 financial statements. However, in order to address our capital needs in the long-term, including our planned clinical trials, we must continue to actively pursue additional equity or debt financing, government funding, and monetization of our existing programs through partnership arrangements or sales to third parties.

Off-Balance Sheet Arrangements

As of June 30, 2020, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as “special purpose” entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (“the “Exchange Act”) as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2020, our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2020 identified in connection with the evaluation thereof by our management, including the Chief Executive Officer and Chief Financial Officer, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

18


 

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

In December 2019, we learned of a complaint that had been filed by Dr. De-Chu Christopher Tang (“Plaintiff”).  We received a copy of the complaint on January 2, 2020, and on January 24, 2020, we removed the case to the United States District Court for the Eastern District of Texas (No. 4:20-CV-00063-ALM-CAN), where it is currently pending (the “Texas Lawsuit”).  Plaintiff amended his complaint on February 25, 2020, naming Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as “Defendants”). In March 2020 the Defendants filed a motion to dismiss the complaint.  The Court denied the motion without prejudice and allowed Plaintiff an opportunity to file an amended complaint. Plaintiff’s second amended complaint was filed on April 17, 2020, and Defendants filed a motion to dismiss that complaint on May 1, 2020. A hearing on Defendants’ motion to dismiss was held on May 20, 2020, and the motion is currently pending. Plaintiff, who is representing himself, alleges five causes of action against Defendants, based on (1) Defendants’ alleged retention of Plaintiff’s lab notebooks after the termination of his employment in 2012; (2) alleged plagiarism based on publishing an article without naming Plaintiff as an author; (3) use of the Adhigh System, which Plaintiff alleges he developed; (4) allegations that Defendants manipulated the Company’s stock and caused a decrease in value; and (5) allegations that the Defendants “wast[ed] government grant money and poison[ed] science by leaving data to rot.”

A prior lawsuit filed by the Plaintiff against us in the United States District Court for the Northern District of Alabama, resulted in the entry of a Final Consent Judgment and Permanent Injunction on August 25, 2016 (the “Alabama Judgment”).  In the Alabama Judgment, the court declared, among other things, that we owned the DVD technology that Plaintiff had developed during his employment with us, and enjoined Plaintiff from “using or disclosing any Proprietary Information or Innovations relating to the DVD technology and any associated intellectual property rights” without our written consent.

Item 1A. Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A, subsection “Risk Factors” in our 2019 Annual Report on Form 10-K filed with the SEC on March 27, 2020 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 13, 2020, as they could materially affect our business, financial condition or future results of operations. The risks described in our 2019 Annual Report on Form 10-K filed with the SEC on March 27, 2020 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 13, 2020 are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition and future results of operations. The following information updates, and should be read in conjunction with, the risk factors previously disclosed in Item 1A, subsection “Risk Factors” to Part I of our 2019 Annual Report on Form 10-K filed with the SEC on March 27, 2020 and in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 13, 2020. Except as set forth below, there have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our 2019 Annual Report on Form 10-K and in our Quarterly Report on Form 10-Q.

Risks Related to COVID-19

 

Our pursuit of potential therapeutic and prophylactic treatments for COVID-19 is at an early stage and subject to many risks. We may be unable to receive approval for any of our COVID-19 product candidates a timely manner, if at all, and our COVID-19 product candidates may never be approved.

The U.S. Food and Drug Administration recently cleared our Investigational New Drug, or IND, application to proceed with a clinical trial of T-COVID, our investigational agent for the treatment of early COVID-19 and we have not yet filed an IND for AdCOVID, our intranasal vaccine candidate for COVID-19. We have not yet initiated a clinical trial for either program, and we may experience difficulties or delays in enrolling patients in clinical trials due to the impact of the global COVID-19 pandemic or other reasons. Many of the risks related to the development of these product candidates are beyond our control, including risks related to clinical development, the regulatory submission process, potential threats to our intellectual property rights and manufacturing delays or difficulties. We may be unable to produce an efficacious and/or approved product for the treatment of patients with early COVID-19 in a timely manner, if at all.

The results of preclinical studies from our COVID-19 product candidates may not be predictive of the results of clinical trials, and the results of any early-stage clinical trials we commence may not be predictive of the results of the later-stage clinical trials. There can be no assurance that any of our clinical trials for our COVID-19 product candidates, or any other of our product candidates, will ultimately be successful or support further clinical development. In addition, the interpretation of the data from our clinical trials of T-COVID or AdCOVID by FDA and other regulatory agencies may differ from our interpretation of such data and the FDA or other regulatory agencies may require that we conduct additional studies or analyses. Any of these factors could delay or prevent us from receiving regulatory approval of T-COVID or AdCOVID and there can be no assurance that either product candidate will be approved in a timely manner, if at all.

If the COVID-19 outbreak is effectively contained or the risk of coronavirus infection is diminished or eliminated before we can successfully develop and manufacture our product candidate, the commercial viability of such product candidate may be diminished or eliminated. We are also committing financial resources and personnel to the development of this product candidate which may cause delays in or otherwise negatively impact our other development programs, despite uncertainties surrounding the longevity and extent of coronavirus as a global health concern. Our business could be negatively impacted by our allocation of significant resources to a global health threat that is

19


 

unpredictable and could rapidly dissipate or against which our treatment, if successfully developed, may not be effective. In addition, other parties are currently producing therapeutic and vaccine candidates for COVID-19, which may be more efficacious or may be approved prior to T-COVID or AdCOVID.

The regulatory pathway for T-COVID and AdCOVID is continually evolving, and may result in unexpected or unforeseen challenges.

The speed at which parties are acting to create and test many therapeutics and vaccines for COVID-19 is unusual, and evolving or changing plans or priorities within the FDA, including those based on new knowledge of COVID-19 and how the disease affects the human body, may significantly affect the regulatory timeline for our product candidates. Results from ongoing clinical trials and discussions with regulatory authorities may raise new questions and require us to redesign proposed clinical trials, including revising proposed endpoints or adding new clinical trial sites or cohorts of subjects. Any such developments could delay the development timeline for our product candidates and materially increase the cost of the development for such candidates.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Default upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

 

20


 

Item 6. Exhibits

 

 

 

Exhibit Index

 

 

 

 

 

 

 

Exhibit No.

 

Description

 

 

 

 

 

 

10.1

  

Equity Distribution Agreement, dated March 27, 2020, by and among Altimmune, Inc. and JMP Securities LLC (incorporated by reference to Exhibit 1.1 to the Registrant’s Form 8-K filed on March 27, 2020)

 

 

 

 

 

10.2

 

Amendment No. 2 to the Second Restated License Agreement, by and among Altimmune, Inc. and Janssen Vaccines & Prevention B.V., dated as of September 20, 2016

 

 

 

 

 

10.3 ^^

 

Amendment No. 3 to the Second Restated License Agreement, by and among Altimmune, Inc. and Janssen Vaccines & Prevention B.V., dated as of April 2, 2020

 

 

 

 

31.1

  

Certification of Principal Executive Officer Pursuant to SEC Rule 13a-14(a)/15d-14(a)

 

 

 

 

31.2

  

Certification of Principal Financial Officer Pursuant to SEC Rule 13a-14(a)/15d-14(a)

 

 

 

 

32.1

  

Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

 

 

 

 

32.2

  

Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

 

 

 

 

101.INS

  

XBRL Instance Document

 

 

 

 

101.SCH

  

XBRL Taxonomy Extension Schema Document

 

 

 

 

101.CAL

  

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

101.DEF

  

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

101.LAB

  

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

101.PRE

  

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

^^

Portions of this exhibit (indicated by asterisks) have been omitted in accordance with the rules of the Securities and Exchange Commission.

 

  

This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.

 

21


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused the report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ALTIMMUNE, INC.

 

 

 

 

Dated: August 11, 2020

By:

 

/s/ Vipin K. Garg

 

Name:

 

Vipin K. Garg

 

Title:

 

President and Chief Executive Officer (Principal Executive Officer)

 

 

 

 

Dated: August 11, 2020

By:

 

/s/ Will Brown

 

Name:

 

Will Brown

 

Title:

 

Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

 

 

 

 

22

EX-10.2 2 alt-ex102_335.htm EX-10.2 alt-ex102_335.htm

Exhibit 10.2

AMENDMENT NO. 2 TO SECOND RESTATED LICENSE AGREEMENT

This Amendment No. 2 to the Second Restated License Agreement (this “Amendment No. 2”) is made and effective as of September 20, 2016 by and between Crucell Holland B.V., a corporation organized under the laws of the Netherlands, having offices at Archimedesweg 4-6, 2333 CN Leiden, the Netherlands (“CRUCELL”) and Altimmune, Inc., a Delaware corporation, having offices located at 19 Firstfield Road, Gaithersburg, Maryland, USA 20878, f/k/a VAXIN INC., a Delaware corporation, having offices located at 1500 First Avenue North, Birmingham, Alabama, U.S.A. (“ALTIMMUNE”).

Recitals

Whereas CRUCELL and ALTIMMUNE entered into a Second Restated License Agreement effective as of October 4, 2005 (the “Agreement”);

Whereas CRUCELL and ALTIMMUNE entered into the Amendment No. 1 to Second Restated License Agreement effective as of September 25, 2015;

Whereas ALTIMMUNE is adding STRATEGIC PARTNERS; and

Whereas CRUCELL and ALTIMMUNE desire to further amend the Agreement on the terms and conditions set forth below in accordance with Section 14.1 of the Agreement.

NOW THEREFORE, for and in consideration of the mutual covenants contained herein, CRUCELL and ALTIMMUNE hereby agree as follows:

 

1.

Definitions and Cross References. Unless otherwise specified herein, each capitalized term shall have the meaning assigned to it in the Agreement and each reference to a Section or Article shall refer to the corresponding Section or Article in the Agreement. For clarity, the terms ALTIMMUNE and VAXIN shall have the same meaning.

 

2.

Exhibit 1.1 of the Agreement. Exhibit 1.1 of the Agreement is amended to add the following under the header Approved STRATEGIC PARTNERS:

Fujifilm Diosynth Biotechnologies
Emergent Biosciences

 

3.

3.Counterparts. This Amendment No. 2 may be executed is one or more counterparts or facsimiles thereof, each of which together shall constitute a single instrument.

(signature page follows)

 

 


 

IN WITNESS WHEREOF, CRUCELL and ALTIMMUNE have caused this Amendment No. 2 to be duly executed by their authorized representatives on the dates written herein below and effective as of September 20, 2016.

For: Crucell Holland B.V.For: Altimmune, Inc.

/s/ Maarten Santman/s/ William Enright

SignatureSignature

Maarten SantmanWilliam Enright

Printed NamePrinted Name

26 Sept 201620 Sept 2016

DateDate

 

 

 

 

 

Page 2 of 2

 

EX-10.3 3 alt-ex103_571.htm EX-10.3 alt-ex103_571.htm

 

Exhibit 10.3

CERTAIN INFORMATION IDENTIFIED BY BRACKETED ASTERISKS ([* * *]) HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.

AMENDMENT NO. 3 TO SECOND RESTATED LICENSE AGREEMENT

This Amendment No. 3 (“Amendment No. 3”) to the Second Restated License Agreement (“License”) is made and entered into on the date of the last signature below by and between:

Janssen Vaccines & Prevention B.V., a company under Dutch law with limited liability, with registered address at Archimedesweg 4, 2333 CN Leiden, The Netherlands (“Janssen Vaccines”);

and

Altimmune, Inc., a Delaware corporation, having offices located at 910 Clopper Road, Suite 201S, Gaithersburg Maryland (MD) 20878, Unites States (“Altimmune”);

Each party hereinafter individually referred to as “Party” and collectively as “Parties”;

WHEREAS Altimmune (Vaxin) and Janssen Vaccines (Crucell) entered into a Second Restated License Agreement effective as of October 4, 2005 (the “Agreement”)

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 1 to Second Restated License Agreement effective as of September 25, 2015;

WHEREAS Altimmune and Janssen Vaccines entered into the Amendment No. 2 to Second Restated License Agreement effective as of September 20, 2016;

WHEREAS Altimmune requested Janssen Vaccines to obtain authorization to use the PER.C6® cell line for development of a COVID-19 vaccine using Altimmune’s Ad5 technology and Janssen Vaccines is willing to provide expansion of the license Field; and

WHEREAS Altimmune and Janssen Vaccines desire to further amend the Agreement on the terms and conditions set forth below in accordance with Section 14.1 of the Agreement.

NOW THEREFORE, the Parties agree as follows:

 

 

1.

Definitions and Cross References. Unless otherwise specified herein, each capitalized term shall have the meaning assigned to it in the Agreement and each reference to a Section or Article shall refer to the corresponding Section or Article in the Agreement.

Page 1 of 5

 


 

The following definitions are amended to read as follows:

“1.5 FIELD means the prevention and/or treatment of human Infectious diseases caused by Infectious agents belonging to the family of Influenza virus, human infections caused by the Bacillus anthracis and Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).“

1.24 VIRAL PARTICLE means any replication-deficient or replicative-defective adenoviral particle, which is capable of replication only in complementing cells, which contains a polynucleotide sequence for a polypeptide derived from either human Influenza virus, Bacillus Anthracis, severe acute respiratory syndrome coronavirus 2, Newcastle disease virus (NDV), an antigen useful in delaying or reducing the progress of Alzheimer's Disease (which antigen the Parties shall specifically identify in an amendment to the Agreement prior to the initiation of the first Phase 1 human trial), and which is based on the genome of human adenovirus serotypes 2, 5, 7 and 35, chimpanzee adenovirus and canine adenovirus. VIRAL PARTICLE shall not include any polynucleotide sequence for polypeptide that is limited to an epitope conserved across multiple subtypes of the influenza A Virus, such as for example, the highly conserved part of the stem region of the main hemagglutinin viral surface protein of the Influenza A virus, which is described in published PCT Patent Application WO 2008/028946, and in Eklert et al, "Antibody Recognition of a Highly Conserved Influenza Virus Epitope," Science, 10 April 2009, vol. 324. no. 5924, pp. 246 - 251, or any hybrid proteins or conjugates encompassing such epitopes. For avoidance of doubt, polypeptides that comprise all or substantially all of an Influenza protein, such as the hemagglutinin viral surface protein of the influenza A virus, are not excluded from the definition of VIRAL PARTICLE.

 

2.

Section 3.2 Development Milestones Payments of the Agreement will be amended and updated by the following:

“3.2.4 Janssen Vaccines shall be entitled to, and Altimmune shall pay Janssen Vaccines, three milestone payments each of [***] dollars, 1) one payment being due within 30 days of the first patient being dosed in the first Phase 3 Clinical Trial of an influenza VACCINE, 2) one payment being due within 30 days of the first patient dosed in the first Phase 3 Clinical Trial of a Bacillus anthracis VACCINE and 3) one payment being due within 30 days of the first patient dosed in the first Phase 3 Clinical Trial of a COVID-19 VACCINE;

3.2.5 Altimmune shall pay Janssen Vaccines three milestone payments of [***] dollars each, 1) one payment being due within 30 days of FDA acceptance to review a filing for an application for marketing authorization, such as the filing of a BLA or its equivalent, for an influenza VACCINE, 2) one payment being due within 30 days of FDA acceptance to review a filing for an application for marketing authorization, such as the filing of a BLA or its equivalent, for a Bacillus anthracis VACCINE and 3) one payment being due within 30 days of FDA acceptance to review a

Page 2 of 5


 

filing for an application for marketing authorization, such as the filing of a BLA or its equivalent, for a COVID-19 VACCINE. Altimmune shall notify Janssen Vaccines in writing of the filing of such applications for marketing authorization within 15 days of such filings;

3.2.6 Altimmune shall pay Janssen Vaccines three milestone payments of [***] dollars each, 1) one payment being due within 30 days of the receiving from the FDA a letter of marketing authorization for an Influenza VACCINE, 2) one payment being due within 30 days of the receiving from the FDA a letter of marketing authorization for a Bacillus anthracis VACCINE and 3) one payment being due within 30 days of the receiving from the FDA a letter of marketing authorization for a COVID-19 VACCINE;

3.2.7. Altimmune shall pay Janssen Vaccines three milestone payments of [***] dollars each, 1) one payment being due within 30 days of the receiving a letter of authorization for marketing outside the United States, for an influenza VACCINE, 2) one payment being due within 30 days of the receiving a letter of authorization for marketing outside the United States for a Bacillus anthracis VACCINE and 3) one payment being due within 30 days of the receiving a letter of authorization for marketing outside the United States for a COVID-19 VACCINE.

3.2.8 Janssen Vaccines shall be entitled to, and Altimmune shall pay Janssen Vaccines, a milestone payment of [***] dollars, within 30 days of the first patient being dosed in the first Phase 1 Clinical Trial of COVID-19 VACCINE;

3.2.9 Janssen Vaccines shall be entitled to, and Altimmune shall pay Janssen Vaccines, a milestone payment of [***] dollars, within 30 days of the first patient being dosed in the first Phase 2 Clinical Trial of COVID-19 VACCINE.“

 

3.

Section 4.1 of the Agreement will be amended as follows:

“4.1 Minimum Royalty/Maintenance Fee. On September 1, 2006, and on each anniversary thereof thereafter until September 1, 2007, Altimmune shall pay Janssen Vaccines a minimum royalty of seventy-five thousand dollars ($75,000). Beginning on, and due on, October 4, 2010, and on every anniversary thereof thereafter until the effective date of this Amendment No. 3, Altimmune shall pay Janssen Vaccines a minimum royalty of one hundred thousand dollars ($100,000), subject to section 5.3. Beginning on the effective date of this Amendment No. 3, and on every anniversary thereof thereafter, Altimmune shall pay Janssen Vaccines a minimum royalty of one hundred fifty thousand dollars ($150,000), subject to section 5.3.”

 

4.

Section 6 TECHNICAL AND MATERIAL TRANSFER will be updated by the following:

“6.6 COVID-19 support. Notwithstanding anything to the contrary in this Section 6, Parties agree that Section 6.2 Technical assistance and Section 6.4 PER.C6® CELL transfer do not apply to the development and

Page 3 of 5


 

manufacturing of COVID-19 VACCINE. For clarity, Altimmune shall provide its Registered Affiliate, or Strategic Partner with PER.C6® Cells from Altimmune’s own inventory. Nothing in this agreement will obligate Janssen Vaccines to provide said support related to the development and manufacturing of a COVID-19 VACCINE”

 

5.

Section 9.2 Press Releases will be replaced by the following:

“9.2 Press Releases: Janssen Vaccines shall have the right to publish the existence of this agreement, and any subsequent related agreements, provided Altimmune has an opportunity to review press releases for at least five (5) working days prior to public disclosure. Altimmune shall have the right to publish the existence of this Agreement limited to Influenza virus and Bacillus anthracis, upon written approval of Janssen Vaccines, which consent shall not be unreasonably withheld. Altimmune may issue subsequent press releases respecting its Influenza and Bacillus anthracis vaccine programs, provided that press releases relating to the influenza vaccine program must characterize such vaccine as being a recombinant adenoviral vaccine against Influenza if the press release also discloses that such vaccine is made using PER.C6® Technology, in a manner of  disclosure that Janssen Vaccines has previously approved.”

 

6.

The Agreement is amended only to the extent necessary to give full effect to this Amendment No. 3. All other terms and conditions of the Agreement shall remain in full force and effect. All capitalized terms in this Amendment No. 3, unless defined in this Amendment No. 3, shall have the meaning as defined in the Agreement.

 

7.

Each signatory to this Amendment No. 3 personally represents that, to the best of his/her knowledge, he/she has authority to legally bind his/her respective Party to this Amendment No. 3.

 

8.

This Amendment No. 3 may be executed in counterparts and when bearing the signatures of all required parties hereto it shall constitute one and the same Amendment No. 3. The Parties agree that exchanged PDF copies of a signature or any other electronically generated signature used in execution of this Amendment No. 3 (including by means of services such as Adobe eSign services) shall constitute a binding original of this Amendment No. 3 for all purposes.

IN WITNESS WHEREOF, the Parties hereto have caused this Amendment No. 3 to be duly executed on the dates written below.

Janssen Vaccines & Prevention B.V.

Altimmune, Inc.

 

 

/s/ M. Santman_______________

 

 

/s/ Vipin K. Garg____________

Name: M. Santman

Name: Vipin K. Garg

Page 4 of 5


 

Function: Director

Function: President & CEO

Date: April 2, 2020

Date: March 27, 2020

 

 

Page 5 of 5

EX-31.1 4 alt-ex311_6.htm EX-31.1 alt-ex311_6.htm

Exhibit 31.1

Certification of Principal Executive Officer

Pursuant to SEC Rule 13a-14(a)/15d-14(a)

I, Vipin K. Garg, certify that:

1.

I have reviewed this report on Form 10-Q of Altimmune, Inc. for the period ended June 30, 2020;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

 

 

Dated: August 11, 2020

 

/s/ Vipin K. Garg

 

 

Name: Vipin K. Garg

 

 

Title: President and Chief Executive Officer

(Principal Executive Officer)

 

 

EX-31.2 5 alt-ex312_7.htm EX-31.2 alt-ex312_7.htm

Exhibit 31.2

Certification of Principal Financial Officer

Pursuant to SEC Rule 13a-14(a)/15d-14(a)

I, Will Brown, certify that:

1.

I have reviewed this report on Form 10-Q of Altimmune, Inc. for the period ended June 30, 2020;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

 

 

Dated: August 11, 2020

 

/s/ Will Brown

 

 

Name: Will Brown

 

 

Title: Chief Financial Officer

(Principal Financial Officer)

 

EX-32.1 6 alt-ex321_8.htm EX-32.1 alt-ex321_8.htm

Exhibit 32.1

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

In connection with the quarterly report on Form 10-Q of Altimmune, Inc. (the “Company”) for the period ended June 30, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, Vipin K. Garg, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Vipin K. Garg

Vipin K. Garg

President and Chief Executive Officer

August 11, 2020

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

EX-32.2 7 alt-ex322_9.htm EX-32.2 alt-ex322_9.htm

Exhibit 32.2

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

In connection with the quarterly report on Form 10-Q of Altimmune, Inc. (the “Company”) for the period ended June 30, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, Will Brown, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Will Brown

Will Brown

Chief Financial Officer

August 11, 2020

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

This certification is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

GRAPHIC 8 gxgpyldmzs5j000001.jpg GRAPHIC begin 644 gxgpyldmzs5j000001.jpg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end EX-101.INS 9 alt-20200630.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0001326190 2020-01-01 2020-06-30 0001326190 2020-08-07 0001326190 2020-06-30 0001326190 2019-12-31 0001326190 2020-04-01 2020-06-30 0001326190 2019-04-01 2019-06-30 0001326190 2019-01-01 2019-06-30 0001326190 us-gaap:CommonStockMember 2019-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001326190 us-gaap:RetainedEarningsMember 2019-12-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001326190 2020-01-01 2020-03-31 0001326190 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001326190 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001326190 us-gaap:CommonStockMember 2020-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001326190 us-gaap:RetainedEarningsMember 2020-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001326190 2020-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001326190 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001326190 us-gaap:CommonStockMember alt:MarketOfferingMember 2020-04-01 2020-06-30 0001326190 us-gaap:AdditionalPaidInCapitalMember alt:MarketOfferingMember 2020-04-01 2020-06-30 0001326190 alt:MarketOfferingMember 2020-04-01 2020-06-30 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001326190 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001326190 us-gaap:CommonStockMember 2020-06-30 0001326190 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001326190 us-gaap:RetainedEarningsMember 2020-06-30 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001326190 us-gaap:CommonStockMember 2018-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001326190 us-gaap:RetainedEarningsMember 2018-12-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001326190 2018-12-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001326190 2019-01-01 2019-03-31 0001326190 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001326190 us-gaap:CommonStockMember alt:RegisteredDirectOfferingMember 2019-01-01 2019-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember alt:RegisteredDirectOfferingMember 2019-01-01 2019-03-31 0001326190 alt:RegisteredDirectOfferingMember 2019-01-01 2019-03-31 0001326190 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001326190 us-gaap:CommonStockMember 2019-03-31 0001326190 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001326190 us-gaap:RetainedEarningsMember 2019-03-31 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001326190 2019-03-31 0001326190 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001326190 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001326190 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001326190 us-gaap:CommonStockMember 2019-06-30 0001326190 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001326190 us-gaap:RetainedEarningsMember 2019-06-30 0001326190 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001326190 2019-06-30 0001326190 alt:SpitfirePharmaIncMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember srt:MaximumMember us-gaap:CommonStockMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationMilestoneMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationMilestoneMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationAndRegulatoryMilestonesMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:InvestigationalNewDrugApplicationAndRegulatoryMilestonesMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:SalesMilestoneMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:SalesMilestoneMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember 2019-04-01 2019-06-30 0001326190 alt:SpitfirePharmaIncMember 2019-01-01 2019-06-30 0001326190 alt:SpitfirePharmaIncMember alt:RegulatoryMilestoneMember 2019-07-12 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:MonteCarloSimulationModelMember alt:RegulatoryMilestoneMember 2019-07-12 0001326190 alt:SpitfirePharmaIncMember alt:MonteCarloSimulationModelMember alt:RegulatoryMilestoneMember 2020-06-30 0001326190 alt:SpitfirePharmaIncMember alt:MonteCarloSimulationModelMember alt:RegulatoryMilestoneMember 2020-01-01 2020-06-30 0001326190 alt:SpitfirePharmaIncMember alt:MonteCarloSimulationModelMember alt:RegulatoryMilestoneMember 2020-04-01 2020-06-30 0001326190 us-gaap:WarrantMember 2020-04-01 2020-06-30 0001326190 us-gaap:WarrantMember 2019-04-01 2019-06-30 0001326190 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-06-30 0001326190 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001326190 us-gaap:RestrictedStockMember 2020-04-01 2020-06-30 0001326190 us-gaap:RestrictedStockMember 2019-04-01 2019-06-30 0001326190 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001326190 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001326190 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001326190 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001326190 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0001326190 us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001326190 alt:InternallyDevelopedPatentsMember 2020-06-30 0001326190 alt:AcquiredLicensesMember 2020-06-30 0001326190 alt:InternallyDevelopedPatentsMember srt:MinimumMember 2020-01-01 2020-06-30 0001326190 alt:InternallyDevelopedPatentsMember srt:MaximumMember 2020-01-01 2020-06-30 0001326190 alt:AcquiredLicensesMember srt:MinimumMember 2020-01-01 2020-06-30 0001326190 alt:AcquiredLicensesMember srt:MaximumMember 2020-01-01 2020-06-30 0001326190 us-gaap:InProcessResearchAndDevelopmentMember 2020-06-30 0001326190 alt:InternallyDevelopedPatentsMember 2019-12-31 0001326190 alt:AcquiredLicensesMember 2019-12-31 0001326190 alt:InternallyDevelopedPatentsMember srt:MinimumMember 2019-01-01 2019-12-31 0001326190 alt:InternallyDevelopedPatentsMember srt:MaximumMember 2019-01-01 2019-12-31 0001326190 alt:AcquiredLicensesMember srt:MinimumMember 2019-01-01 2019-12-31 0001326190 alt:AcquiredLicensesMember srt:MaximumMember 2019-01-01 2019-12-31 0001326190 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0001326190 us-gaap:ResearchAndDevelopmentExpenseMember 2020-04-01 2020-06-30 0001326190 us-gaap:ResearchAndDevelopmentExpenseMember 2019-04-01 2019-06-30 0001326190 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-06-30 0001326190 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-06-30 0001326190 alt:PaycheckProtectionProgramLoanMember 2020-04-13 2020-04-13 0001326190 alt:PaycheckProtectionProgramLoanMember 2020-01-01 2020-06-30 0001326190 alt:PaycheckProtectionProgramLoanMember 2020-06-30 0001326190 alt:RegisteredDirectOfferingATMUsageAndWarrantExercisesMember us-gaap:SubsequentEventMember 2020-07-01 2020-08-11 0001326190 alt:EquityDistributionAgreementMember alt:JMPSecuritiesLimitedLiabilityCompanyMember alt:AtTheMarketOfferingMember 2020-03-27 0001326190 alt:EquityDistributionAgreementMember alt:JMPSecuritiesLimitedLiabilityCompanyMember srt:MaximumMember alt:AtTheMarketOfferingMember 2020-03-26 2020-03-27 0001326190 alt:EquityDistributionAgreementMember alt:JMPSecuritiesLimitedLiabilityCompanyMember alt:AtTheMarketOfferingMember 2020-03-26 2020-03-27 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-06-01 2020-06-01 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-06-28 2020-06-30 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-06-30 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember us-gaap:SubsequentEventMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-07-01 2020-08-11 0001326190 alt:EquityDistributionAgreementMember alt:AtTheMarketOfferingMember us-gaap:SubsequentEventMember alt:JMPSecuritiesLimitedLiabilityCompanyMember 2020-08-11 0001326190 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-12-31 0001326190 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-01-01 2020-06-30 0001326190 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2020-06-30 0001326190 us-gaap:SubsequentEventMember 2020-07-01 2020-08-11 0001326190 us-gaap:IPOMember us-gaap:SubsequentEventMember 2020-07-01 2020-08-11 0001326190 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001326190 us-gaap:EmployeeStockOptionMember 2020-06-30 0001326190 us-gaap:RestrictedStockMember 2020-06-30 0001326190 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0001326190 us-gaap:RestrictedStockUnitsRSUMember 2020-04-01 2020-06-30 0001326190 us-gaap:RestrictedStockUnitsRSUMember 2020-06-30 0001326190 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-06-30 0001326190 alt:TwoThousandAndNineteenEmployeeStockPurchasePlanMember 2020-01-01 2020-06-30 0001326190 alt:TwoThousandAndNineteenEmployeeStockPurchasePlanMember 2020-04-01 2020-06-30 0001326190 us-gaap:GeneralAndAdministrativeExpenseMember 2020-04-01 2020-06-30 0001326190 us-gaap:GeneralAndAdministrativeExpenseMember 2019-04-01 2019-06-30 0001326190 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-06-30 0001326190 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0001326190 alt:JanssenVaccinesAndPreventionsBvMember us-gaap:LicenseMember srt:MaximumMember 2020-04-02 2020-04-02 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001326190 us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001326190 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001326190 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-06-30 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001326190 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001326190 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001326190 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001326190 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001326190 us-gaap:CertificatesOfDepositMember 2020-06-30 0001326190 us-gaap:CorporateDebtSecuritiesMember 2020-06-30 0001326190 alt:ContingentConsiderationLiabilityMember 2019-12-31 0001326190 alt:ContingentConsiderationLiabilityMember 2020-01-01 2020-06-30 0001326190 alt:ContingentConsiderationLiabilityMember 2020-06-30 0001326190 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputPriceVolatilityMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 alt:MeasurementInputCostOfCapitalMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 alt:MeasurementInputCostOfCapitalMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:MinimumMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:MaximumMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 alt:MeasurementInputProbabilityOfPaymentMember srt:MinimumMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 alt:MeasurementInputProbabilityOfPaymentMember srt:MaximumMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 alt:MeasurementInputProbabilityOfPaymentMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member 2020-06-30 0001326190 us-gaap:MeasurementInputMaturityMember srt:MinimumMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-06-30 0001326190 us-gaap:MeasurementInputMaturityMember srt:MaximumMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-06-30 0001326190 us-gaap:MeasurementInputMaturityMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-06-30 0001326190 us-gaap:SubsequentEventMember us-gaap:IPOMember us-gaap:CommonStockMember 2020-07-15 2020-07-16 0001326190 us-gaap:SubsequentEventMember us-gaap:IPOMember us-gaap:CommonStockMember 2020-07-16 0001326190 us-gaap:SubsequentEventMember us-gaap:IPOMember alt:PreFundedWarrantsMember 2020-07-16 0001326190 us-gaap:SubsequentEventMember us-gaap:IPOMember alt:PreFundedWarrantsMember 2020-07-15 2020-07-16 0001326190 us-gaap:SubsequentEventMember us-gaap:IPOMember 2020-07-15 2020-07-16 0001326190 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember us-gaap:CommonStockMember 2020-07-15 2020-07-16 10-Q false 2020-06-30 2020 Q2 ALT ALTIMMUNE, INC. 0001326190 --12-31 Non-accelerated Filer true false false Yes Yes 32904333 001-32587 20-2726770 DE 910 Clopper Road Suite 201S Gaithersburg MD 20878 (240) 654-1450 Common stock, par value $0.0001 per share NASDAQ true false 64741921 8962686 34174 34174 64776095 8996860 15484402 28277386 1182099 1021179 5506946 629096 1020876 470228 87970418 39394749 1024640 1104208 662074 698321 12785655 12732195 100980 128547 102543767 54058020 195217 18232 4089749 3904767 632000 4916966 3922999 16390000 2750000 1715024 1864875 23021990 8537874 2635 1508 242579532 187914916 -158028687 -137376122 -5031703 -5020156 79521777 45520146 102543767 54058020 0.0001 0.0001 200000000 200000000 26553957 15312381 26553886 15312167 721636 1626029 2934330 4581622 16594250 2945096 23781781 6162768 2545356 2231817 4877273 4298299 19139606 5176913 28659054 10461067 -18417970 -3550884 -25724724 -5879445 46000 46000 3308 748 5193 1488 81458 239964 233027 425211 -5878 -29220 19664 17528 72272 163996 247498 395251 -18345698 -3386888 -25477226 -5484194 -1578782 -4824661 -16766916 -3386888 -20652565 -5484194 20888 -11547 -16746028 -3386888 -20664112 -5484194 452925 -16766916 -3386888 -20652565 -5937119 -0.94 -0.26 -1.25 -0.52 17886853 13127773 16498719 11318819 15312167 1508 187914916 -137376122 -5020156 214921 214921 -5974 1 -17080 -17079 38809 3 56736 56739 14500 2 39972 39974 -32435 -32435 -3885649 -3885649 15359502 1514 188209465 -141261771 -5052591 41896617 330510 330510 13935 1 36174 36175 -5974 1 -46390 -46389 2965144 297 22780432 22780729 8221279 822 31269341 31270163 20888 -16766916 26553886 2635 242579532 -158028687 -5031703 9078239 876 170207844 -116855991 -5040163 48312566 407714 407714 71 28 28 4361370 436 12668348 12668784 11000 1 30323 30324 -2097306 -2097306 13450680 1313 183314257 -118953297 -5040163 59322110 71 289800 289800 -3386888 13450751 1313 183604057 -122340185 -5040163 56225022 -20652565 -5484194 13640000 545431 697486 120169 121899 25876 107580 18851 24943 46000 160920 -832098 343337 113200 176985 -102763 26761 -1181457 4877851 71586 -11518302 -5173080 24900000 12118563 40601 1226 79336 15874 12661500 -17100 179743 31310137 30324 22780729 12668784 632000 56739 36175 156145 54636037 12542963 55779235 7352783 34353129 41705912 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Nature of Business and Basis of Presentation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Nature of Business</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Altimmune, Inc., headquartered in Gaithersburg, Maryland, together with its subsidiaries (collectively, the &#8220;Company&#8221; or &#8220;Altimmune&#8221;) is a clinical stage biopharmaceutical company incorporated under the laws of the State of Delaware. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. The Company&#8217;s diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital, and has financed its operations through the issuance of common and preferred stock, long-term debt, and proceeds from research grants and government contracts. The Company has not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2019 included in the annual report on Form&#160;10-K which was filed with the SEC on March 27, 2020. In the opinion of management, the Company has prepared the accompanying unaudited consolidated financial statements on the same basis as the audited consolidated financial statements, and these consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year 2020 or any future years or periods.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The unaudited consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June&#160;30, 2020, there have been no significant changes to the Company&#8217;s summary of significant accounting policies contained in the Company&#8217;s Annual report on Form 10-K for the year ended December 31, 2019 as filed with the SEC, except for the recently adopted accounting standard for investments.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company&#8217;s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company&#8217;s estimates and assumptions and determined that there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended June 30, 2020. However, actual results could differ from those estimates and there may be changes to the Company&#8217;s estimates in future periods.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements - Adopted</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2018-13, <font style="font-style:italic;">Fair Value Measurement (Topic 820) &#8211; Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement</font> (&#8220;ASU No. 20218-13&#8221;). ASU No. 2018-13 was issued to modify and enhance the disclosure requirements for fair value measurements and eliminates certain disclosure requirements, such as the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy. This ASU adds new disclosure requirements for Level 3 measurements and is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2020 which resulted in expanded disclosures in Note 15 regarding the Company&#8217;s recurring Level 3 fair value measurements.<font style="font-family:Calibri;font-size:11pt;">&nbsp;&nbsp;&nbsp;&nbsp; </font></p> <p style="text-align:justify;margin-bottom:12pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Contingent Consideration</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company entered into a definitive agreement to acquire all of the equity interests of Spitfire Pharma, Inc. (&#8220;Spitfire&#8221;) on July 8, 2019. Spitfire was a privately held, preclinical pharmaceutical company developing a novel dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis.&nbsp;&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The transaction closed on July 12, 2019. The Company issued 1,887,250 unregistered shares of its common stock (the &#8220;shares&#8221;) as upfront consideration to certain former securityholders of Spitfire (collectively, the &#8220;Spitfire Equityholders&#8221;), representing an amount equal to $5.0 million less working capital and transaction expense adjustment amounts as defined in the agreement.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Merger Agreement also includes future contingent payments up to $88.0 million in cash and shares of the Company&#8217;s common stock as follows (each, a &#8220;Milestone Event&#8221;): <font style="margin-left:36pt;"></font></p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a one-time payment of $5.0 million (the &#8220;IND Milestone Consideration Amount&#8221;) within sixty days of the submission of an Investigational New Drug Application (&#8220;IND&#8221;) to the United States Food and Drug Administration (the &#8220;FDA&#8221;) or other applicable governmental authority in a foreign jurisdiction, which IND has not been rejected or placed on clinical hold by the FDA or such applicable foreign governmental authority within time specified in the Merger Agreement; </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-bottom:8pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-bottom:8pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a one-time payment of $3.0 million (the &#8220;Phase 2 Milestone Consideration Amount&#8221; and together with the IND Milestone Consideration Amount, the &#8220;Regulatory Milestones&#8221;) within sixty days of the initiation of a Phase 2 clinical trial of a product candidate anywhere in the world; and </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.12%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payments of up to $80.0 million upon the achievement of specified worldwide net sales (the &#8220;Sales Milestones&#8221;) of all products developed using the technology acquired in the License Agreement within ten years following the approval of a new drug application filed with the FDA.</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:8pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Regulatory Milestones will be payable in shares of the Company&#8217;s Common Stock, with the number of shares of the Company&#8217;s Common Stock to be issued in connection with each milestone amount, if any, are dependent on the share price at the time of achievement. The number of any shares issued in consideration for the IND Milestone Consideration Amount will be determined based on lower of (A) the average of the closing prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days prior to the IND Reference Date or (B) $2.95. The value of any shares issued in consideration for the Phase 2 Milestone Consideration Amount shall be determined based the lower of (A) on the average of the closing trading prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days immediately preceding the date of the occurrence of the Phase 2 Milestone Event or (B) $3.54.</p> <p style="text-align:justify;margin-bottom:8pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The acquisition of Spitfire was accounted for as an asset acquisition instead of a business combination because substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets, and therefore, the asset was not considered a business. The Company expensed the acquired intellectual property as of the acquisition date as in-process research and development with no alternative future uses. The Company recorded an in-process research and development expense for the up-front consideration during the third quarter of 2019. Transaction costs of $0.6 million were recorded within research and development expense on the Company&#8217;s consolidated statements of operations and comprehensive loss during the three and six months ended June&#160;30, 2019.</p> <p style="text-align:justify;margin-bottom:8pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The future contingent payments related to the Regulatory Milestones are stock-based payments accounted for under FASB Accounting Standards Codification Topic 480, <font style="font-style:italic;">Distinguishing Liabilities From Equity</font>. Such stock-based payments are subject to a lock-up whereby 50% of the shares are released at 3 months and 50% are released at 6 months. As of the acquisition date, the Company estimated future contingent consideration of $2.8 million based upon a Monte Carlo simulation that was risk adjusted based on the probability of achieving the milestones and a discount for lack of marketability, which was expensed to in-process research and development expenses during the third quarter of 2019. The Company remeasured the fair value of the contingent consideration as of June&#160;30, 2020, and increased the liability from March 31, 2020 to $16.4 million primarily due to an increase in the share price during the six months ended June 30, 2020 and an increase in the probability of milestone achievement. The increased change in the liability of $11.9 million and $13.6 million was expensed to research and development expense during the three and six months ended June&#160;30, 2020, respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The future contingent payments related to the Sales Milestones are predominately cash-based payments accounted for under FASB Accounting Standards Codification Topic 450, <font style="font-style:italic;">Contingencies</font>. Accordingly, the Company will recognize the Sales Milestones when the contingency is resolved and the amount is paid or payable.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Net Loss Per Share</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because the Company has reported a net loss attributable to common stockholders for all periods presented, basic and diluted net loss per share attributable to common stockholders are the same for all periods presented. For periods presented, all unvested restricted stock, common stock warrants, and stock options have been excluded from the computation of diluted weighted-average shares outstanding because such securities would have an antidilutive impact.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three and Six Months&#160;Ended</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three and Six Months&#160;Ended</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,150,285</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,386,256</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,527,978</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">873,066</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">304,686</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">323,262</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Intangible Assets</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s intangible assets consisted of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-10 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">825,659</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(466,866</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">358,793</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,105</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,895</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,110,659</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(743,971</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,688</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,529,626</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(743,971</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,785,655</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-10 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">746,323</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(448,874</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297,449</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(269,221</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,779</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,031,323</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(718,095</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">313,228</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.16%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,450,290</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(718,095</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,732,195</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization expense of intangible assets was $12,025 and $14,836 for the three months ended June&#160;30, 2020 and 2019, and $25,876 and $107,580 for the six months ended June&#160;30, 2020 and 2019, respectively. Amortization expense was classified as research and development expenses in the accompanying unaudited consolidated statements of operations and comprehensive loss.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June&#160;30, 2020, future estimated amortization expense are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years ending December 31,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remainder of 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,596</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,687</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,687</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,687</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,781</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 and thereafter</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,250</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,688</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Accrued Expenses</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consist of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional services</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">472,329</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">429,467</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and employee benefits</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">956,584</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,183,130</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,240</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,047</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,343,629</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,966,111</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, current portion (see Note 12)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,276</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">259,449</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,691</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,563</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,089,749</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,904,767</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Notes Payable</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Paycheck Protection Program</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 7, 2020, the Company applied for a loan from ServisFirst Bank, as lender, pursuant to the Paycheck Protection Program of the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) as administered by the U.S. Small Business Administration (the "SBA"). On April 13, 2020, the Loan was approved and the Company received the proceeds from a loan in the amount of $632,000 <font style="Background-color:#FFFFFF;">(the &#8220;PPP Loan&#8221;). </font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The PPP Loan, which took the form of a promissory note (the &#8220;Promissory Note&#8221;), was set to mature on April 7, 2022 and bore interest at a rate of 1% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (discussed below), was to commence on November 7, 2020. The Company did not provide any collateral or guarantees for the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan. The Promissory Note provided for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company could prepay the principal of the PPP Loan at any time without incurring any prepayment charges.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All or a portion of the Loan may be forgiven by the SBA and lender upon application by the Company upon documentation of expenditures in accordance with the SBA requirements. Subsequent to the quarter ended June 30, 2020, the Company received approximately $136.2 million in net proceeds from warrant exercises, ATM usage, and the public offering of its common stock and decided to voluntarily extinguish the Promissory Note on July 21, 2020 by paying the outstanding principal and accrued interest in cash.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8. Other Long-Term Liabilities</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s other long-term liabilities are summarized as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, long-term portion (see Note 12)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,344,779</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,484,679</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrant liability (see Note 10)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Economic conditional grants</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,245</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,196</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other long-term liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,715,024</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,864,875</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. At-the-Market Offering</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">O<font style="font-size:10pt;">n March 27, 2020, the Company entered into an Equity Distribution Agreement (the &#8220;Agreement&#8221;) with JMP Securities LLC, serving as placement agent (the &#8220;Placement Agent&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), having an aggregate offering price of up to $50.0 million (the &#8220;Shares&#8221;) through the Placement Agent (the &#8220;Offering&#8221;).</font> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any Shares offered and sold in the Offering will be issued pursuant to the Company&#8217;s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on April 4, 2019, which was declared effective on April 12, 2019, the prospectus supplement relating to the Offering filed with the SEC on March 27, 2020 and any applicable additional prospectus supplements related to the Offering that form a part of the Registration Statement. The aggregate market value of Shares eligible for sale in the Offering and under the Equity Distribution Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. The Company offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2020, the Company filed an amendment to the Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, the Company has sold 2,965,144 shares of Common Stock under the Agreement resulting in $22.8 million in net proceeds, leaving $26.3 million available to be sold under the amended Agreement. As of June 30, 2020, the Company recorded approximately $0.3 million of offering costs which offset the proceeds received from the shares sold through June 30, 2020 and recognized approximately $0.2 million of deferred offering costs which will offset future proceeds received under the Agreement. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subsequent to the quarter ended June 30, 2020, the Company sold 234,856 shares of Common Stock under the Equity Distribution Agreement, that resulted in $2.5 million in net proceeds, leaving $23.7 million available to be sold under the amended Agreement.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">10. Warrants</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of warrant activity during the six months ended June&#160;30, 2020 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, December 31, 2019</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,384,706</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants issued due to anti-dilution features triggered from Registered Direct Offering</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,358</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercises</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,235,779</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,150,285</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.25%;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020, the Company received net proceeds of $31.3 million from warrant exercises.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For warrants classified as a liability, the following is a summary of the periodic changes in their fair value during the six months ended June&#160;30, 2020:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance, December 31, 2019</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.06%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in fair value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.06%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance, June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subsequent to the quarter ended June 30, 2020, there were additionally 1,983,110 warrants exercised resulting in net proceeds of $9.6 million and 1,630,436 pre-funded warrants issued in connection with a Public Offering (see Note 16).</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. Stock-Based Compensation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock Options</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s stock option awards generally vest over four years and typically have a contractual life of ten years. At June&#160;30, 2020, there was $1.9 million of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 3.06&#160;years. During the six months ended June&#160;30, 2020, the Company granted 520,500 stock options with a weighted average exercise price of $2.31 and per share weighted average grant date fair value of $1.83. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information related to stock options outstanding at June&#160;30, 2020 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Stock</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,477,153</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.65</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.96</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,804,940</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">416,022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.97</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.69</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,097,502</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr style="height:9.6pt;"> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,061,131</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.74</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.07</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,707,438</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At June&#160;30, 2020, the Company had unvested restricted stock of 195,161 shares with total unrecognized compensation expense of $0.7 million, which the Company expects to recognize over a weighted average period of approximately 2.42&#160;years. During the six months ended June&#160;30, 2020, the Company released 40,505&#160;shares of common stock from restriction as a result of the vesting of restricted stock. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three months ended June 30, 2020, the Company granted 109,525 shares of restricted stock units which vest during the third quarter of 2020. At June&#160;30, 2020, the Company had unvested restricted stock units of 109,525 shares with total unrecognized compensation expense of $0.9 million, which the Company expects to recognize over a weighted average period of approximately 0.25 years. </p> <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2019 Employee Stock Purchase Plan</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), employees purchased 38,809 shares for $56,739 during the six months ended June&#160;30, 2020. During the three and six months ended June&#160;30, 2020, the Company recognized compensation expense of $20,372 and $35,084, respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Stock-based Compensation Expense</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019 as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,939</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,060</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,939</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">168,684</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">252,571</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,712</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">438,492</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">528,802</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">330,510</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">289,772</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">545,431</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">697,486</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12. Operating Leases</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company rents office and laboratory space in the United States. The Company also leases office equipment under a non-cancellable equipment lease through December 2022. Rent expense during the three and six months ended June&#160;30, 2020 under all of the Company&#8217;s operating leases was $86,295 and $173,894, respectively. Rent expense during the three and six months ended June&#160;30, 2019 was $83,903 and $174,079, respectively. Rent expense includes short-term leases and variable lease costs that are not included in the lease obligation. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The office space lease provides for increases in future minimum annual rental payments as defined in the lease agreements. The Company has determined the lease renewal option is not reasonably certain.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cash paid for operating lease liabilities for the three and six months ended June&#160;30, 2020 was $64,193 and $126,073, respectively.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental other information related to the operating leases balance sheet information is as follows: </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,618,055</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">662,074</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.83</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.0</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maturities of lease liabilities is as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:6pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ending December 31,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remainder of 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">194,596</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">393,542</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,198</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">407,054</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414,116</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 and thereafter</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138,831</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,948,337</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less imputed interest</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(330,282</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,618,055</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13. Income Taxes </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In response to global pandemic associated with COVID-19, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) on March 27, 2020. The CARES Act provided both stimulus measures and a number of tax provisions, including: temporary changes regarding the utilization and carry back of net operating losses, temporary changes to the prior and future limitations on interest deductions, technical corrections from prior tax legislation for tax depreciation of qualified improvement property, and certain refundable employee retention credits. The CARES Act enables the Company to file a refund claim to reflect a refund of its 2016 tax liability by carrying back its 2018, 2019 and 2020 losses to fully offset this liability. The refund claim attributable to the 2018 and 2019 tax years has been recorded as a discrete item in the income tax benefit for the three months ended March 31, 2020 of<font style="font-family:Calibri;"> </font>$2.9 million. In addition, the Company is currently estimating it will be able to carry back a portion of its current and forecasted 2020 net operating losses as of the end of the year and has included an estimate in its annual effective tax rate calculation as of June 30, 2020, which resulted in an additional income tax benefit of $1.0 million recorded during the six months ended June&#160;30, 2020. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:8pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 12, 2020, the Comptroller of Maryland issued a report announcing that the state decoupled from the CARES Act loss carryback provisions for the 2020 year only, but indicated uncertainty as to whether the General Assembly would pass a measure to decouple from all years in the CARES Act and not process amended filings in the interim. As a result, an additional discrete item in the income tax benefit of $1.0 million was recognized for the three months ended June 30, 2020 related to the release of valuation allowance related to losses that could potentially be carried back to the 2016 tax year under current law. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accordingly, the Company has recognized a total tax benefit of $4.8 million for the six months ended June 30, 2020.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14. Commitments and Contingencies</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Spitfire Acquisition</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As disclosed in Note 3, the Company is obligated to make payments of up to $80.0 million upon the achievement of specified worldwide net sales of all products developed using the technology acquired from Spitfire Pharma Inc. within ten years following the approval of a new drug application filed with the FDA.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">PER.C6 License Agreement Expansion</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">On April 2, 2020, the Company entered into Amendment No. 3 to the Second Restated License Agreement (the &#8220;Amendment&#8221;), by and between the Company and Janssen Vaccines &amp; Prevention B.V. (formerly known as Crucell Holland B.V.) (as amended by Amendment No. 1 to Second Restated License Agreement and Amendment No. 2 to Second Restated License Agreement, together with the Amendment, the &#8220;License Agreement&#8221;). Pursuant to the Amendment, the field of licenses granted to the Company for the use of the PER.C6 cell line under the License Agreement is expanded to cover COVID-19 caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in addition to the existing licenses related to Bacillus anthracis and influenza virus. All capitalized terms not defined herein shall have the meanings assigned to them in the Amendment or the License Agreement, as applicable.</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Pursuant to the Amendment, the Company agreed to pay certain additional development-based milestone payments through approval of licensed products by the FDA for the treatment or prevention of COVID-19, up to an aggregate amount of $1.2 million. The Company also agreed to pay royalty payments as a percentage of net sales of products to a royalty stacking reduction and minimum annual royalty payments, until the expiration of the term of the License Agreement, as amended. As of June 30, 2020, payments made under the License Agreement were de minimis.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Litigation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (&#8220;Plaintiff&#8221;) against the Company in U.S. District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as &#8220;Defendants&#8221;). In March 2020 the Defendants&#8217; filed a motion to dismiss the complaint. The Court denied the motion without prejudice and allowed Plaintiff an opportunity to file an amended complaint. Plaintiff&#8217;s second amended complaint was filed on April 17, 2020, and Defendants filed a motion to dismiss that complaint on May 1, 2020. Plaintiff, who is representing himself, alleges five causes of action as follows: (1) Defendants&#8217; alleged retention of Plaintiff&#8217;s lab notebooks; (2) alleged plagiarism based on publishing an article without naming Plaintiff as an author; (3) use of the Adhigh System, which Plaintiff alleges he developed; (4) allegations that Defendants manipulated the Company&#8217;s stock and caused a decrease in value; and (5) allegations that the Defendants &#8220;wast[ed] government grant money and poison[ed] science by leaving data to rot.&#8221; A hearing on Defendants&#8217; motion to dismiss was held on May 20, 2020, and the motion is currently pending. The Company believes the allegations in the complaint are without merit and intends to vigorously defend the litigation. However, the outcome of this legal proceeding is uncertain at this time and the Company cannot reasonably estimate a range of loss, if any. Accordingly, the Company has not accrued any liability associated with this action. The Company is a party in various other contractual disputes, litigation, and potential claims arising in the ordinary course of business none of which are currently reasonably possible or probable of material loss.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15. Fair Value Measurement</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at June&#160;30, 2020 consisted of the following:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.6%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recurring fair value measurements</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,011,208</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,011,208</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,484,402</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,484,402</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at December&#160;31, 2019 consisted of the following:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at December&#160;31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recurring fair value measurements</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,034,640</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,034,640</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,277,386</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,277,386</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant liability</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets recorded at fair value on a nonrecurring basis, such as property and equipment and intangible assets are recognized at fair value when they are impaired. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;"> Cash equivalents and short-term investments have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value. Short-term investments had quoted prices at June&#160;30, 2020 as shown below:</font></p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain (Loss)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of deposit</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial and corporate debt securities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,475,942</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,460</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,484,402</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,475,942</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,460</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,484,402</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:2pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of contingent payments classified as a liability was based on the regulatory milestones described in Note 3 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs. The following table is a reconciliation of the beginning and ending balance of contingent consideration liability:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.66%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.66%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,640,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.66%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The assumptions used to estimate the fair value of contingent payments that are classified as a liability at June&#160;30, 2020 include the following significant unobservable inputs:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unobservable input</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.92%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Value or Range</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.92%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.92%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112.9%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112.9%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.16%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.16%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of capital</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.0%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.0%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discount for lack of marketability</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14%-22%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.0%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Probability of payment</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52%-83%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Projected year of payment</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020-2022</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s warrant liability is valued using the Monte Carlo simulation valuation model. If applicable, the Company will recognize transfers into and out of levels within the fair value hierarchy at the end of the reporting period in which the actual event or change in circumstance occurs. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no transfers into and out of any of the levels of the fair value hierarchy as of June&#160;30, 2020 and December&#160;31, 2019.</p> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">16. Subsequent Events</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Public Offering</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 16, 2020, the Company offered and sold (i) 3,369,564 shares of common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants of the Company to purchase 1,630,436 shares of common stock at an exercise price equal to $0.0001 per share (the &#8220;Pre-Funded Warrants&#8221;), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of the Company&#8217;s common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company&#8217;s common stock then issued and outstanding, which percentage may change at the holders&#8217; election to any other number less than or equal to 19.99% upon 61 days&#8217; notice to the Company. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters&#8217; option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company&#8217;s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company&#8217;s estimates and assumptions and determined that there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended June 30, 2020. However, actual results could differ from those estimates and there may be changes to the Company&#8217;s estimates in future periods.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements - Adopted</p> In August 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2018-13, <font style="font-style:italic;">Fair Value Measurement (Topic 820) &#8211; Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement</font> (&#8220;ASU No. 20218-13&#8221;). ASU No. 2018-13 was issued to modify and enhance the disclosure requirements for fair value measurements and eliminates certain disclosure requirements, such as the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy. This ASU adds new disclosure requirements for Level 3 measurements and is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2020 which resulted in expanded disclosures in Note 15 regarding the Company&#8217;s recurring Level 3 fair value measurements. <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three and Six Months&#160;Ended</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three and Six Months&#160;Ended</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.5%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrants</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,150,285</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,386,256</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,527,978</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">873,066</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.76%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">304,686</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">323,262</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s intangible assets consisted of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-10 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">825,659</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(466,866</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">358,793</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,105</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,895</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,110,659</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(743,971</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,688</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,529,626</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(743,971</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,785,655</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="12" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lives</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Book</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Internally developed patents</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6-10 years</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">746,323</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(448,874</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297,449</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired licenses</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16-20 years</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(269,221</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,779</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.1%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,031,323</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(718,095</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.4%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">313,228</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IPR&amp;D assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.16%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indefinite</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,418,967</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.16%; border-bottom:double 2.5pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,450,290</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(718,095</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,732,195</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June&#160;30, 2020, future estimated amortization expense are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years ending December 31,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remainder of 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,596</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,687</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,687</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,687</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,781</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 and thereafter</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,250</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366,688</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other current liabilities consist of the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional services</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">472,329</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">429,467</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and employee benefits</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">956,584</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,183,130</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,240</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,047</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued research and development</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,343,629</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,966,111</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, current portion (see Note 12)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273,276</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">259,449</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,691</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,563</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued expenses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,089,749</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,904,767</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s other long-term liabilities are summarized as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease obligation, long-term portion (see Note 12)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,344,779</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,484,679</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock warrant liability (see Note 10)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Economic conditional grants</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,245</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,196</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other long-term liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,715,024</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,864,875</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of warrant activity during the six months ended June&#160;30, 2020 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="4" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, December 31, 2019</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,384,706</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants issued due to anti-dilution features triggered from Registered Direct Offering</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,358</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercises</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,235,779</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants outstanding, June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,150,285</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For warrants classified as a liability, the following is a summary of the periodic changes in their fair value during the six months ended June&#160;30, 2020:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:82.06%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance, December 31, 2019</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.06%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in fair value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:82.06%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance, June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.86%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.06%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information related to stock options outstanding at June&#160;30, 2020 is as follows:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Stock</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,477,153</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.65</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.96</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,804,940</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">416,022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.97</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.69</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,097,502</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr style="height:9.6pt;"> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,061,131</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.74</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.07</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,707,438</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three and six months ended June&#160;30, 2020 and 2019 as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.66%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the Six Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,939</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,060</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,939</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">168,684</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">252,571</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">197,712</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">438,492</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">528,802</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">330,510</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">289,772</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">545,431</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">697,486</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental other information related to the operating leases balance sheet information is as follows: </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.68%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.78%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,618,055</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">662,074</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.83</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.68%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.0</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maturities of lease liabilities is as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:6pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ending December 31,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The remainder of 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">194,596</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">393,542</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,198</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">407,054</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414,116</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 and thereafter</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138,831</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,948,337</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less imputed interest</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(330,282</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,618,055</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.25%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at June&#160;30, 2020 consisted of the following:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.6%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.82%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recurring fair value measurements</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,011,208</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,011,208</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,484,402</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,484,402</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.82%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:12pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s assets and liabilities measured at fair value on a recurring basis at December&#160;31, 2019 consisted of the following:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="14" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurement at December&#160;31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.12%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;2</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.08%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recurring fair value measurements</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents - money market funds</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,034,640</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,034,640</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,277,386</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,277,386</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant liability</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.12%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.08%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> Short-term investments had quoted prices at June&#160;30, 2020 as shown below: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gain (Loss)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Value</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of deposit</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial and corporate debt securities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,475,942</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,460</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,484,402</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:46.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,475,942</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,460</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,484,402</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:12pt;margin-top:2pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of contingent payments classified as a liability was based on the regulatory milestones described in Note 3 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs. The following table is a reconciliation of the beginning and ending balance of contingent consideration liability:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.66%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.32%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,750,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.66%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.32%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,640,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.66%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at June&#160;30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.32%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,390,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:6.25%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The assumptions used to estimate the fair value of contingent payments that are classified as a liability at June&#160;30, 2020 include the following significant unobservable inputs:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unobservable input</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.92%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Value or Range</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.92%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.92%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112.9%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112.9%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.16%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.16%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of capital</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.0%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30.0%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discount for lack of marketability</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14%-22%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.0%</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Probability of payment</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52%-83%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76%</p></td> <td valign="middle" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:46.78%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Projected year of payment</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020-2022</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.42%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="middle" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> 2019-07-08 1887250 5000000 88000000 5000000 P60D 3000000 P60D 80000000 P10Y P20D P20D 2.95 3.54 600000 600000 0.50 0.50 2800000 16400000 13600000 11900000 2150285 10386256 1527978 873066 304686 323262 2150285 10386256 1527978 873066 304686 323262 825659 285000 1110659 466866 277105 743971 358793 7895 366688 P6Y P10Y P16Y P20Y 12418967 12418967 13529626 746323 285000 1031323 448874 269221 718095 297449 15779 313228 P6Y P10Y P16Y P20Y 12418967 12418967 13450290 12025 14836 25876 107580 20596 27687 27687 27687 23781 239250 472329 429467 956584 1183130 10240 5047 2343629 1966111 273276 259449 33691 61563 4089749 3904767 632000 2022-04-07 0.01 136200000 1344779 1484679 10000 10000 250000 250000 110245 120196 1715024 1864875 0.0001 50000000 18900000 50000000 2965144 22800000 26300000 200000 300000 234856 2500000 23700000 10384706 1358 8235779 2150285 10000 10000 1983110 9600000 1630436 P4Y P10Y 1900000 P3Y21D 520500 2.31 1.83 1477153 416022 1061131 3.65 5.97 2.74 P5Y11M15D P5Y8M8D P6Y25D 12804940 3097502 9707438 195161 700000 P2Y5M1D 40505 109525 109525 900000 P3M 38809 56739 35084 20372 77939 92060 106939 168684 252571 197712 438492 528802 330510 289772 545431 697486 2022-12 86295 173894 83903 174079 64193 126073 1618055 P4Y9M29D 0.080 194596 393542 400198 407054 414116 138831 1948337 330282 2900000 1000000 -1000000 1200000 38011208 38011208 15484402 15484402 16390000 16390000 10000 10000 8034640 8034640 28277386 28277386 2750000 2750000 10000 10000 5000000 10475942 15475942 8460 8460 5000000 10484402 15484402 2750000 -13640000 16390000 1.129 1.129 0.0016 0.0016 0.300 0.300 0.14 0.22 0.180 0.52 0.83 0.76 2020 2022 2020 0 0 0 0 0 0 0 0 3369564 23.00 1630436 0.0001 22.9999 0.0499 0.1999 P61D 132200000 750000 124000000 EX-101.SCH 10 alt-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Consolidated Statements of changes in Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Nature of Business and Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Contingent Consideration link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Intangible Assets link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Accrued Expenses link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Notes Payable link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Other Long-Term Liabilities link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - At-the-Market Offering link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Warrants link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Operating Leases link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Fair Value Measurement link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Accrued Expenses (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Other Long-Term Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Warrants (Tables) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Operating Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Fair Value Measurement (Tables) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Contingent Consideration - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Intangible Assets - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Intangible Assets - Schedule of Future Estimated Amortization Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Notes Payable - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - At-the-Market Offering - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Warrants - Summary of Warrant Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Warrants - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Warrants - Summary of Periodic Changes in Fair Value of Warrant Liability (Detail) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Operating Leases - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Operating Leases - Summary of Maturities of Lease Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Operating Leases - Summary of Maturities of Lease Liabilities (Detail)2 link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - Fair Value Measurement - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - Fair Value Measurement - Schedule of Short Term Investments (Detail) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Fair Value Measurement - Schedule of Reconciliation of Beginning and Ending Balance of Contingent Consideration Liability (Detail) link:calculationLink link:presentationLink link:definitionLink 100550 - Disclosure - Fair Value Measurement - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) link:calculationLink link:presentationLink link:definitionLink 100560 - Disclosure - Fair Value Measurement - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100570 - Disclosure - Subsequent Events - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 11 alt-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 alt-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 alt-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Also includes the aggregate carrying amount, as of the balance sheet date, of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed in the balance sheet. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Restricted cash Restricted Cash Current Total cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Short-term investments Short Term Investments Accounts receivable Accounts Receivable Gross Current Tax refund receivable Income Taxes Receivable Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Right of use asset Operating Lease Right Of Use Asset Intangible assets, net Intangible Assets Net Excluding Goodwill Other assets Other Assets Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities Notes payable Notes Payable Current Total current liabilities Liabilities Current Contingent consideration Business Combination Contingent Consideration Liability Noncurrent Other long-term liabilities Other Long Term Debt Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 14) Commitments And Contingencies Stockholders’ equity: Stockholders Equity [Abstract] Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,553,957 and 15,312,381 shares issued; 26,553,886 and 15,312,167 shares outstanding at June 30, 2020 and December 31, 2019, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Accumulated deficit Retained Earnings Accumulated Deficit Accumulated other comprehensive loss, net Accumulated Other Comprehensive Income Loss Net Of Tax Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Common stock, par or stated value per share Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Changes in fair value of warrant liability. Deemed dividends. Income Statement [Abstract] Revenues Revenue From Contract With Customer Excluding Assessed Tax Operating expenses: Operating Expenses [Abstract] Research and development Research And Development Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other (expense) income: Nonoperating Income Expense [Abstract] Changes in fair value of warrant liability Changes In Fair Value Of Warrant Liability Interest expense Interest Expense Interest income Investment Income Interest Other (expense) income, net Other Nonoperating Income Expense Total other (expense) income, net Nonoperating Income Expense Net loss before income tax benefit Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit Income Tax Expense Benefit Net loss Net Income Loss Other comprehensive loss – unrealized gain (loss) on investments Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax Comprehensive loss Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest Net loss Deemed dividends Deemed Dividends Net loss attributed to common stockholders Net Income Loss Available To Common Stockholders Basic Net loss per share attributed to common stockholders, basic and diluted Earnings Per Share Basic And Diluted Weighted-average common shares outstanding, basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Stock issued during period share exercise of warrants. Stock issued during period value exercise of warrants. Stock issued during period value stock based compensation and restricted stock vesting. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Accumulated Other Comprehensive Loss [Member] Accumulated Other Comprehensive Income [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Market offering. Market Offering [Member] Market Offering [Member] Registered direct offering. Registered Direct Offering [Member] Registered Direct Offering [Member] Statement [Line Items] Statement [Line Items] Beginning Balance Beginning Balance (in shares) Shares Outstanding Stock-based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Stock-based compensation and vesting of restricted stock Stock Issued During Period Value Stock Based Compensation And Restricted Stock Vesting Stock issued during period share stock based compensation and restricted stock vesting. Stock based compensation and vesting of restricted stock (in shares) Stock Issued During Period Share Stock Based Compensation And Restricted Stock Vesting Exercise of stock options Stock Issued During Period Value Stock Options Exercised Exercises of stock options (in shares) Stock Issued During Period Shares Stock Options Exercised Vesting of restricted stock awards including withholding, net Restricted Stock Value Shares Issued Net Of Tax Withholdings Vesting of restricted stock awards including withholding, net (in shares) Restricted Stock Shares Issued Net Of Shares For Tax Withholdings Issuance of common stock, net of offering costs Stock Issued During Period Value New Issues Issuance of common stock, net of offering costs (in shares) Stock Issued During Period Shares New Issues Issuance of common stock from Employee Stock Purchase Plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock from Employee Stock Purchase Plan (in shares) Stock Issued During Period Shares Employee Stock Purchase Plans Issuance of common stock upon exercise of warrants Stock Issued During Period Value Exercise Of Warrants Issuance of common stock upon exercise of warrants (in shares) Stock Issued During Period Share Exercise Of Warrants Unrealized (loss) gain on short-term investments Ending Balance Ending Balance (in shares) Payments of deferred offering costs. Statement Of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Change in fair value of contingent consideration Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 Stock-based compensation expense Share Based Compensation Depreciation Depreciation Amortization Adjustment For Amortization Unrealized losses (gains) on foreign currency exchange Foreign Currency Transaction Gain Loss Unrealized Changes in fair value of warrant liability Fair Value Adjustment Of Warrants Changes in operating assets and liabilities: Increase Decrease In Operating Capital [Abstract] Accounts receivable Increase Decrease In Accounts Receivable Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable Increase Decrease In Accounts Payable Accrued expenses and other liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Tax refund receivable Increase Decrease In Income Taxes Receivable Net cash used in operating activities Net Cash Provided By Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided By Used In Investing Activities [Abstract] Proceeds from sales and maturities of short-term investments Proceeds From Sale And Maturity Of Available For Sale Securities Purchases of short-term investments Payments To Acquire Available For Sale Securities Debt Purchase of property and equipment Payments To Acquire Property Plant And Equipment Cash paid for internally developed patents Payments To Acquire Intangible Assets Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided By Used In Financing Activities [Abstract] Payments of deferred offering costs Payments Of Deferred Offering Costs Proceeds from exercises of warrants Proceeds From Warrant Exercises Proceeds from issuance of common stock in at the market offering, net of offering costs Proceeds From Issuance Of Common Stock Proceeds from issuance of common units, net of issuance costs Proceeds From Issuance Of Common Limited Partners Units Proceeds from issuance of notes payable Proceeds From Notes Payable Proceeds from issuance of common stock from Employee Stock Purchase Plan Proceeds From Stock Plans Proceeds from exercises of stock options Proceeds From Stock Options Exercised Payments of notes payable Repayments Of Notes Payable Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Net increase in cash and cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Accounting Policies [Abstract] Nature of Business and Basis of Presentation Business Description And Basis Of Presentation [Text Block] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Business Combinations [Abstract] Contingent consideration Business Combination Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Goodwill And Intangible Assets Disclosure [Abstract] Intangible Assets Intangible Assets Disclosure [Text Block] Payables And Accruals [Abstract] Accrued Expenses Accounts Payable And Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Notes Payable Debt Disclosure [Text Block] Other Liabilities Disclosure [Abstract] Other Long-Term Liabilities Other Liabilities Disclosure [Text Block] The entire disclosure of At-the-Market offering. Text Block [Abstract] At-the-Market Offering At Market Offering [Text Block] Equity [Abstract] Warrants Stockholders Equity Note Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Leases [Abstract] Operating Leases Lessee Operating Leases [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurement Fair Value Disclosures [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Use of Estimates Use Of Estimates New Accounting Pronouncements - Adopted New Accounting Pronouncements Policy Policy [Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Schedule of intangible assets. Schedule of Intangible Assets Schedule Of Intangible Assets Table [Text Block] Schedule of Future Estimated Amortization Expense Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block] Schedule of Accrued Expenses and Other Current Liabilities Schedule Of Accrued Liabilities Table [Text Block] Summary of Other Long-Term Liabilities Other Noncurrent Liabilities Table [Text Block] Summary of Warrant Activity Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Summary of Periodic Changes in Fair Value of Warrant Liability Schedule Of Derivative Liabilities At Fair Value Table [Text Block] Schedule of Information Related to Stock Options Outstanding Schedule Of Other Share Based Compensation Activity Table [Text Block] Schedule of Stock-based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of supplemental balance sheet information related to Operating leases. Summary of Supplemental other Information Related to Operating Leases Balance Sheet Schedule Of Supplemental Balance Sheet Information Related To Operating Leases Table [Text Block] Summary of Maturities of Lease Liabilities Lessee Operating Lease Liability Maturity Table [Text Block] Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Table [Text Block] Schedule of Short Term Investments Schedule Of Available For Sale Securities Reconciliation Table [Text Block] Schedule of Reconciliation of Beginning and Ending Balance of Contingent Consideration Liability Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block] Summary of Assumptions Used to Estimate Fair Value of Contingent Payments Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block] Schedule Of Business Acquisitions By Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] Spitfire Pharma, Inc. Spitfire Pharma, Inc. [Member] Spitfire Pharma Inc [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Contingent Consideration by Type Contingent Consideration By Type [Axis] Contingent Consideration Type Contingent Consideration Type [Domain] Investigational New Drug Application milestone. Investigational New Drug Application Milestone [Member] Investigational New Drug Application Milestone [Member] Investigational New Drug Application and Regulatory milestones. Investigational New Drug Application and Regulatory Milestones [Member] Investigational New Drug Application And Regulatory Milestones [Member] Sales milestone. Sales Milestones [Member] Sales Milestone [Member] Regulatory milestone. Regulatory Milestones [Member] Regulatory Milestone [Member] Valuation Approach and Technique Valuation Technique [Axis] Valuation Approach and Technique Valuation Technique [Domain] Monte Carlo simulation model. Monte Carlo Simulation [Member] Monte Carlo Simulation Model [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Agreement date Business Acquisition Date Of Acquisition Agreement1 Unregistered shares of common stock Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued Up-front consideration Payments To Acquire Businesses Gross Future contingent payments Business Combination Contingent Consideration Liability Business combination contingent consideration payment term. Future contingent payment term Business Combination Contingent Consideration Payment Term Business acquisition term of license agreement. License agreement term Business Acquisition Term Of License Agreement Number of consecutive trading days. Number of consecutive trading days Number Of Consecutive Trading Days Condiseration amount Business Acquisition Share Price Transaction cost recorded within research and development expense Business Combination Acquisition Related Costs Percentage of upfront consideration release at period four. Percentage of upfront consideration release at period one. Upfront consideration release at 3 months Percentage Of Upfront Consideration Release At Period Four Upfront consideration release at 6 months Percentage Of Upfront Consideration Release At Period One Estimated future contingent consideration Change in value of contingent consideration for acquired in-process research and development Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Restricted Stock [Member] Restricted Stock [Member] Option Indexed to Issuer's Equity Option Indexed To Issuers Equity Equity [Axis] Option Indexed to Issuer's Equity, Type Option Indexed To Issuers Equity Type [Domain] Stock Options [Member] Employee Stock Option [Member] Common Stock Warrants [Member] Warrant [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Schedule of intangible assets. Schedule Of Intangible Assets [Table] Schedule Of Intangible Assets [Table] Schedule Of Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Internally developed patents. Internally Developed Patents [Member] Internally Developed Patents [Member] Acquired licenses. Acquired Licenses [Member] Acquired Licenses [Member] Indefinite-lived Intangible Assets Indefinite Lived Intangible Assets By Major Class [Axis] Indefinite-lived Intangible Assets, Major Class Name Indefinite Lived Intangible Assets Major Class Name [Domain] IPR&D [Member] In Process Research And Development [Member] Schedule Of Intangible Assets [Line Items] Schedule Of Intangible Assets [Line Items] Intangible assets subject to amortization, Gross Carrying Value Finite Lived Intangible Assets Gross Intangible assets subject to amortization, Accumulated Amortization Finite Lived Intangible Assets Accumulated Amortization Intangible assets subject to amortization, Net Book Value Finite Lived Intangible Assets Net Estimated Useful Lives Finite Lived Intangible Asset Useful Life Total intangible assets, Gross Carrying Value Intangible Assets Gross Excluding Goodwill Total intangible assets, Net Book Value Indefinite Lived Intangible Assets Excluding Goodwill Total intangible assets, Net Book Value Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Research and Development [Member] Research And Development Expense [Member] Amortization expense of intangible assets Amortization Of Intangible Assets The remainder of 2020 Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year 2021 Finite Lived Intangible Assets Amortization Expense Year Two 2022 Finite Lived Intangible Assets Amortization Expense Year Three 2023 Finite Lived Intangible Assets Amortization Expense Year Four 2024 Finite Lived Intangible Assets Amortization Expense Year Five 2025 and thereafter Finite Lived Intangible Assets Amortization Expense After Year Five Accrued research and development. Accrued Liabilities And Other Liabilities [Abstract] Accrued professional services Accrued Professional Fees Current Accrued payroll and employee benefits Employee Related Liabilities Current Accrued interest Interest Payable Current Accrued research and development Accrued Research And Development Lease obligation, current portion (see Note 12) Operating Lease Liability Current Deferred revenue Deferred Revenue Current Total accrued expenses Accrued Liabilities Current Debt Instrument [Table] Debt Instrument [Table] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Paycheck Protection Program Loan. Paycheck Protection Program Loan [Member] Paycheck Protection Program Loan [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Registered direct offering, ATM usage and warrant exercises. Registered Direct Offering, ATM Usage and Warrant Exercises [Member] Registered Direct Offering A T M Usage And Warrant Exercises [Member] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Proceeds from unsecured loan Proceeds From Issuance Of Unsecured Tax Exempt Debt Maturity date Debt Instrument Maturity Date Interest rate Debt Instrument Interest Rate Effective Percentage Net proceeds from issuance or sale of equity. Net proceeds from issuance or sale of equity Net Proceeds From Issuance Or Sale Of Equity Economic conditional incentive grants. Lease obligation, long-term portion (see Note 12) Operating Lease Liability Noncurrent Common stock warrant liability (see Note 10) Derivative Liabilities Noncurrent Economic conditional grants Economic Conditional Incentive Grants Other Other Liabilities Noncurrent Total other long-term liabilities Long Term Debt Noncurrent Aggregate offering price. Class Of Stock Disclosures [Abstract] Changes In Equity And Comprehensive Income Line Items [Line Items] Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Equity Distribution Agreement. Equity Distribution Agreement [Member] Equity Distribution Agreement [Member] At-the-market offering. At-The-Market Offering [Member] At The Market Offering [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] JMP securities limited liability company. JMP Securities LLC [Member] J M P Securities Limited Liability Company [Member] Changes In Equity And Comprehensive Income Line Items [Line Items] Changes In Equity And Comprehensive Income Line Items [Line Items] Common stock par value Aggregate offering price Aggregate Offering Price Common stock, value of capital shares reserved for future issuance. Shares of common stock sold Net proceeds from offering Common stock available to be sold Common Stock Value Of Capital Shares Reserved For Future Issuance Deferred offering costs Deferred Offering Costs Issuance costs Payments Of Stock Issuance Costs Number of warrants issued due to anti-dilution features triggered from registered direct offering. Number of warrants exercised for conversion of securities. Warrants outstanding, December 31, 2019 Class Of Warrant Or Right Outstanding Warrants issued due to anti-dilution features triggered from Registered Direct Offering Number Of Warrants Issued Due To Anti Dilution Features Triggered From Registered Direct Offering Exercises Number Of Warrants Exercised For Conversion Of Securities Warrants outstanding, June 30, 2020 Public Offering [Member] I P O [Member] Net proceeds from warrant exercises Warrants And Rights Note Disclosure [Abstract] Derivative Instruments And Hedging Activities Disclosures [Table] Derivative Instruments And Hedging Activities Disclosures [Table] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 3 [Member] Fair Value Inputs Level3 [Member] Financial Instrument Financial Instrument [Axis] Financial Instruments Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain] Derivative Instruments And Hedging Activities Disclosures [Line Items] Derivative Instruments And Hedging Activities Disclosures [Line Items] Balance, December 31, 2019 Derivative Liabilities Changes in fair value Unrealized Gain Loss On Securities Balance, June 30, 2020 Class of warrant or rights, number exercised. Pre-funded warrants issued. Number of warrants exercised Class Of Warrant Or Rights Number Exercised Pre-funded warrants issued Pre Funded Warrants Issued Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Restricted Stock Units [Member] Restricted Stock Units R S U [Member] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] Two thousand and nineteen employee stock purchase plan. 2019 Employee Stock Purchase Plan [Member] Two Thousand And Nineteen Employee Stock Purchase Plan [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Stock option vesting Period Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Stock option expiration Period Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Unrecognized compensation cost, stock options Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Unrecognized stock-based compensation expense, period for recognition Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Number of Stock Options, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Stock options granted, weighted-average exercise price Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted-average grant date fair value of stock options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Number of Stock Options, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Stock Options, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Number of Stock Options, Unvested Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares Share based compensation arrangement by share based payment award options unvested outstanding weighted average exercise price. Weighted-average Exercise Price, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted-average Exercise Price, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Weighted-average Exercise Price, Unvested Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price Share based compensation arrangement by share based payment award options unvested outstanding weighted average remaining contractual term. Weighted-average Remaining Contractual Term, Outstanding Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted-average Remaining Contractual Term, Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Weighted-average Remaining Contractual Term, Unvested Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term Share based compensation arrangement by share based payment award options nonvested outstanding intrinsic value. Aggregate Intrinsic Value, Outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate Intrinsic Value, Exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Aggregate Intrinsic Value, Unvested Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value Unvested restricted stock, shares Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Unrecognized compensation expense Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Common stock issued as result of vesting of restricted stock Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures Shares granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Employees purchased, shares Employees purchased, value Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] General and Administrative [Member] General And Administrative Expense [Member] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Stock based compensation expense Allocated Share Based Compensation Expense Non-cancellable lease maturity period. Non-cancellable lease maturity period Non Cancellable Lease Maturity Period Operating lease rent expense Lease And Rental Expense Cash paid for operating lease liabilities Operating Lease Payments Operating lease obligations Operating Lease Liability Operating lease right-of-use assets Weighted-average remaining lease term Operating Lease Weighted Average Remaining Lease Term1 Weighted-average discount rate Operating Lease Weighted Average Discount Rate Percent The remainder of 2020 Lessee Operating Lease Liability Payments Remainder Of Fiscal Year 2021 Lessee Operating Lease Liability Payments Due Year Two 2022 Lessee Operating Lease Liability Payments Due Year Three 2023 Lessee Operating Lease Liability Payments Due Year Four 2024 Lessee Operating Lease Liability Payments Due Year Five 2025 and thereafter Lessee Operating Lease Liability Payments Due After Year Five Total lease payments Lessee Operating Lease Liability Payments Due Less imputed interest Lessee Operating Lease Liability Undiscounted Excess Amount Total Effective income tax rate reconciliation, additional discrete item of income tax benefit. Income tax, refund claim Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority Effective income tax rate reconciliation, additional discrete item of income tax benefit Effective Income Tax Rate Reconciliation Additional Discrete Item Of Income Tax Benefit Additional income tax benefit Tax Adjustments Settlements And Unusual Provisions Commitments and contingencies. Commitments and contingencies. Commitments And Contingencies [Table] Commitments And Contingencies [Table] Janssen Vaccines and Preventions BV. Janssen Vaccines and Prevention BV [Member] Janssen Vaccines And Preventions Bv [Member] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] License [Member] License [Member] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] License agreement term Development-based milestone payments. Development-based milestone payments Development Based Milestone Payments Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Cash and Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Money Market Funds [Member] Money Market Funds [Member] Fair Value, Measurements, Recurring [Member] Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Fair Value Measurements Recurring [Member] Level 1 [Member] Fair Value Inputs Level1 [Member] Level 2 [Member] Fair Value Inputs Level2 [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Cash equivalents Investments Fair Value Disclosure Contingent consideration Warrant liability Debt Securities Available For Sale [Table] Debt Securities Available For Sale [Table] Certificate of Deposit [Member] Certificates Of Deposit [Member] Financial and Corporate Debt Securities [Member] Corporate Debt Securities [Member] Schedule Of Available For Sale Securities [Line Items] Schedule Of Available For Sale Securities [Line Items] Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Unrealized Gain (Loss) Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax Market Value Available For Sale Securities Debt Securities Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table] Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table] Liability Class Fair Value By Liability Class [Axis] Fair Value by Liability Class Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain] Contingent consideration liability. Contingent Consideration Liability [Member] Contingent Consideration Liability [Member] Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] Balance at December 31, 2019 Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Change in fair value Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings Balance at June 30, 2020 Business combination, contingent consideration, liability, payment year. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Measurement Input Type Measurement Input Type [Axis] Measurement Input Type Measurement Input Type [Domain] Expected Volatility [Member] Measurement Input Price Volatility [Member] Risk-free Interest Rate [Member] Measurement Input Risk Free Interest Rate [Member] Measurement input cost of capital. Cost of Capital [Member] Measurement Input Cost Of Capital [Member] Discount for Lack of Marketability [Member] Measurement Input Discount For Lack Of Marketability [Member] Measurement input, probability of payment. Probability of Payment [Member] Measurement Input Probability Of Payment [Member] Projected Year of Payment [Member] Measurement Input Maturity [Member] Weighted Average [Member] Weighted Average [Member] Assumptions used to estimate fair value of contingent payments Business Combination Contingent Consideration Liability Measurement Input Assumptions used to estimate fair value of contingent payments Business Combination Contingent Consideration Liability Payment Year Fair value transfers, Level 1 to Level 2 assets Fair Value Assets Level1 To Level2 Transfers Amount Fair value transfers, Level 2 to Level 1 assets Fair Value Assets Level2 To Level1 Transfers Amount Fair value transfers, Level 1 to Level 2 liabilities Fair Value Liabilities Level1 To Level2 Transfers Amount Fair value transfers, Level 2 to Level 1 liabilities Fair Value Liabilities Level2 To Level1 Transfers Amount Class of warrant or right, issuance price per warrant or right. Ownership percentage on exercise of warrants without notice, minimum. Ownership percentage on exercise of warrants with notice, maximum. Notice period to increase ownership percentage on exercise of warrants. Subsequent Event [Table] Subsequent Event [Table] Over-Allotment Option [Member] Over Allotment Option [Member] Class of Warrant or Right Class Of Warrant Or Right [Axis] Class of Warrant or Right Class Of Warrant Or Right [Domain] Pre-funded warrants. Pre-Funded Warrants [Member] Pre Funded Warrants [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Public offering price, per share Shares Issued Price Per Share Number of securities called by warrants or rights Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exercise price of warrants or rights Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Purchase price of warrants issued Class Of Warrant Or Right Issuance Price Per Warrant Or Right Ownership percentage on exercise of warrants without notice, minimum Ownership Percentage On Exercise Of Warrants Without Notice Minimum Ownership percentage on exercise of warrants with notice, maximum Ownership Percentage On Exercise Of Warrants With Notice Maximum Notice period to increase ownership percentage on exercise of warrants Notice Period To Increase Ownership Percentage On Exercise Of Warrants Gross proceeds from offering including exercise of underwriter's option Proceeds From Issuance Or Sale Of Equity EX-101.PRE 14 alt-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2020
Aug. 07, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q2  
Trading Symbol ALT  
Entity Registrant Name ALTIMMUNE, INC.  
Entity Central Index Key 0001326190  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Common Stock, Shares Outstanding   32,904,333
Entity File Number 001-32587  
Entity Tax Identification Number 20-2726770  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 910 Clopper Road  
Entity Address, Address Line Two Suite 201S  
Entity Address, City or Town Gaithersburg  
Entity Address, State or Province MD  
Entity Address, Postal Zip Code 20878  
City Area Code (240)  
Local Phone Number 654-1450  
Title of 12(b) Security Common stock, par value $0.0001 per share  
Security Exchange Name NASDAQ  
Document Quarterly Report true  
Document Transition Report false  
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 64,741,921 $ 8,962,686
Restricted cash 34,174 34,174
Total cash, cash equivalents and restricted cash 64,776,095 8,996,860
Short-term investments 15,484,402 28,277,386
Accounts receivable 1,182,099 1,021,179
Tax refund receivable 5,506,946 629,096
Prepaid expenses and other current assets 1,020,876 470,228
Total current assets 87,970,418 39,394,749
Property and equipment, net 1,024,640 1,104,208
Right of use asset 662,074 698,321
Intangible assets, net 12,785,655 12,732,195
Other assets 100,980 128,547
Total assets 102,543,767 54,058,020
Current liabilities:    
Accounts payable 195,217 18,232
Accrued expenses and other current liabilities 4,089,749 3,904,767
Notes payable 632,000  
Total current liabilities 4,916,966 3,922,999
Contingent consideration 16,390,000 2,750,000
Other long-term liabilities 1,715,024 1,864,875
Total liabilities 23,021,990 8,537,874
Commitments and contingencies (Note 14)
Stockholders’ equity:    
Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,553,957 and 15,312,381 shares issued; 26,553,886 and 15,312,167 shares outstanding at June 30, 2020 and December 31, 2019, respectively 2,635 1,508
Additional paid-in capital 242,579,532 187,914,916
Accumulated deficit (158,028,687) (137,376,122)
Accumulated other comprehensive loss, net (5,031,703) (5,020,156)
Total stockholders’ equity 79,521,777 45,520,146
Total liabilities and stockholders’ equity $ 102,543,767 $ 54,058,020
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Common stock, par or stated value per share $ 0.0001 $ 0.0001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 26,553,957 15,312,381
Common stock, shares outstanding 26,553,886 15,312,167
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenues $ 721,636 $ 1,626,029 $ 2,934,330 $ 4,581,622
Operating expenses:        
Research and development 16,594,250 2,945,096 23,781,781 6,162,768
General and administrative 2,545,356 2,231,817 4,877,273 4,298,299
Total operating expenses 19,139,606 5,176,913 28,659,054 10,461,067
Loss from operations (18,417,970) (3,550,884) (25,724,724) (5,879,445)
Other (expense) income:        
Changes in fair value of warrant liability   (46,000)   (46,000)
Interest expense (3,308) (748) (5,193) (1,488)
Interest income 81,458 239,964 233,027 425,211
Other (expense) income, net (5,878) (29,220) 19,664 17,528
Total other (expense) income, net 72,272 163,996 247,498 395,251
Net loss before income tax benefit (18,345,698) (3,386,888) (25,477,226) (5,484,194)
Income tax benefit 1,578,782   4,824,661  
Net loss (16,766,916) (3,386,888) (20,652,565) (5,484,194)
Other comprehensive loss – unrealized gain (loss) on investments 20,888   (11,547)  
Comprehensive loss (16,746,028) (3,386,888) (20,664,112) (5,484,194)
Net loss (16,766,916) (3,386,888) (20,652,565) (5,484,194)
Deemed dividends       (452,925)
Net loss attributed to common stockholders $ (16,766,916) $ (3,386,888) $ (20,652,565) $ (5,937,119)
Net loss per share attributed to common stockholders, basic and diluted $ (0.94) $ (0.26) $ (1.25) $ (0.52)
Weighted-average common shares outstanding, basic and diluted 17,886,853 13,127,773 16,498,719 11,318,819
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of changes in Stockholders' Equity - USD ($)
Total
Market Offering [Member]
Registered Direct Offering [Member]
Common Stock [Member]
Common Stock [Member]
Market Offering [Member]
Common Stock [Member]
Registered Direct Offering [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Market Offering [Member]
Additional Paid-In Capital [Member]
Registered Direct Offering [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2018 $ 48,312,566     $ 876     $ 170,207,844     $ (116,855,991) $ (5,040,163)
Beginning Balance (in shares) at Dec. 31, 2018       9,078,239              
Stock-based compensation 407,714           407,714        
Vesting of restricted stock awards including withholding, net 28           28        
Vesting of restricted stock awards including withholding, net (in shares)       71              
Issuance of common stock, net of offering costs     $ 12,668,784     $ 436     $ 12,668,348    
Issuance of common stock, net of offering costs (in shares)           4,361,370          
Issuance of common stock upon exercise of warrants 30,324     $ 1     30,323        
Issuance of common stock upon exercise of warrants (in shares)       11,000              
Net loss (2,097,306)                 (2,097,306)  
Ending Balance at Mar. 31, 2019 59,322,110     $ 1,313     183,314,257     (118,953,297) (5,040,163)
Ending Balance (in shares) at Mar. 31, 2019       13,450,680              
Beginning Balance at Dec. 31, 2018 48,312,566     $ 876     170,207,844     (116,855,991) (5,040,163)
Beginning Balance (in shares) at Dec. 31, 2018       9,078,239              
Net loss (5,484,194)                    
Ending Balance at Jun. 30, 2019 56,225,022     $ 1,313     183,604,057     (122,340,185) (5,040,163)
Ending Balance (in shares) at Jun. 30, 2019       13,450,751              
Beginning Balance at Mar. 31, 2019 59,322,110     $ 1,313     183,314,257     (118,953,297) (5,040,163)
Beginning Balance (in shares) at Mar. 31, 2019       13,450,680              
Stock-based compensation and vesting of restricted stock 289,800           289,800        
Stock based compensation and vesting of restricted stock (in shares)       71              
Net loss (3,386,888)                 (3,386,888)  
Ending Balance at Jun. 30, 2019 56,225,022     $ 1,313     183,604,057     (122,340,185) (5,040,163)
Ending Balance (in shares) at Jun. 30, 2019       13,450,751              
Beginning Balance at Dec. 31, 2019 45,520,146     $ 1,508     187,914,916     (137,376,122) (5,020,156)
Beginning Balance (in shares) at Dec. 31, 2019       15,312,167              
Stock-based compensation 214,921           214,921        
Vesting of restricted stock awards including withholding, net (17,079)     $ 1     (17,080)        
Vesting of restricted stock awards including withholding, net (in shares)       (5,974)              
Issuance of common stock from Employee Stock Purchase Plan 56,739     $ 3     56,736        
Issuance of common stock from Employee Stock Purchase Plan (in shares)       38,809              
Issuance of common stock upon exercise of warrants 39,974     $ 2     39,972        
Issuance of common stock upon exercise of warrants (in shares)       14,500              
Unrealized (loss) gain on short-term investments (32,435)                   (32,435)
Net loss (3,885,649)                 (3,885,649)  
Ending Balance at Mar. 31, 2020 41,896,617     $ 1,514     188,209,465     (141,261,771) (5,052,591)
Ending Balance (in shares) at Mar. 31, 2020       15,359,502              
Beginning Balance at Dec. 31, 2019 45,520,146     $ 1,508     187,914,916     (137,376,122) (5,020,156)
Beginning Balance (in shares) at Dec. 31, 2019       15,312,167              
Unrealized (loss) gain on short-term investments (11,547)                    
Net loss (20,652,565)                    
Ending Balance at Jun. 30, 2020 79,521,777     $ 2,635     242,579,532     (158,028,687) (5,031,703)
Ending Balance (in shares) at Jun. 30, 2020       26,553,886              
Beginning Balance at Mar. 31, 2020 41,896,617     $ 1,514     188,209,465     (141,261,771) (5,052,591)
Beginning Balance (in shares) at Mar. 31, 2020       15,359,502              
Stock-based compensation 330,510           330,510        
Exercise of stock options 36,175     $ 1     36,174        
Exercises of stock options (in shares)       13,935              
Vesting of restricted stock awards including withholding, net (46,389)     $ 1     (46,390)        
Vesting of restricted stock awards including withholding, net (in shares)       (5,974)              
Issuance of common stock, net of offering costs   $ 22,780,729     $ 297     $ 22,780,432      
Issuance of common stock, net of offering costs (in shares)         2,965,144            
Issuance of common stock upon exercise of warrants 31,270,163     $ 822     31,269,341        
Issuance of common stock upon exercise of warrants (in shares)       8,221,279              
Unrealized (loss) gain on short-term investments 20,888                   20,888
Net loss (16,766,916)                 (16,766,916)  
Ending Balance at Jun. 30, 2020 $ 79,521,777     $ 2,635     $ 242,579,532     $ (158,028,687) $ (5,031,703)
Ending Balance (in shares) at Jun. 30, 2020       26,553,886              
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (20,652,565) $ (5,484,194)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of contingent consideration 13,640,000  
Stock-based compensation expense 545,431 697,486
Depreciation 120,169 121,899
Amortization 25,876 107,580
Unrealized losses (gains) on foreign currency exchange (18,851) (24,943)
Changes in fair value of warrant liability   46,000
Changes in operating assets and liabilities:    
Accounts receivable (160,920) 832,098
Prepaid expenses and other current assets (343,337) (113,200)
Accounts payable 176,985 (102,763)
Accrued expenses and other liabilities 26,761 (1,181,457)
Tax refund receivable (4,877,851) (71,586)
Net cash used in operating activities (11,518,302) (5,173,080)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sales and maturities of short-term investments 24,900,000  
Purchases of short-term investments (12,118,563)  
Purchase of property and equipment (40,601) (1,226)
Cash paid for internally developed patents (79,336) (15,874)
Net cash provided by (used in) investing activities 12,661,500 (17,100)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of deferred offering costs (179,743)  
Proceeds from exercises of warrants 31,310,137 30,324
Proceeds from issuance of common stock in at the market offering, net of offering costs 22,780,729  
Proceeds from issuance of common units, net of issuance costs   12,668,784
Proceeds from issuance of notes payable 632,000  
Proceeds from issuance of common stock from Employee Stock Purchase Plan 56,739  
Proceeds from exercises of stock options 36,175  
Payments of notes payable   (156,145)
Net cash provided by financing activities 54,636,037 12,542,963
Net increase in cash and cash equivalents and restricted cash 55,779,235 7,352,783
Cash, cash equivalents and restricted cash at beginning of period 8,996,860 34,353,129
Cash, cash equivalents and restricted cash at end of period $ 64,776,095 $ 41,705,912
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Nature of Business and Basis of Presentation
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Nature of Business and Basis of Presentation

1. Nature of Business and Basis of Presentation

Nature of Business

Altimmune, Inc., headquartered in Gaithersburg, Maryland, together with its subsidiaries (collectively, the “Company” or “Altimmune”) is a clinical stage biopharmaceutical company incorporated under the laws of the State of Delaware.

The Company is focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. The Company’s diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID), anthrax (NasoShield) and influenza (NasoVAX); an intranasal immune modulating therapeutic for COVID-19 (T-COVID); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell). Since its inception, the Company has devoted substantially all of its efforts to business planning, research and development, recruiting management and technical staff, and raising capital, and has financed its operations through the issuance of common and preferred stock, long-term debt, and proceeds from research grants and government contracts. The Company has not generated any revenues from the sale of any products to date, and there is no assurance of any future revenues from product sales.

Basis of Presentation

The accompanying unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States (“U.S. GAAP”) for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2019 included in the annual report on Form 10-K which was filed with the SEC on March 27, 2020. In the opinion of management, the Company has prepared the accompanying unaudited consolidated financial statements on the same basis as the audited consolidated financial statements, and these consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year 2020 or any future years or periods.

The unaudited consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and liabilities that might be necessary should we be unable to continue as a going concern.

XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

During the six months ended June 30, 2020, there have been no significant changes to the Company’s summary of significant accounting policies contained in the Company’s Annual report on Form 10-K for the year ended December 31, 2019 as filed with the SEC, except for the recently adopted accounting standard for investments.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s consolidated financial statements as of and for the three and six months ended June 30, 2020. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.

Recently Issued Accounting Pronouncements - Adopted

In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820) – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU No. 20218-13”). ASU No. 2018-13 was issued to modify and enhance the disclosure requirements for fair value measurements and eliminates certain disclosure requirements, such as the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy. This ASU adds new disclosure requirements for Level 3 measurements and is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2020 which resulted in expanded disclosures in Note 15 regarding the Company’s recurring Level 3 fair value measurements.    

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Contingent Consideration
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Contingent consideration

3. Contingent Consideration

The Company entered into a definitive agreement to acquire all of the equity interests of Spitfire Pharma, Inc. (“Spitfire”) on July 8, 2019. Spitfire was a privately held, preclinical pharmaceutical company developing a novel dual GLP-1/glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis.  

The transaction closed on July 12, 2019. The Company issued 1,887,250 unregistered shares of its common stock (the “shares”) as upfront consideration to certain former securityholders of Spitfire (collectively, the “Spitfire Equityholders”), representing an amount equal to $5.0 million less working capital and transaction expense adjustment amounts as defined in the agreement.

The Merger Agreement also includes future contingent payments up to $88.0 million in cash and shares of the Company’s common stock as follows (each, a “Milestone Event”):

 

a one-time payment of $5.0 million (the “IND Milestone Consideration Amount”) within sixty days of the submission of an Investigational New Drug Application (“IND”) to the United States Food and Drug Administration (the “FDA”) or other applicable governmental authority in a foreign jurisdiction, which IND has not been rejected or placed on clinical hold by the FDA or such applicable foreign governmental authority within time specified in the Merger Agreement;

 

a one-time payment of $3.0 million (the “Phase 2 Milestone Consideration Amount” and together with the IND Milestone Consideration Amount, the “Regulatory Milestones”) within sixty days of the initiation of a Phase 2 clinical trial of a product candidate anywhere in the world; and

 

payments of up to $80.0 million upon the achievement of specified worldwide net sales (the “Sales Milestones”) of all products developed using the technology acquired in the License Agreement within ten years following the approval of a new drug application filed with the FDA.

The Regulatory Milestones will be payable in shares of the Company’s Common Stock, with the number of shares of the Company’s Common Stock to be issued in connection with each milestone amount, if any, are dependent on the share price at the time of achievement. The number of any shares issued in consideration for the IND Milestone Consideration Amount will be determined based on lower of (A) the average of the closing prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days prior to the IND Reference Date or (B) $2.95. The value of any shares issued in consideration for the Phase 2 Milestone Consideration Amount shall be determined based the lower of (A) on the average of the closing trading prices of our Common Stock as reported on the Nasdaq Global Market for the twenty (20) consecutive trading days immediately preceding the date of the occurrence of the Phase 2 Milestone Event or (B) $3.54.

The acquisition of Spitfire was accounted for as an asset acquisition instead of a business combination because substantially all of the fair value of the gross assets acquired was concentrated in a single identifiable asset or group of similar identifiable assets, and therefore, the asset was not considered a business. The Company expensed the acquired intellectual property as of the acquisition date as in-process research and development with no alternative future uses. The Company recorded an in-process research and development expense for the up-front consideration during the third quarter of 2019. Transaction costs of $0.6 million were recorded within research and development expense on the Company’s consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2019.

The future contingent payments related to the Regulatory Milestones are stock-based payments accounted for under FASB Accounting Standards Codification Topic 480, Distinguishing Liabilities From Equity. Such stock-based payments are subject to a lock-up whereby 50% of the shares are released at 3 months and 50% are released at 6 months. As of the acquisition date, the Company estimated future contingent consideration of $2.8 million based upon a Monte Carlo simulation that was risk adjusted based on the probability of achieving the milestones and a discount for lack of marketability, which was expensed to in-process research and development expenses during the third quarter of 2019. The Company remeasured the fair value of the contingent consideration as of June 30, 2020, and increased the liability from March 31, 2020 to $16.4 million primarily due to an increase in the share price during the six months ended June 30, 2020 and an increase in the probability of milestone achievement. The increased change in the liability of $11.9 million and $13.6 million was expensed to research and development expense during the three and six months ended June 30, 2020, respectively.

The future contingent payments related to the Sales Milestones are predominately cash-based payments accounted for under FASB Accounting Standards Codification Topic 450, Contingencies. Accordingly, the Company will recognize the Sales Milestones when the contingency is resolved and the amount is paid or payable.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Net Loss Per Share

4. Net Loss Per Share

Because the Company has reported a net loss attributable to common stockholders for all periods presented, basic and diluted net loss per share attributable to common stockholders are the same for all periods presented. For periods presented, all unvested restricted stock, common stock warrants, and stock options have been excluded from the computation of diluted weighted-average shares outstanding because such securities would have an antidilutive impact.

 

Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:

 

 

 

For the Three and Six Months Ended

 

 

For the Three and Six Months Ended

 

 

 

June 30, 2020

 

 

June 30, 2019

 

Common stock warrants

 

 

2,150,285

 

 

 

10,386,256

 

Common stock options

 

 

1,527,978

 

 

 

873,066

 

Restricted stock

 

 

304,686

 

 

 

323,262

 

 

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets
6 Months Ended
Jun. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]  
Intangible Assets

5. Intangible Assets

The Company’s intangible assets consisted of the following:

 

 

 

June 30, 2020

 

 

 

Estimated

Useful

Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

825,659

 

 

$

(466,866

)

 

$

358,793

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(277,105

)

 

 

7,895

 

Total intangible assets subject to amortization

 

 

 

 

1,110,659

 

 

 

(743,971

)

 

 

366,688

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,529,626

 

 

$

(743,971

)

 

$

12,785,655

 

 

 

 

December 31, 2019

 

 

 

Estimated

Useful

Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

746,323

 

 

$

(448,874

)

 

$

297,449

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(269,221

)

 

 

15,779

 

Total intangible assets subject to amortization

 

 

 

 

1,031,323

 

 

 

(718,095

)

 

 

313,228

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,450,290

 

 

$

(718,095

)

 

$

12,732,195

 

Amortization expense of intangible assets was $12,025 and $14,836 for the three months ended June 30, 2020 and 2019, and $25,876 and $107,580 for the six months ended June 30, 2020 and 2019, respectively. Amortization expense was classified as research and development expenses in the accompanying unaudited consolidated statements of operations and comprehensive loss.

As of June 30, 2020, future estimated amortization expense are as follows:

 

Years ending December 31,

 

 

 

 

The remainder of 2020

 

$

20,596

 

2021

 

 

27,687

 

2022

 

 

27,687

 

2023

 

 

27,687

 

2024

 

 

23,781

 

2025 and thereafter

 

 

239,250

 

Total

 

$

366,688

 

 

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses
6 Months Ended
Jun. 30, 2020
Payables And Accruals [Abstract]  
Accrued Expenses

6. Accrued Expenses

Accrued expenses and other current liabilities consist of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Accrued professional services

 

$

472,329

 

 

$

429,467

 

Accrued payroll and employee benefits

 

 

956,584

 

 

 

1,183,130

 

Accrued interest

 

 

10,240

 

 

 

5,047

 

Accrued research and development

 

 

2,343,629

 

 

 

1,966,111

 

Lease obligation, current portion (see Note 12)

 

 

273,276

 

 

 

259,449

 

Deferred revenue

 

 

33,691

 

 

 

61,563

 

Total accrued expenses

 

$

4,089,749

 

 

$

3,904,767

 

 

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Notes Payable

7. Notes Payable

Paycheck Protection Program

On April 7, 2020, the Company applied for a loan from ServisFirst Bank, as lender, pursuant to the Paycheck Protection Program of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) as administered by the U.S. Small Business Administration (the "SBA"). On April 13, 2020, the Loan was approved and the Company received the proceeds from a loan in the amount of $632,000 (the “PPP Loan”).

The PPP Loan, which took the form of a promissory note (the “Promissory Note”), was set to mature on April 7, 2022 and bore interest at a rate of 1% per annum. Monthly principal and interest payments, less the amount of any potential forgiveness (discussed below), was to commence on November 7, 2020. The Company did not provide any collateral or guarantees for the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan. The Promissory Note provided for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company could prepay the principal of the PPP Loan at any time without incurring any prepayment charges.

All or a portion of the Loan may be forgiven by the SBA and lender upon application by the Company upon documentation of expenditures in accordance with the SBA requirements. Subsequent to the quarter ended June 30, 2020, the Company received approximately $136.2 million in net proceeds from warrant exercises, ATM usage, and the public offering of its common stock and decided to voluntarily extinguish the Promissory Note on July 21, 2020 by paying the outstanding principal and accrued interest in cash.

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Liabilities
6 Months Ended
Jun. 30, 2020
Other Liabilities Disclosure [Abstract]  
Other Long-Term Liabilities

8. Other Long-Term Liabilities

The Company’s other long-term liabilities are summarized as follows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Lease obligation, long-term portion (see Note 12)

 

$

1,344,779

 

 

$

1,484,679

 

Common stock warrant liability (see Note 10)

 

 

10,000

 

 

 

10,000

 

Economic conditional grants

 

 

250,000

 

 

 

250,000

 

Other

 

 

110,245

 

 

 

120,196

 

Total other long-term liabilities

 

$

1,715,024

 

 

$

1,864,875

 

 

XML 29 R15.htm IDEA: XBRL DOCUMENT v3.20.2
At-the-Market Offering
6 Months Ended
Jun. 30, 2020
Text Block [Abstract]  
At-the-Market Offering

9. At-the-Market Offering

On March 27, 2020, the Company entered into an Equity Distribution Agreement (the “Agreement”) with JMP Securities LLC, serving as placement agent (the “Placement Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $50.0 million (the “Shares”) through the Placement Agent (the “Offering”).

Any Shares offered and sold in the Offering will be issued pursuant to the Company’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on April 4, 2019, which was declared effective on April 12, 2019, the prospectus supplement relating to the Offering filed with the SEC on March 27, 2020 and any applicable additional prospectus supplements related to the Offering that form a part of the Registration Statement. The aggregate market value of Shares eligible for sale in the Offering and under the Equity Distribution Agreement will be subject to the limitations of General Instruction I.B.6 of Form S-3, to the extent required under such instruction. The Company offered Shares having an aggregate offering price of $18.9 million pursuant to the prospectus supplement filed with the SEC on March 27, 2020.

On June 1, 2020, the Company filed an amendment to the Agreement which amended the prospectus supplement dated March 27, 2020 to increase the aggregate offering price to $50.0 million.

As of June 30, 2020, the Company has sold 2,965,144 shares of Common Stock under the Agreement resulting in $22.8 million in net proceeds, leaving $26.3 million available to be sold under the amended Agreement. As of June 30, 2020, the Company recorded approximately $0.3 million of offering costs which offset the proceeds received from the shares sold through June 30, 2020 and recognized approximately $0.2 million of deferred offering costs which will offset future proceeds received under the Agreement.

Subsequent to the quarter ended June 30, 2020, the Company sold 234,856 shares of Common Stock under the Equity Distribution Agreement, that resulted in $2.5 million in net proceeds, leaving $23.7 million available to be sold under the amended Agreement.

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Warrants

10. Warrants

A summary of warrant activity during the six months ended June 30, 2020 is as follows:

 

 

 

 

 

 

 

 

 

Warrants outstanding, December 31, 2019

 

 

10,384,706

 

 

Warrants issued due to anti-dilution features triggered from Registered Direct Offering

 

 

1,358

 

 

Exercises

 

 

(8,235,779

)

 

Warrants outstanding, June 30, 2020

 

 

2,150,285

 

 

 

During the six months ended June 30, 2020, the Company received net proceeds of $31.3 million from warrant exercises.

 

For warrants classified as a liability, the following is a summary of the periodic changes in their fair value during the six months ended June 30, 2020:

 

Balance, December 31, 2019

 

$

10,000

 

Changes in fair value

 

 

 

Balance, June 30, 2020

 

$

10,000

 

 

Subsequent to the quarter ended June 30, 2020, there were additionally 1,983,110 warrants exercised resulting in net proceeds of $9.6 million and 1,630,436 pre-funded warrants issued in connection with a Public Offering (see Note 16).

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

11. Stock-Based Compensation

Stock Options

The Company’s stock option awards generally vest over four years and typically have a contractual life of ten years. At June 30, 2020, there was $1.9 million of unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted-average period of 3.06 years. During the six months ended June 30, 2020, the Company granted 520,500 stock options with a weighted average exercise price of $2.31 and per share weighted average grant date fair value of $1.83.

Information related to stock options outstanding at June 30, 2020 is as follows:

 

 

Number

of Stock

Options

 

 

Weighted-

average

Exercise

Price

 

 

Weighted-

average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding

 

 

1,477,153

 

 

$

3.65

 

 

 

5.96

 

 

$

12,804,940

 

Exercisable

 

 

416,022

 

 

$

5.97

 

 

 

5.69

 

 

$

3,097,502

 

Unvested

 

 

1,061,131

 

 

$

2.74

 

 

 

6.07

 

 

$

9,707,438

 

Restricted Stock

At June 30, 2020, the Company had unvested restricted stock of 195,161 shares with total unrecognized compensation expense of $0.7 million, which the Company expects to recognize over a weighted average period of approximately 2.42 years. During the six months ended June 30, 2020, the Company released 40,505 shares of common stock from restriction as a result of the vesting of restricted stock.

Restricted Stock Units

During the three months ended June 30, 2020, the Company granted 109,525 shares of restricted stock units which vest during the third quarter of 2020. At June 30, 2020, the Company had unvested restricted stock units of 109,525 shares with total unrecognized compensation expense of $0.9 million, which the Company expects to recognize over a weighted average period of approximately 0.25 years.

2019 Employee Stock Purchase Plan

Under the Employee Stock Purchase Plan (“ESPP”), employees purchased 38,809 shares for $56,739 during the six months ended June 30, 2020. During the three and six months ended June 30, 2020, the Company recognized compensation expense of $20,372 and $35,084, respectively.

Stock-based Compensation Expense

Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2020 and 2019 as follows:

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Research and development

 

$

77,939

 

 

$

92,060

 

 

$

106,939

 

 

$

168,684

 

General and administrative

 

 

252,571

 

 

 

197,712

 

 

 

438,492

 

 

 

528,802

 

Total

 

$

330,510

 

 

$

289,772

 

 

$

545,431

 

 

$

697,486

 

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Operating Leases
6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Operating Leases

12. Operating Leases

The Company rents office and laboratory space in the United States. The Company also leases office equipment under a non-cancellable equipment lease through December 2022. Rent expense during the three and six months ended June 30, 2020 under all of the Company’s operating leases was $86,295 and $173,894, respectively. Rent expense during the three and six months ended June 30, 2019 was $83,903 and $174,079, respectively. Rent expense includes short-term leases and variable lease costs that are not included in the lease obligation.

Short-term leases are leases having a term of twelve months or less. The Company recognizes short-term leases on a straight-line basis and does not record a related lease asset or liability for such leases.

The office space lease provides for increases in future minimum annual rental payments as defined in the lease agreements. The Company has determined the lease renewal option is not reasonably certain.

The cash paid for operating lease liabilities for the three and six months ended June 30, 2020 was $64,193 and $126,073, respectively.

Supplemental other information related to the operating leases balance sheet information is as follows:

 

 

June 30, 2020

 

Operating lease obligations

 

$

1,618,055

 

Operating lease right-of-use assets

 

$

662,074

 

Weighted-average remaining lease term

 

 

4.83

 

Weighted-average discount rate

 

 

8.0

%

Maturities of lease liabilities is as follows:

 

Year ending December 31,

 

 

 

 

The remainder of 2020

 

$

194,596

 

2021

 

 

393,542

 

2022

 

 

400,198

 

2023

 

 

407,054

 

2024

 

 

414,116

 

2025 and thereafter

 

 

138,831

 

Total lease payments

 

 

1,948,337

 

Less imputed interest

 

 

(330,282

)

Total

 

$

1,618,055

 

 

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes
6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

13. Income Taxes

 

In response to global pandemic associated with COVID-19, President Donald Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) on March 27, 2020. The CARES Act provided both stimulus measures and a number of tax provisions, including: temporary changes regarding the utilization and carry back of net operating losses, temporary changes to the prior and future limitations on interest deductions, technical corrections from prior tax legislation for tax depreciation of qualified improvement property, and certain refundable employee retention credits. The CARES Act enables the Company to file a refund claim to reflect a refund of its 2016 tax liability by carrying back its 2018, 2019 and 2020 losses to fully offset this liability. The refund claim attributable to the 2018 and 2019 tax years has been recorded as a discrete item in the income tax benefit for the three months ended March 31, 2020 of $2.9 million. In addition, the Company is currently estimating it will be able to carry back a portion of its current and forecasted 2020 net operating losses as of the end of the year and has included an estimate in its annual effective tax rate calculation as of June 30, 2020, which resulted in an additional income tax benefit of $1.0 million recorded during the six months ended June 30, 2020.

 

On June 12, 2020, the Comptroller of Maryland issued a report announcing that the state decoupled from the CARES Act loss carryback provisions for the 2020 year only, but indicated uncertainty as to whether the General Assembly would pass a measure to decouple from all years in the CARES Act and not process amended filings in the interim. As a result, an additional discrete item in the income tax benefit of $1.0 million was recognized for the three months ended June 30, 2020 related to the release of valuation allowance related to losses that could potentially be carried back to the 2016 tax year under current law.

Accordingly, the Company has recognized a total tax benefit of $4.8 million for the six months ended June 30, 2020.

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2020
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

14. Commitments and Contingencies

 

Spitfire Acquisition

As disclosed in Note 3, the Company is obligated to make payments of up to $80.0 million upon the achievement of specified worldwide net sales of all products developed using the technology acquired from Spitfire Pharma Inc. within ten years following the approval of a new drug application filed with the FDA.

PER.C6 License Agreement Expansion

On April 2, 2020, the Company entered into Amendment No. 3 to the Second Restated License Agreement (the “Amendment”), by and between the Company and Janssen Vaccines & Prevention B.V. (formerly known as Crucell Holland B.V.) (as amended by Amendment No. 1 to Second Restated License Agreement and Amendment No. 2 to Second Restated License Agreement, together with the Amendment, the “License Agreement”). Pursuant to the Amendment, the field of licenses granted to the Company for the use of the PER.C6 cell line under the License Agreement is expanded to cover COVID-19 caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), in addition to the existing licenses related to Bacillus anthracis and influenza virus. All capitalized terms not defined herein shall have the meanings assigned to them in the Amendment or the License Agreement, as applicable.

Pursuant to the Amendment, the Company agreed to pay certain additional development-based milestone payments through approval of licensed products by the FDA for the treatment or prevention of COVID-19, up to an aggregate amount of $1.2 million. The Company also agreed to pay royalty payments as a percentage of net sales of products to a royalty stacking reduction and minimum annual royalty payments, until the expiration of the term of the License Agreement, as amended. As of June 30, 2020, payments made under the License Agreement were de minimis.

Litigation

In December 2019, a complaint was filed by Dr. De-Chu Christopher Tang (“Plaintiff”) against the Company in U.S. District Court for the Eastern District of Texas. The Plaintiff amended the complaint in February 2020 to include Vipin K. Garg and David J. Drutz as defendants, in addition to the Company (Dr. Garg, Dr. Drutz, and the Company are collectively referred to as “Defendants”). In March 2020 the Defendants’ filed a motion to dismiss the complaint. The Court denied the motion without prejudice and allowed Plaintiff an opportunity to file an amended complaint. Plaintiff’s second amended complaint was filed on April 17, 2020, and Defendants filed a motion to dismiss that complaint on May 1, 2020. Plaintiff, who is representing himself, alleges five causes of action as follows: (1) Defendants’ alleged retention of Plaintiff’s lab notebooks; (2) alleged plagiarism based on publishing an article without naming Plaintiff as an author; (3) use of the Adhigh System, which Plaintiff alleges he developed; (4) allegations that Defendants manipulated the Company’s stock and caused a decrease in value; and (5) allegations that the Defendants “wast[ed] government grant money and poison[ed] science by leaving data to rot.” A hearing on Defendants’ motion to dismiss was held on May 20, 2020, and the motion is currently pending. The Company believes the allegations in the complaint are without merit and intends to vigorously defend the litigation. However, the outcome of this legal proceeding is uncertain at this time and the Company cannot reasonably estimate a range of loss, if any. Accordingly, the Company has not accrued any liability associated with this action. The Company is a party in various other contractual disputes, litigation, and potential claims arising in the ordinary course of business none of which are currently reasonably possible or probable of material loss.

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurement

15. Fair Value Measurement

The Company’s assets and liabilities measured at fair value on a recurring basis at June 30, 2020 consisted of the following:

 

 

Fair Value Measurement at June 30, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Recurring fair value measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

38,011,208

 

 

$

38,011,208

 

 

$

 

 

$

 

Short-term investments

 

 

15,484,402

 

 

 

 

 

 

15,484,402

 

 

 

 

Contingent consideration

 

 

16,390,000

 

 

 

 

 

 

 

 

 

16,390,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

The Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2019 consisted of the following:

 

 

Fair Value Measurement at December 31, 2019

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Recurring fair value measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

8,034,640

 

 

$

8,034,640

 

 

$

 

 

$

 

Short-term investments

 

 

28,277,386

 

 

 

 

 

 

28,277,386

 

 

 

 

Contingent consideration

 

 

2,750,000

 

 

 

 

 

 

 

 

 

2,750,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Assets recorded at fair value on a nonrecurring basis, such as property and equipment and intangible assets are recognized at fair value when they are impaired.

Cash equivalents and short-term investments have been initially valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third party pricing services or other market observable data. The pricing services utilize industry standard valuation models, including both income and market-based approaches and observable market inputs to determine value. Short-term investments had quoted prices at June 30, 2020 as shown below:

 

 

June 30, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificate of deposit

 

$

5,000,000

 

 

$

 

 

$

5,000,000

 

Financial and corporate debt securities

 

 

10,475,942

 

 

 

8,460

 

 

 

10,484,402

 

Total

 

$

15,475,942

 

 

$

8,460

 

 

$

15,484,402

 

 

The fair value of contingent payments classified as a liability was based on the regulatory milestones described in Note 3 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs. The following table is a reconciliation of the beginning and ending balance of contingent consideration liability:

Balance at December 31, 2019

$

2,750,000

 

Change in fair value

 

13,640,000

 

Balance at June 30, 2020

$

16,390,000

 

The assumptions used to estimate the fair value of contingent payments that are classified as a liability at June 30, 2020 include the following significant unobservable inputs:

Unobservable input

 

Value or Range

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

112.9%

 

 

112.9%

 

Risk-free interest rate

 

0.16%

 

 

0.16%

 

Cost of capital

 

30.0%

 

 

30.0%

 

Discount for lack of marketability

 

14%-22%

 

 

18.0%

 

Probability of payment

 

52%-83%

 

 

76%

 

Projected year of payment

 

2020-2022

 

 

2020

 

The Company’s warrant liability is valued using the Monte Carlo simulation valuation model. If applicable, the Company will recognize transfers into and out of levels within the fair value hierarchy at the end of the reporting period in which the actual event or change in circumstance occurs.

There were no transfers into and out of any of the levels of the fair value hierarchy as of June 30, 2020 and December 31, 2019.

XML 36 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

16. Subsequent Events

Public Offering

On July 16, 2020, the Company offered and sold (i) 3,369,564 shares of common stock, at a price to the public of $23.00 per share, and (ii) pre-funded warrants of the Company to purchase 1,630,436 shares of common stock at an exercise price equal to $0.0001 per share (the “Pre-Funded Warrants”), at a price to the public of $22.9999 per share of common stock underlying the Pre-Funded Warrants (equal to the public offering price per share of Common Stock, minus the exercise price of each Pre-Funded Warrant). The Pre-Funded Warrants are exercisable at any time, provided that each Pre-Funded Warrant holder will be prohibited from exercising such Pre-Funded Warrants into shares of the Company’s common stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of the Company’s common stock then issued and outstanding, which percentage may change at the holders’ election to any other number less than or equal to 19.99% upon 61 days’ notice to the Company. The gross proceeds of this offering were approximately $132.2 million, which includes the exercise in full of the underwriters’ option to purchase an additional 750,000 shares of common stock, before deducting underwriting discounts and commissions and offering expenses. The net proceeds of this offering were approximately $124.0 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

    

 

XML 37 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company’s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company’s estimates and assumptions and determined that there was not a material impact to the Company’s consolidated financial statements as of and for the three and six months ended June 30, 2020. However, actual results could differ from those estimates and there may be changes to the Company’s estimates in future periods.

New Accounting Pronouncements - Adopted

Recently Issued Accounting Pronouncements - Adopted

In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820) – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU No. 20218-13”). ASU No. 2018-13 was issued to modify and enhance the disclosure requirements for fair value measurements and eliminates certain disclosure requirements, such as the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy. This ASU adds new disclosure requirements for Level 3 measurements and is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company adopted this guidance effective January 1, 2020 which resulted in expanded disclosures in Note 15 regarding the Company’s recurring Level 3 fair value measurements.
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potential common shares issuable upon conversion, vesting or exercise of unvested restricted stock, common stock warrants, and stock options that are excluded from the computation of diluted weighted-average shares outstanding, as they are anti-dilutive, are as follows:

 

 

 

For the Three and Six Months Ended

 

 

For the Three and Six Months Ended

 

 

 

June 30, 2020

 

 

June 30, 2019

 

Common stock warrants

 

 

2,150,285

 

 

 

10,386,256

 

Common stock options

 

 

1,527,978

 

 

 

873,066

 

Restricted stock

 

 

304,686

 

 

 

323,262

 

XML 39 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets (Tables)
6 Months Ended
Jun. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets

The Company’s intangible assets consisted of the following:

 

 

 

June 30, 2020

 

 

 

Estimated

Useful

Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

825,659

 

 

$

(466,866

)

 

$

358,793

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(277,105

)

 

 

7,895

 

Total intangible assets subject to amortization

 

 

 

 

1,110,659

 

 

 

(743,971

)

 

 

366,688

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,529,626

 

 

$

(743,971

)

 

$

12,785,655

 

 

 

 

December 31, 2019

 

 

 

Estimated

Useful

Lives

 

Gross

Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Book

Value

 

Internally developed patents

 

6-10 years

 

$

746,323

 

 

$

(448,874

)

 

$

297,449

 

Acquired licenses

 

16-20 years

 

 

285,000

 

 

 

(269,221

)

 

 

15,779

 

Total intangible assets subject to amortization

 

 

 

 

1,031,323

 

 

 

(718,095

)

 

 

313,228

 

IPR&D assets

 

Indefinite

 

 

12,418,967

 

 

 

 

 

 

12,418,967

 

Total

 

 

 

$

13,450,290

 

 

$

(718,095

)

 

$

12,732,195

 

Schedule of Future Estimated Amortization Expense

As of June 30, 2020, future estimated amortization expense are as follows:

 

Years ending December 31,

 

 

 

 

The remainder of 2020

 

$

20,596

 

2021

 

 

27,687

 

2022

 

 

27,687

 

2023

 

 

27,687

 

2024

 

 

23,781

 

2025 and thereafter

 

 

239,250

 

Total

 

$

366,688

 

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2020
Payables And Accruals [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Accrued professional services

 

$

472,329

 

 

$

429,467

 

Accrued payroll and employee benefits

 

 

956,584

 

 

 

1,183,130

 

Accrued interest

 

 

10,240

 

 

 

5,047

 

Accrued research and development

 

 

2,343,629

 

 

 

1,966,111

 

Lease obligation, current portion (see Note 12)

 

 

273,276

 

 

 

259,449

 

Deferred revenue

 

 

33,691

 

 

 

61,563

 

Total accrued expenses

 

$

4,089,749

 

 

$

3,904,767

 

 

XML 41 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Liabilities (Tables)
6 Months Ended
Jun. 30, 2020
Other Liabilities Disclosure [Abstract]  
Summary of Other Long-Term Liabilities

The Company’s other long-term liabilities are summarized as follows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Lease obligation, long-term portion (see Note 12)

 

$

1,344,779

 

 

$

1,484,679

 

Common stock warrant liability (see Note 10)

 

 

10,000

 

 

 

10,000

 

Economic conditional grants

 

 

250,000

 

 

 

250,000

 

Other

 

 

110,245

 

 

 

120,196

 

Total other long-term liabilities

 

$

1,715,024

 

 

$

1,864,875

 

XML 42 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Summary of Warrant Activity

A summary of warrant activity during the six months ended June 30, 2020 is as follows:

 

 

 

 

 

 

 

 

 

Warrants outstanding, December 31, 2019

 

 

10,384,706

 

 

Warrants issued due to anti-dilution features triggered from Registered Direct Offering

 

 

1,358

 

 

Exercises

 

 

(8,235,779

)

 

Warrants outstanding, June 30, 2020

 

 

2,150,285

 

 

Summary of Periodic Changes in Fair Value of Warrant Liability

For warrants classified as a liability, the following is a summary of the periodic changes in their fair value during the six months ended June 30, 2020:

 

Balance, December 31, 2019

 

$

10,000

 

Changes in fair value

 

 

 

Balance, June 30, 2020

 

$

10,000

 

XML 43 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Information Related to Stock Options Outstanding

Information related to stock options outstanding at June 30, 2020 is as follows:

 

 

Number

of Stock

Options

 

 

Weighted-

average

Exercise

Price

 

 

Weighted-

average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding

 

 

1,477,153

 

 

$

3.65

 

 

 

5.96

 

 

$

12,804,940

 

Exercisable

 

 

416,022

 

 

$

5.97

 

 

 

5.69

 

 

$

3,097,502

 

Unvested

 

 

1,061,131

 

 

$

2.74

 

 

 

6.07

 

 

$

9,707,438

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is classified in the unaudited consolidated statements of operations and comprehensive loss for the three and six months ended June 30, 2020 and 2019 as follows:

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Research and development

 

$

77,939

 

 

$

92,060

 

 

$

106,939

 

 

$

168,684

 

General and administrative

 

 

252,571

 

 

 

197,712

 

 

 

438,492

 

 

 

528,802

 

Total

 

$

330,510

 

 

$

289,772

 

 

$

545,431

 

 

$

697,486

 

XML 44 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Operating Leases (Tables)
6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Summary of Supplemental other Information Related to Operating Leases Balance Sheet

Supplemental other information related to the operating leases balance sheet information is as follows:

 

 

June 30, 2020

 

Operating lease obligations

 

$

1,618,055

 

Operating lease right-of-use assets

 

$

662,074

 

Weighted-average remaining lease term

 

 

4.83

 

Weighted-average discount rate

 

 

8.0

%

Summary of Maturities of Lease Liabilities

Maturities of lease liabilities is as follows:

 

Year ending December 31,

 

 

 

 

The remainder of 2020

 

$

194,596

 

2021

 

 

393,542

 

2022

 

 

400,198

 

2023

 

 

407,054

 

2024

 

 

414,116

 

2025 and thereafter

 

 

138,831

 

Total lease payments

 

 

1,948,337

 

Less imputed interest

 

 

(330,282

)

Total

 

$

1,618,055

 

 

XML 45 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement (Tables)
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis

The Company’s assets and liabilities measured at fair value on a recurring basis at June 30, 2020 consisted of the following:

 

 

Fair Value Measurement at June 30, 2020

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Recurring fair value measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

38,011,208

 

 

$

38,011,208

 

 

$

 

 

$

 

Short-term investments

 

 

15,484,402

 

 

 

 

 

 

15,484,402

 

 

 

 

Contingent consideration

 

 

16,390,000

 

 

 

 

 

 

 

 

 

16,390,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

The Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2019 consisted of the following:

 

 

Fair Value Measurement at December 31, 2019

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Recurring fair value measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents - money market funds

 

$

8,034,640

 

 

$

8,034,640

 

 

$

 

 

$

 

Short-term investments

 

 

28,277,386

 

 

 

 

 

 

28,277,386

 

 

 

 

Contingent consideration

 

 

2,750,000

 

 

 

 

 

 

 

 

 

2,750,000

 

Warrant liability

 

 

10,000

 

 

 

 

 

 

 

 

 

10,000

 

Schedule of Short Term Investments Short-term investments had quoted prices at June 30, 2020 as shown below:

 

 

June 30, 2020

 

 

 

Amortized Cost

 

 

Unrealized Gain (Loss)

 

 

Market Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificate of deposit

 

$

5,000,000

 

 

$

 

 

$

5,000,000

 

Financial and corporate debt securities

 

 

10,475,942

 

 

 

8,460

 

 

 

10,484,402

 

Total

 

$

15,475,942

 

 

$

8,460

 

 

$

15,484,402

 

 

Schedule of Reconciliation of Beginning and Ending Balance of Contingent Consideration Liability

The fair value of contingent payments classified as a liability was based on the regulatory milestones described in Note 3 and estimated using the Monte Carlo simulation valuation model with Level 3 inputs. The following table is a reconciliation of the beginning and ending balance of contingent consideration liability:

Balance at December 31, 2019

$

2,750,000

 

Change in fair value

 

13,640,000

 

Balance at June 30, 2020

$

16,390,000

 

Summary of Assumptions Used to Estimate Fair Value of Contingent Payments

The assumptions used to estimate the fair value of contingent payments that are classified as a liability at June 30, 2020 include the following significant unobservable inputs:

Unobservable input

 

Value or Range

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

112.9%

 

 

112.9%

 

Risk-free interest rate

 

0.16%

 

 

0.16%

 

Cost of capital

 

30.0%

 

 

30.0%

 

Discount for lack of marketability

 

14%-22%

 

 

18.0%

 

Probability of payment

 

52%-83%

 

 

76%

 

Projected year of payment

 

2020-2022

 

 

2020

 

XML 46 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Contingent Consideration - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jul. 12, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Business Acquisition [Line Items]            
Estimated future contingent consideration   $ 16,390,000   $ 16,390,000   $ 2,750,000
Change in value of contingent consideration for acquired in-process research and development       13,640,000    
Spitfire Pharma, Inc. [Member]            
Business Acquisition [Line Items]            
Agreement date Jul. 08, 2019          
Unregistered shares of common stock 1,887,250          
Up-front consideration $ 5,000,000          
Transaction cost recorded within research and development expense     $ 600,000   $ 600,000  
Spitfire Pharma, Inc. [Member] | Investigational New Drug Application Milestone [Member]            
Business Acquisition [Line Items]            
Future contingent payments $ 5,000,000          
Future contingent payment term 60 days          
Number of consecutive trading days 20 days          
Condiseration amount $ 2.95          
Spitfire Pharma, Inc. [Member] | Investigational New Drug Application and Regulatory Milestones [Member]            
Business Acquisition [Line Items]            
Future contingent payments $ 3,000,000          
Future contingent payment term 60 days          
Number of consecutive trading days 20 days          
Condiseration amount $ 3.54          
Spitfire Pharma, Inc. [Member] | Sales Milestones [Member]            
Business Acquisition [Line Items]            
Future contingent payments $ 80,000,000          
License agreement term 10 years          
Spitfire Pharma, Inc. [Member] | Regulatory Milestones [Member]            
Business Acquisition [Line Items]            
Upfront consideration release at 3 months 50.00%          
Upfront consideration release at 6 months 50.00%          
Spitfire Pharma, Inc. [Member] | Regulatory Milestones [Member] | Monte Carlo Simulation [Member]            
Business Acquisition [Line Items]            
Estimated future contingent consideration $ 2,800,000 16,400,000   16,400,000    
Change in value of contingent consideration for acquired in-process research and development   $ 11,900,000   $ 13,600,000    
Spitfire Pharma, Inc. [Member] | Maximum [Member] | Common Stock [Member]            
Business Acquisition [Line Items]            
Future contingent payments $ 88,000,000          
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Common Stock Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 2,150,285 10,386,256 2,150,285 10,386,256
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 1,527,978 873,066 1,527,978 873,066
Restricted Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share 304,686 323,262 304,686 323,262
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Schedule Of Intangible Assets [Line Items]    
Intangible assets subject to amortization, Gross Carrying Value $ 1,110,659 $ 1,031,323
Intangible assets subject to amortization, Accumulated Amortization (743,971) (718,095)
Intangible assets subject to amortization, Net Book Value 366,688 313,228
Total intangible assets, Gross Carrying Value 13,529,626 13,450,290
Total intangible assets, Net Book Value 12,785,655 12,732,195
IPR&D [Member]    
Schedule Of Intangible Assets [Line Items]    
Total intangible assets, Gross Carrying Value 12,418,967 12,418,967
Total intangible assets, Net Book Value 12,418,967 12,418,967
Internally Developed Patents [Member]    
Schedule Of Intangible Assets [Line Items]    
Intangible assets subject to amortization, Gross Carrying Value 825,659 746,323
Intangible assets subject to amortization, Accumulated Amortization (466,866) (448,874)
Intangible assets subject to amortization, Net Book Value $ 358,793 $ 297,449
Internally Developed Patents [Member] | Minimum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 6 years 6 years
Internally Developed Patents [Member] | Maximum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 10 years 10 years
Acquired Licenses [Member]    
Schedule Of Intangible Assets [Line Items]    
Intangible assets subject to amortization, Gross Carrying Value $ 285,000 $ 285,000
Intangible assets subject to amortization, Accumulated Amortization (277,105) (269,221)
Intangible assets subject to amortization, Net Book Value $ 7,895 $ 15,779
Acquired Licenses [Member] | Minimum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 16 years 16 years
Acquired Licenses [Member] | Maximum [Member]    
Schedule Of Intangible Assets [Line Items]    
Estimated Useful Lives 20 years 20 years
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Research and Development [Member]        
Schedule Of Intangible Assets [Line Items]        
Amortization expense of intangible assets $ 12,025 $ 14,836 $ 25,876 $ 107,580
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets - Schedule of Future Estimated Amortization Expense (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]    
The remainder of 2020 $ 20,596  
2021 27,687  
2022 27,687  
2023 27,687  
2024 23,781  
2025 and thereafter 239,250  
Intangible assets subject to amortization, Net Book Value $ 366,688 $ 313,228
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Accrued Liabilities And Other Liabilities [Abstract]    
Accrued professional services $ 472,329 $ 429,467
Accrued payroll and employee benefits 956,584 1,183,130
Accrued interest 10,240 5,047
Accrued research and development 2,343,629 1,966,111
Lease obligation, current portion (see Note 12) 273,276 259,449
Deferred revenue 33,691 61,563
Total accrued expenses $ 4,089,749 $ 3,904,767
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Notes Payable - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended
Apr. 13, 2020
Aug. 11, 2020
Jun. 30, 2020
Registered Direct Offering, ATM Usage and Warrant Exercises [Member] | Subsequent Event [Member]      
Debt Instrument [Line Items]      
Net proceeds from issuance or sale of equity   $ 136,200,000  
Paycheck Protection Program Loan [Member]      
Debt Instrument [Line Items]      
Proceeds from unsecured loan $ 632,000    
Maturity date     Apr. 07, 2022
Interest rate     1.00%
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Other Liabilities Disclosure [Abstract]    
Lease obligation, long-term portion (see Note 12) $ 1,344,779 $ 1,484,679
Common stock warrant liability (see Note 10) 10,000 10,000
Economic conditional grants 250,000 250,000
Other 110,245 120,196
Total other long-term liabilities $ 1,715,024 $ 1,864,875
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.20.2
At-the-Market Offering - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 01, 2020
Mar. 27, 2020
Aug. 11, 2020
Jun. 30, 2020
Dec. 31, 2019
Changes In Equity And Comprehensive Income Line Items [Line Items]            
Common stock par value $ 0.0001       $ 0.0001 $ 0.0001
Net proceeds from offering         $ 22,780,729  
Equity Distribution Agreement [Member] | At-The-Market Offering [Member] | JMP Securities LLC [Member]            
Changes In Equity And Comprehensive Income Line Items [Line Items]            
Common stock par value     $ 0.0001      
Aggregate offering price   $ 50,000,000 $ 18,900,000      
Shares of common stock sold 2,965,144          
Net proceeds from offering $ 22,800,000          
Common stock available to be sold 26,300,000       26,300,000  
Deferred offering costs 200,000       $ 200,000  
Issuance costs $ 300,000          
Equity Distribution Agreement [Member] | At-The-Market Offering [Member] | JMP Securities LLC [Member] | Subsequent Event [Member]            
Changes In Equity And Comprehensive Income Line Items [Line Items]            
Shares of common stock sold       234,856    
Net proceeds from offering       $ 2,500,000    
Common stock available to be sold       $ 23,700,000    
Equity Distribution Agreement [Member] | At-The-Market Offering [Member] | JMP Securities LLC [Member] | Maximum [Member]            
Changes In Equity And Comprehensive Income Line Items [Line Items]            
Aggregate offering price     $ 50,000,000      
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants - Summary of Warrant Activity (Detail)
6 Months Ended
Jun. 30, 2020
shares
Equity [Abstract]  
Warrants outstanding, December 31, 2019 10,384,706
Warrants issued due to anti-dilution features triggered from Registered Direct Offering 1,358
Exercises (8,235,779)
Warrants outstanding, June 30, 2020 2,150,285
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants - Additional Information (Detail) - USD ($)
1 Months Ended 6 Months Ended
Aug. 11, 2020
Jun. 30, 2020
Jun. 30, 2019
Net proceeds from warrant exercises   $ 31,310,137 $ 30,324
Subsequent Event [Member]      
Net proceeds from warrant exercises $ 9,600,000    
Number of warrants exercised 1,983,110    
Public Offering [Member] | Subsequent Event [Member]      
Pre-funded warrants issued 1,630,436    
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants - Summary of Periodic Changes in Fair Value of Warrant Liability (Detail) - Level 3 [Member] - Common Stock Warrants [Member]
6 Months Ended
Jun. 30, 2020
USD ($)
Derivative Instruments And Hedging Activities Disclosures [Line Items]  
Balance, December 31, 2019 $ 10,000
Changes in fair value
Balance, June 30, 2020 $ 10,000
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Employees purchased, value   $ 56,739    
Stock-based compensation expense     $ 545,431 $ 697,486
2019 Employee Stock Purchase Plan [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Employees purchased, shares     38,809  
Employees purchased, value     $ 56,739  
Stock-based compensation expense $ 20,372   $ 35,084  
Stock Options [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Stock option vesting Period     4 years  
Stock option expiration Period     10 years  
Unrecognized compensation cost, stock options $ 1,900,000   $ 1,900,000  
Unrecognized stock-based compensation expense, period for recognition     3 years 21 days  
Number of Stock Options, Granted     520,500  
Stock options granted, weighted-average exercise price     $ 2.31  
Weighted-average grant date fair value of stock options granted     $ 1.83  
Restricted Stock [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Unrecognized stock-based compensation expense, period for recognition     2 years 5 months 1 day  
Unvested restricted stock, shares 195,161   195,161  
Unrecognized compensation expense $ 700,000   $ 700,000  
Common stock issued as result of vesting of restricted stock     40,505  
Restricted Stock Units [Member]        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Unrecognized stock-based compensation expense, period for recognition     3 months  
Unvested restricted stock, shares 109,525   109,525  
Unrecognized compensation expense $ 900,000   $ 900,000  
Shares granted 109,525      
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail)
6 Months Ended
Jun. 30, 2020
USD ($)
$ / shares
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Number of Stock Options, Outstanding | shares 1,477,153
Number of Stock Options, Exercisable | shares 416,022
Number of Stock Options, Unvested | shares 1,061,131
Weighted-average Exercise Price, Outstanding | $ / shares $ 3.65
Weighted-average Exercise Price, Exercisable | $ / shares 5.97
Weighted-average Exercise Price, Unvested | $ / shares $ 2.74
Weighted-average Remaining Contractual Term, Outstanding 5 years 11 months 15 days
Weighted-average Remaining Contractual Term, Exercisable 5 years 8 months 8 days
Weighted-average Remaining Contractual Term, Unvested 6 years 25 days
Aggregate Intrinsic Value, Outstanding | $ $ 12,804,940
Aggregate Intrinsic Value, Exercisable | $ 3,097,502
Aggregate Intrinsic Value, Unvested | $ $ 9,707,438
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Stock based compensation expense $ 330,510 $ 289,772 $ 545,431 $ 697,486
Research and Development [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Stock based compensation expense 77,939 92,060 106,939 168,684
General and Administrative [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Stock based compensation expense $ 252,571 $ 197,712 $ 438,492 $ 528,802
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Operating Leases - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Leases [Abstract]        
Non-cancellable lease maturity period     2022-12  
Operating lease rent expense $ 86,295 $ 83,903 $ 173,894 $ 174,079
Cash paid for operating lease liabilities $ 64,193   $ 126,073  
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Leases [Abstract]    
Operating lease obligations $ 1,618,055  
Operating lease right-of-use assets $ 662,074 $ 698,321
Weighted-average remaining lease term 4 years 9 months 29 days  
Weighted-average discount rate 8.00%  
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Operating Leases - Summary of Maturities of Lease Liabilities (Detail)
Jun. 30, 2020
USD ($)
Leases [Abstract]  
The remainder of 2020 $ 194,596
2021 393,542
2022 400,198
2023 407,054
2024 414,116
2025 and thereafter 138,831
Total lease payments 1,948,337
Less imputed interest (330,282)
Total $ 1,618,055
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Income Taxes - Additional Information (Detail)
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Income Tax Disclosure [Abstract]    
Income tax, refund claim $ 2,900,000 $ 2,900,000
Effective income tax rate reconciliation, additional discrete item of income tax benefit   1,000,000
Additional income tax benefit 1,000,000  
Income tax benefit $ 1,578,782 $ 4,824,661
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Millions
Apr. 02, 2020
Jul. 12, 2019
Janssen Vaccines and Prevention BV [Member] | License [Member] | Maximum [Member]    
Commitments And Contingencies [Line Items]    
Development-based milestone payments $ 1.2  
Spitfire Pharma, Inc. [Member] | Sales Milestones [Member]    
Commitments And Contingencies [Line Items]    
Future contingent payments   $ 80.0
License agreement term   10 years
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Short-term investments $ 15,484,402 $ 28,277,386
Fair Value, Measurements, Recurring [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Short-term investments 15,484,402 28,277,386
Contingent consideration 16,390,000 2,750,000
Warrant liability 10,000 10,000
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Short-term investments 15,484,402 28,277,386
Fair Value, Measurements, Recurring [Member] | Level 3 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Contingent consideration 16,390,000 2,750,000
Warrant liability 10,000 10,000
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cash equivalents 38,011,208 8,034,640
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Level 1 [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Cash equivalents $ 38,011,208 $ 8,034,640
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement - Schedule of Short Term Investments (Detail)
Jun. 30, 2020
USD ($)
Schedule Of Available For Sale Securities [Line Items]  
Amortized Cost $ 15,475,942
Unrealized Gain (Loss) 8,460
Market Value 15,484,402
Certificate of Deposit [Member]  
Schedule Of Available For Sale Securities [Line Items]  
Amortized Cost 5,000,000
Market Value 5,000,000
Financial and Corporate Debt Securities [Member]  
Schedule Of Available For Sale Securities [Line Items]  
Amortized Cost 10,475,942
Unrealized Gain (Loss) 8,460
Market Value $ 10,484,402
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement - Schedule of Reconciliation of Beginning and Ending Balance of Contingent Consideration Liability (Detail) - Contingent Consideration Liability [Member]
6 Months Ended
Jun. 30, 2020
USD ($)
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Balance at December 31, 2019 $ 2,750,000
Change in fair value 13,640,000
Balance at June 30, 2020 $ 16,390,000
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) - Level 3 [Member]
6 Months Ended
Jun. 30, 2020
Expected Volatility [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 1.129
Expected Volatility [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 1.129
Risk-free Interest Rate [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.0016
Risk-free Interest Rate [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.0016
Cost of Capital [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.300
Cost of Capital [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.300
Discount for Lack of Marketability [Member] | Minimum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.14
Discount for Lack of Marketability [Member] | Maximum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.22
Discount for Lack of Marketability [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.180
Probability of Payment [Member] | Minimum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.52
Probability of Payment [Member] | Maximum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.83
Probability of Payment [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 0.76
Projected Year of Payment [Member] | Minimum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 2020
Projected Year of Payment [Member] | Maximum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 2022
Projected Year of Payment [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Assumptions used to estimate fair value of contingent payments 2020
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurement - Additional Information (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Fair Value Disclosures [Abstract]    
Fair value transfers, Level 1 to Level 2 assets $ 0 $ 0
Fair value transfers, Level 2 to Level 1 assets 0 0
Fair value transfers, Level 1 to Level 2 liabilities 0 0
Fair value transfers, Level 2 to Level 1 liabilities $ 0 $ 0
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events - Additional Information (Detail) - USD ($)
6 Months Ended
Jul. 16, 2020
Jun. 30, 2020
Subsequent Event [Line Items]    
Proceeds from issuance of common stock in at the market offering, net of offering costs   $ 22,780,729
Subsequent Event [Member] | Public Offering [Member]    
Subsequent Event [Line Items]    
Gross proceeds from offering including exercise of underwriter's option $ 132,200,000  
Subsequent Event [Member] | Public Offering [Member] | Pre-Funded Warrants [Member]    
Subsequent Event [Line Items]    
Number of securities called by warrants or rights 1,630,436  
Exercise price of warrants or rights $ 0.0001  
Purchase price of warrants issued $ 22.9999  
Ownership percentage on exercise of warrants without notice, minimum 4.99%  
Ownership percentage on exercise of warrants with notice, maximum 19.99%  
Notice period to increase ownership percentage on exercise of warrants 61 days  
Subsequent Event [Member] | Public Offering [Member] | Common Stock [Member]    
Subsequent Event [Line Items]    
Shares of common stock sold 3,369,564  
Public offering price, per share $ 23.00  
Subsequent Event [Member] | Over-Allotment Option [Member] | Common Stock [Member]    
Subsequent Event [Line Items]    
Shares of common stock sold 750,000  
Proceeds from issuance of common stock in at the market offering, net of offering costs $ 124,000,000  
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 73 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 169 337 1 false 53 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.altimmune.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.altimmune.com/20200630/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.altimmune.com/20200630/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.altimmune.com/20200630/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of changes in Stockholders' Equity Sheet http://www.altimmune.com/20200630/taxonomy/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity Consolidated Statements of changes in Stockholders' Equity Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.altimmune.com/20200630/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100060 - Disclosure - Nature of Business and Basis of Presentation Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 7 false false R8.htm 100070 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Contingent Consideration Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureContingentConsideration Contingent Consideration Notes 9 false false R10.htm 100090 - Disclosure - Net Loss Per Share Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 10 false false R11.htm 100100 - Disclosure - Intangible Assets Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIntangibleAssets Intangible Assets Notes 11 false false R12.htm 100110 - Disclosure - Accrued Expenses Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses Notes 12 false false R13.htm 100120 - Disclosure - Notes Payable Notes http://www.altimmune.com/20200630/taxonomy/role/DisclosureNotesPayable Notes Payable Notes 13 false false R14.htm 100130 - Disclosure - Other Long-Term Liabilities Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOtherLongTermLiabilities Other Long-Term Liabilities Notes 14 false false R15.htm 100140 - Disclosure - At-the-Market Offering Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureAtMarketOffering At-the-Market Offering Notes 15 false false R16.htm 100150 - Disclosure - Warrants Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureWarrants Warrants Notes 16 false false R17.htm 100160 - Disclosure - Stock-Based Compensation Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 17 false false R18.htm 100170 - Disclosure - Operating Leases Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOperatingLeases Operating Leases Notes 18 false false R19.htm 100180 - Disclosure - Income Taxes Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 100190 - Disclosure - Commitments and Contingencies Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 100200 - Disclosure - Fair Value Measurement Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurement Fair Value Measurement Notes 21 false false R22.htm 100210 - Disclosure - Subsequent Events Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 22 false false R23.htm 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.altimmune.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 100230 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureNetLossPerShare 24 false false R25.htm 100240 - Disclosure - Intangible Assets (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureIntangibleAssets 25 false false R26.htm 100250 - Disclosure - Accrued Expenses (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureAccruedExpenses 26 false false R27.htm 100260 - Disclosure - Other Long-Term Liabilities (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOtherLongTermLiabilitiesTables Other Long-Term Liabilities (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureOtherLongTermLiabilities 27 false false R28.htm 100270 - Disclosure - Warrants (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureWarrantsTables Warrants (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureWarrants 28 false false R29.htm 100280 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureStockBasedCompensation 29 false false R30.htm 100290 - Disclosure - Operating Leases (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOperatingLeasesTables Operating Leases (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureOperatingLeases 30 false false R31.htm 100300 - Disclosure - Fair Value Measurement (Tables) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurementTables Fair Value Measurement (Tables) Tables http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurement 31 false false R32.htm 100310 - Disclosure - Contingent Consideration - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureContingentConsiderationAdditionalInformationDetail Contingent Consideration - Additional Information (Detail) Details 32 false false R33.htm 100320 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetail Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Detail) Details 33 false false R34.htm 100330 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIntangibleAssetsScheduleOfIntangibleAssetsDetail Intangible Assets - Schedule of Intangible Assets (Detail) Details 34 false false R35.htm 100340 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail Intangible Assets - Additional Information (Detail) Details 35 false false R36.htm 100350 - Disclosure - Intangible Assets - Schedule of Future Estimated Amortization Expense (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIntangibleAssetsScheduleOfFutureEstimatedAmortizationExpenseDetail Intangible Assets - Schedule of Future Estimated Amortization Expense (Detail) Details 36 false false R37.htm 100360 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail Accrued Expenses - Schedule of Accrued Expenses and Other Current Liabilities (Detail) Details 37 false false R38.htm 100370 - Disclosure - Notes Payable - Additional Information (Detail) Notes http://www.altimmune.com/20200630/taxonomy/role/DisclosureNotesPayableAdditionalInformationDetail Notes Payable - Additional Information (Detail) Details 38 false false R39.htm 100380 - Disclosure - Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOtherLongTermLiabilitiesSummaryOfOtherLongTermLiabilitiesDetail Other Long-Term Liabilities - Summary of Other Long-Term Liabilities (Detail) Details 39 false false R40.htm 100390 - Disclosure - At-the-Market Offering - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureAtMarketOfferingAdditionalInformationDetail At-the-Market Offering - Additional Information (Detail) Details 40 false false R41.htm 100400 - Disclosure - Warrants - Summary of Warrant Activity (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantActivityDetail Warrants - Summary of Warrant Activity (Detail) Details 41 false false R42.htm 100410 - Disclosure - Warrants - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetail Warrants - Additional Information (Detail) Details 42 false false R43.htm 100420 - Disclosure - Warrants - Summary of Periodic Changes in Fair Value of Warrant Liability (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfPeriodicChangesInFairValueOfWarrantLiabilityDetail Warrants - Summary of Periodic Changes in Fair Value of Warrant Liability (Detail) Details 43 false false R44.htm 100430 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 44 false false R45.htm 100440 - Disclosure - Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfInformationRelatedToStockOptionsOutstandingDetail Stock-Based Compensation - Schedule of Information Related to Stock Options Outstanding (Detail) Details 45 false false R46.htm 100450 - Disclosure - Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetail Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Detail) Details 46 false false R47.htm 100460 - Disclosure - Operating Leases - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOperatingLeasesAdditionalInformationDetail Operating Leases - Additional Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOperatingLeasesSummaryOfSupplementalOtherInformationRelatedToOperatingLeasesBalanceSheetDetail Operating Leases - Summary of Supplemental other Information Related to Operating Leases Balance Sheet (Detail) Details 48 false false R49.htm 100480 - Disclosure - Operating Leases - Summary of Maturities of Lease Liabilities (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureOperatingLeasesSummaryOfMaturitiesOfLeaseLiabilitiesDetail Operating Leases - Summary of Maturities of Lease Liabilities (Detail) Details 49 false false R50.htm 100500 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 50 false false R51.htm 100510 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 51 false false R52.htm 100520 - Disclosure - Fair Value Measurement - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurementScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail Fair Value Measurement - Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) Details 52 false false R53.htm 100530 - Disclosure - Fair Value Measurement - Schedule of Short Term Investments (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurementScheduleOfShortTermInvestmentsDetail Fair Value Measurement - Schedule of Short Term Investments (Detail) Details 53 false false R54.htm 100540 - Disclosure - Fair Value Measurement - Schedule of Reconciliation of Beginning and Ending Balance of Contingent Consideration Liability (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurementScheduleOfReconciliationOfBeginningAndEndingBalanceOfContingentConsiderationLiabilityDetail Fair Value Measurement - Schedule of Reconciliation of Beginning and Ending Balance of Contingent Consideration Liability (Detail) Details 54 false false R55.htm 100550 - Disclosure - Fair Value Measurement - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurementSummaryOfAssumptionsUsedToEstimateFairValueOfContingentPaymentsDetail Fair Value Measurement - Summary of Assumptions Used to Estimate Fair Value of Contingent Payments (Detail) Details 55 false false R56.htm 100560 - Disclosure - Fair Value Measurement - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureFairValueMeasurementAdditionalInformationDetail Fair Value Measurement - Additional Information (Detail) Details 56 false false R57.htm 100570 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.altimmune.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 57 false false All Reports Book All Reports alt-20200630.xml alt-20200630.xsd alt-20200630_cal.xml alt-20200630_def.xml alt-20200630_lab.xml alt-20200630_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 77 0001564590-20-039314-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-039314-xbrl.zip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